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form a chromatin loop, causing recruitment and phosphorylation of RNA polymerase II. ZF-Ldb1 proteins
were inactive in primary erythroblasts with LCR deletion, demonstrating that their activities depend on long-
range interactions. Our findings establish Ldb1 as critical effector of GATA1-mediated loop formation and
indicate that chromatin looping causally underlies gene regulation. Our studies have for the first time forced
long-range chromatin looping at a native locus and provide a novel approach to manipulate gene activity in
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ABSTRACT 
 
HIGHER-ORDER CHROMATIN ORGANIZATION  
IN HEMATOPOIETIC TRANSCRIPTION 
Wulan Deng 
Gerd A. Blobel 
Coordinated transcriptional networks underlie complex developmental processes. 
Transcription factors play central roles in such networks by binding to core promoters 
and regulatory elements and thereby controlling transcription activities and chromatin 
states in the genome. GATA1 is a hematopoietic transcription factor that controls 
multiple hematopoietic lineages by activating and repressing gene expression, yet the in 
vivo mechanisms that specify these opposing activities are unknown. By examining the 
composition of GATA1 associated protein complexes in a genetic complementary 
erythroid cell system as well as through the use of tiling arrays, we found that a multi-
protein complex containing SCL/TAL1, LMO2, Ldb1, and E2A (the SCL complex  
thereafter) is present at most sites where GATA1 functions as an activator but depleted at 
most repressive GATA1 sites. Functional interference of the SCL complex selectively 
impairs activation but not repression by GATA1. These results identify the SCL complex 
as a critical and consistent determinant of positive GATA1 activity. The SCL complex 
and GATA1 co-occupy the active β-globin promoter and the distant locus control region 
(LCR), which are juxtaposed into close proximity by chromatin looping. The physical 
interaction of genes with their cis-regulatory elements are commonly observed in the 
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metazoan genome, however, the molecular architecture of loop formation and the cause-
effect relationship between transcription and looping remain unclear. A few lines of 
evidence suggest Ldb1, one component of the SCL complex, mediates GATA1 induced 
chromatin looping. To manipulate chromatin loop formation, we employed artificial zinc 
fingers (ZF) to tether Ldb1 to the β-globin promoter in GATA1 null erythroblasts in 
which the β-globin locus is relaxed and inactive. Remarkably, targeting Ldb1 or only its 
self-association domain to the β-globin promoter substantially activated β-globin 
transcription in the absence of GATA1. Promoter-tethered Ldb1 interacted with 
endogenous Ldb1 complexes at the LCR to form a chromatin loop, causing recruitment 
and phosphorylation of RNA polymerase II. ZF-Ldb1 proteins were inactive in primary 
erythroblasts with LCR deletion, demonstrating that their activities depend on long-range 
interactions. Our findings establish Ldb1 as critical effector of GATA1-mediated loop 
formation and indicate that chromatin looping causally underlies gene regulation. Our 
studies have for the first time forced long-range chromatin looping at a native locus and 
provide a novel approach to manipulate gene activity in cells. 
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CHAPTER 1: INTRODUCTION 
 
The identity and function of a cell are determined by its specific transcription 
program. Transcription is a highly regulated process that involves the interaction and 
combinatorial action of tissue-specific transcription factors and basal transcription 
machinery on chromatin, selectively activating or repressing specific groups of genes. A 
fundamental question remains: how do numerous transcription factors coordinate to 
specify transcription activities of their target genes?  Moreover, in metazoans, many 
transcription factors regulate gene expression by binding to distal cis-regulatory elements 
that can be spaced kilobases and megabases from the promoters. These distant elements 
are found to physically interact with their target genes with intervening chromatin looped 
out, forming so called “chromatin loop” structures. Despite that many factors are known 
to be involved and/or required for chromatin loop formation, the molecular forces that 
configure the chromatin fiber and importantly the cause-effect relationship between 
chromatin looping dynamics and transcription regulation are still enigmatic. This thesis 
probes these important questions by studying the transcriptional network of 
hematopoietic cells and investigating the molecular mechanisms of chromatin looping at 
a model locus, the β-globin locus.?
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1.1: Transcriptional Network of Hematopoiesis 
1.1.1: Hematopoietic development 
Hematopoiesis is the process by which blood cells arise from the pluripotent 
hematopoietic stem cells (HSC). It is a complex, multistage process that begins during 
embryonic development and continues throughout adulthood to sustain all lineages of 
blood cells. In mammals, hematopoiesis occurs first in the yolk sac blood islands, then 
the aorta-gonad mesonephros region and the placenta (known as primitive hematopoiesis) 
and later in the fetal liver and finally the bone marrow (know as definitive hematopoiesis) 
(for review, see (Orkin and Zon, 2008); Figure 1.1). At these sites, instructed by extrinsic 
signals, HSCs develop into multipotential progenitors, committed precursors, and 
eventually differentiate into specific hematopoietic lineages. For example, red blood cells 
and megakaryocytes arise from a common precursor, the megakaryocyte-erythroid 
progenitor. This process is orchestrated by a number of lineage-restricted transcription 
regulators, including GATA1, FOG1, SCL/TAL1, KLF1/EKLF and Gfi-1b, together with 
various ubiquitously expressed transcriptional factors (for review, see (Hattangadi et al., 
2011)). These regulators are found in numerous combinations of multi-protein complexes 
and are essential to ensure normal erythroid commitment and maturation, i.e. to activate 
lineage-specific genes and to simultaneously suppress genes associated with immature 
stages and alternative lineages. 
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Figure 1.1. Murine hematopoiesis (From (Orkin and Zon, 2008)). During 
development hematopoiesis occurs sequentially at indicated sites (A) and favors the 
production of specific blood lineages (B).   
 
1.1.2: GATA transcription factors 
(i). GATA1 
GATA factors comprise a family of zinc finger transcription factors controlling 
diverse developmental processes in vertebrates and invertebrates (Patient and McGhee, 
2002). GATA proteins directly bind to the WGATAR consensus sequence and interact 
with various co-factors via its two highly conserved zinc finger domains. GATA1, the 
founding member of the GATA family, is essential for the normal development of 
4 
 
erythroid cells, megakaryocytes, mast cells and eosinophil granulocytes (Crispino, 2005). 
Loss of GATA1 in mice leads to embryonic death at around day 11.5 due to failure to 
produce mature erythroid cells (Fujiwara et al., 1996). Both a block in differentiation and 
apoptosis account for the observed lack of mature erythroid cells in GATA1 null mice 
(Weiss and Orkin, 1995; Weiss et al., 1997). Tissue-specific loss of GATA1 in mice 
leads to an arrest in megakaryocytic maturation associated with decreased platelet 
production and deregulated proliferation of immature megakaryocytes (Shivdasani et al., 
1997). Importantly, mutations or rearrangements in the human GATA1 gene contribute to 
various hematological disorders including leukemias and congenital anemias. For 
example, point mutations in the N-terminal zinc finger of GATA1 are found in patients 
with X-linked anemia and thrombocytopenia (Nichols et al., 2000). Moreover, mutations 
in the GATA1 gene that lead to production of an N-terminally truncated GATA1 protein 
contribute to megakaryoblastic leukemias in patients with Down Syndrome (Wechsler et 
al., 2002). These disease-causing mutations of GATA1 interfere with the interaction of 
GATA1 with its co-factors, underlining the importance of co-factors in determining 
GATA1 activity. 
Our understanding of the mechanisms of GATA1 function has been greatly aided by 
the use of the GATA1 null erythroid cell line G1E (Weiss et al., 1997). G1E cells were 
derived from GATA1 null ES cells and are arrested at the immature proerythroblast stage 
due to the absence of GATA1. GATA1 fused to the ligand binding domain of the 
estrogen receptor (GATA1-ER) was introduced to G1E cells (G1E-ER4 cells), providing 
a convenient inducible system to study GATA1 function in erythroid differentiation. 
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Treatment with estradiol or tamoxifen leads to activation of GATA1 protein and 
subsequently completion of erythroid differentiation as reflected by synchronous cell 
cycle arrest, expression of erythroid genes, including the α- and β-globin genes, and 
repression of genes associated with immature stages and proliferation (Weiss et al., 
1997). Whole genome expression studies have revealed that differentiating G1E cells 
mimic the normal erythroid maturation program with high fidelity (Cheng et al., 2009; 
Fujiwara et al., 2009; Welch et al., 2004), therefore G1E cells provide a physiologically 
relevant assay for the functions of GATA1 in its natural environment.  
(ii). GATA2 and GATA switch 
The dual zinc finger domains of GATA factors are highly conserved among the six 
mammalian proteins, while the N and C termini are divergent. GATA2, another essential 
regulator of hematopoiesis, binds to the WGATAR motif and shares many chromatin 
binding sites with GATA1. Although GATA1 and GATA2 share many co-factors 
including FOG1 and the SCL complex, they display different and often opposing 
activities at particular target genes. In contrast to GATA1 which drives hematopoietic 
differentiation, GATA2 is closely linked to the emergence and maintenance of 
hematopoietic stem cells and multiple hematopoietic progenitors (Rodrigues et al., 2012). 
During erythroid development, GATA1 directly represses Gata2 transcription, and 
GATA1 displaces GATA2 from chromatin of its target genes, a process termed “GATA 
switch” (Bresnick et al., 2010). Such switches occur at numerous loci and correlate with 
alteration of transcription activity. The divergent N and C termini confer differential 
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stabilities to GATA1 and GATA2, with GATA1 being more stable than GATA2, 
providing a possible mechanism to ensure efficient GATA switches (Lurie et al., 2008).  
1.1.3: GATA1 co-factors 
GATA1 associates with many tissue-specific or ubiquitously-expressed transcription 
factors through direct interaction or as components of multi-protein complexes 
(Rodriguez et al., 2005). The challenge has been to sort out which of these interactions 
are functionally significant, determine the mechanisms by which they modulate GATA1 
activity, and understand how they relate to one another. 
(i). FOG1/NuRD 
Many co-factors associate with GATA1 and modulate its activity (Rodriguez et al., 
2005). FOG1 is the first known tissue-specific GATA1 co-factor. It binds to the N-
terminal zinc finger of GATA1 (Tsang et al., 1997). FOG1 is recruited to virtually all 
sites occupied by GATA1 and is essential for the differentiation of multiple GATA1-
regulated hematopoietic lineages. Physical interaction of GATA1 and FOG1 is required 
for GATA1 chromatin occupancy at a subset of its target sites (Letting et al., 2004; Pal et 
al., 2004), and for the long-range chromatin interaction of the LCR and the active 
promoter at the β-globin locus (Vakoc et al., 2005). FOG1 interacts tightly with the 
histone deacetylase complex NuRD, providing a mechanism for GATA1-dependent gene 
repression (Hong et al., 2005). However, ChIP studies found that the NuRD complex is 
present at both active and repressed genes (Miccio et al., 2010), leaving open the 
possibility that other mechanisms may determine the repressive activity of GATA1. 
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Nevertheless, interaction of FOG1 and NuRD is important since disruption of FOG1 
binding to NuRD leads to defects in erythroid and megakaryocyte development in mice 
(Miccio et al., 2010).  
(ii). CBP/Brd3 
GATA1 also interacts directly with the lysine acetyltransferase CBP (Blobel et al., 
1998). GATA1 is acetylated by CBP at two conserved lysine clusters C-terminal to its 
two zinc finger domains in vitro and in cells (Boyes et al., 1998; Hung et al., 1999). 
Acetylation of GATA1 is required for its chromatin occupancy but dispensable for its 
nuclear localization, protein stability and DNA binding (Boyes et al., 1998; Lamonica et 
al., 2006). Bromodomain-containing protein 3, Brd3, was recently identified as a novel 
co-factor of GATA1, recognizing acetylated lysine residues of GATA1 via its first 
bromodomain (Lamonica et al., 2011). Brd3 is recruited to both active and repressed 
GATA1 targets, regardless of the histone acetylation state. Its interaction with acetylated 
GATA1 is important for chromatin association of GATA1 and erythroid maturation 
(Lamonica et al., 2011).  
 (iii). SCL/LMO2/Ldb1/E2A/GATA multi-protein complex  
A protein complex composed of SCL, LMO2, Ldb1, and E2A can physically and 
functionally associate with GATA factors in normal and leukemic blood cells (Lecuyer 
and Hoang, 2004) (Figure 1.2). LMO2 functions as a scaffold protein bridging the two 
DNA-binding proteins, SCL and GATA, via direct interaction (Goardon et al., 2006; 
Osada et al., 1995; Schuh et al., 2005; Wadman et al., 1997). In erythroid cells, GATA1 
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and SCL synergistically transactivate transcription at many erythroid-specific genes. 
Tandem GATA-E-box elements separated by 9 to 12 base pairs  were found at their 
binding sites at some critical erythroid genes including Klf1 (Anderson et al., 1998), 
Gata1 (Nishimura et al., 2000; Vyas et al., 1999), p4.2 (Xu et al., 2003) and GPA (Lahlil 
et al., 2004).  
                                        
Figure 1.2 Schematic model of the SCL/GATA complex (from (El Omari et al., 
2011)). 
 
SCL is an essential transcriptional regulator in normal hematopoiesis. It is the most 
frequent target of chromosomal rearrangement in children with T-cell acute 
lymphoblastic leukemia (T-ALL) (Begley and Green, 1999). SCL null ES cells fail to 
contribute to all hematopoietic lineages in adult chimeric mice, and SCL null mice die 
during embryogenesis with a complete absence of yolk sac blood, indicating that SCL 
plays an essential role in early hematopoiesis (Porcher et al., 1996; Robb et al., 1995; 
Shivdasani et al., 1995). Conditional knockout experiments, which bypass the embryonic 
lethality, have demonstrated that SCL is also vital for erythroid and megakaryocytic 
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differentiation (Mikkola et al., 2003). Like other members of the bHLH family, SCL 
heterodimerizes with E proteins such as E2A (E12 and E47) through HLH domain, and 
binds DNA in the major groove on consensus E-box motifs CANNTG via residues in 
their basic (b) domain. Within the basic domain, three highly conserved residues RER 
(195-197) are required for DNA binding and substitution of these three residues by 
alanines disrupts DNA binding of SCL (Porcher et al., 1999).  Notably, the DNA-binding 
activity of SCL is dispensable for specification of primitive and definitive hematopoiesis, 
but is required for complete erythroid maturation (Kassouf et al., 2008; Porcher et al., 
1999). Strikingly, a small fraction of mice homozygous for a DNA-binding-defective 
form of SCL (SCL-RER) survived to adulthood (Kassouf et al., 2008). Like most 
transcriptional regulators, SCL can function as an activator or repressor. The latter 
function is controlled at least in part through interaction with the transcriptional co-
repressor ETO-2 (Goardon et al., 2006; Meier et al., 2006; Schuh et al., 2005).  
Ldb, LIM-domain binding protein, is a family of evolutionarily conserved nuclear 
factors that are widely expressed throughout embryonic and adult tissues (Matthews and 
Visvader, 2003). The founding member Ldb1 was originally identified as a co-factor of 
LIM-homeodomain and LIM-only (LMO) proteins that have fundamental roles in 
development. Ldb1 interacts with the LIM-containing protein through its LIM-interaction 
domain (LID). Ldb1 can self-associate to form dimer or oligomers (Cross et al., 2010), 
which might underlie its functions in transcription regulation (see below).  
Ldb1 functions as a multi-adaptor protein mediating interactions between many 
different classes of lineage-specific transcription factors and thus plays important roles in 
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cell fate determination and differentiation (Matthews and Visvader, 2003). It is essential 
for normal secondary axis formation in Xenopus embryos, and for normal segmentation, 
neuronal axon guidance and wing morphology in Drosophila. Deletion of Ldb1 in mice 
causes severe patterning defects during gastrulation and mutant embryos die around E9.5 
(Mukhopadhyay et al., 2003), indicating Ldb1 plays evolutionarily conserved roles in 
development. In hematopoietic cells, Ldb1 is found to mostly function in the SCL/GATA 
complex (this study and (Li et al., 2011)). There is a critical and continuous requirement 
for Ldb1 in hematopoiesis. It is required for the maintenance of both fetal and adult 
mouse HSCs, as well as for the commitment and differentiation of erythroid cells and 
megakaryocytes.  
 
1.2: Higher-order Chromatin Organization  
1.2.1: Features of genome organization 
The eukaryotic genome is organized in the cell nucleus to fit the spatial constraints 
and at the same time allow for access of regulatory factors to the underlying DNA 
sequences. The first layer of organization involves the winding of 147 base pairs of DNA 
around the histone octamer to form a nucleosome, the crystal structure of which has been 
solved (Luger et al., 1997). A string of nucleosomes without any further folding presents 
itself as an 11 nm fiber under the electron microscope. The next layer of packaging 
involves the helical stacking of nucleosomes to form a chromatin fiber with a diameter of 
~30 nm, of which the structural organization is beginning to be unraveled (Robinson and 
11 
 
Rhodes, 2006). The architecture of the chromatin fiber at the next higher level is much 
more obscure. Direct visualization by microscopy and DNA fluorescence in situ 
hybridization (FISH) suggests that individual chromosomes occupy a defined volume and 
territory of the nucleus but can overlap with their immediate neighbors and contact even 
farther regions in the nucleus (Cremer et al., 2006). Recent genomic studies combining 
chromosome conformation capture (3C) with high-throughput sequencing have been used 
to construct comprehensive maps of spatial proximity within mammalian genomes 
(Dixon et al., 2012; Lieberman-Aiden et al., 2009). These maps confirmed the presence 
of chromosome territories and identified thousands of megabase-sized local chromatin 
interaction domains with distinct boundaries, termed as “topological domains” (Dixon et 
al., 2012; Lieberman-Aiden et al., 2009). Surprisingly, these domains are largely 
unchanged across different cell types regardless of cell differentiation states and are 
highly conserved across mouse and human ES cells. These findings suggest that 
topological domains may present a general folding principle of chromosomes that might 
be determined by intrinsic properties of the genome and can be largely inherited 
throughout cell cycle and cell differentiation. The insulator binding protein CTCF, active 
housekeeping genes, transfer RNAs and SINE retrotransposons were found enriched at 
the boundaries of topological domains, indicating that these factors may have a role in 
establishing such genomic organization (Dixon et al., 2012; Lieberman-Aiden et al., 
2009). However, it is still to be further investigated whether these observations hold true 
for a broader spectrum of cell types.  
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1.2.2: Mechanisms of remote gene activation   
Enhancers were originally identified as cis-acting DNA sequences that increase 
transcription in a manner that is independent of their orientation and distance relative to 
the transcription start site (Blackwood and Kadonaga, 1998). In metazoan cells, gene 
activity is often under control of distal enhancers that can be up to hundreds of kilobases 
from the gene promoter. A key question is how enhancer elements communicate over 
long genomic distance with the target genes to regulate transcription activity (Bulger and 
Groudine, 2011). Proposed mechanistic models fall into two categories (Blackwood and 
Kadonaga, 1998; Bulger and Groudine, 1999). One is a non-contact model proposing that 
enhancers act at a distance to create a favorable environment for transcription, or to act as 
nucleation sites for transcription factors and RNA polymerase to spread along the 
chromatin fiber to reach the promoters (also called the “tracking” model, Figure 1.3 A). 
There are only a few studies  in support of this model, and it is not clear in this model 
what mediates the spreading of transcription factors and RNA polymerase along the 
chromatin, what determines the direction of spreading and what prevents the unintended 
activation of intervening genes. The other model is a contact model proposing that long-
range communication occurs through direct and specific interactions between the distant 
enhancers and the promoters of regulated genes, without involvement of the intervening 
chromatin fiber (Figure 1.3 B). The contact model predicts a looped configuration of 
chromatin fiber in which distant enhancers and genes are juxtaposed into physical 
proximity and intervening chromatin is looped out. Such looped conformations have been 
observed at many loci thanks to the invention of chromosome conformation capture assay 
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(3C) (Cullen et al., 1993; Dekker et al., 2002) that allows a direct assessment of 
chromatin interactions. The use of 3C and its high-throughput derivatives have revealed 
juxtaposition of genomic distant DNA elements, i.e. chromatin looping, as a general 
principle of chromatin organization and enhancer-promoter communication (for review 
see (Dean, 2011; Kadauke and Blobel, 2009; Miele and Dekker, 2008; Schoenfelder et 
al., 2010a; Sexton et al., 2009)). Nevertheless, the tracking model and looping model are 
not mutually exclusive but a possible scenario remains that chromatin tracking proceeds 
and facilitates the formation of chromatin loops.  
Enhancers regulate gene expression by diverse manners and mechanisms (Bulger and 
Groudine, 2011). It is widely observed in vertebrates and invertebrates that transcription 
activity of a gene can be regulated by multiple enhancers. At some genes, individual 
enhancers drive distinct expression patterns of a gene independent of other enhancers 
(e.g. tissue-specific expression). Whereas at other genes, multiple enhancers are activated 
simultaneously by the same transcription factors and robustly promote active 
transcription in similar spatio-temporal patterns. The functions of co-regulated enhancers 
can be non-redundant and additive such as the β-globin enhancers (see Chapter 1.3), or 
apparently redundant or semi-redundant such as shadow enhancers found in Drosophila 
(for review see (Barolo, 2012)). Multiple distant enhancers are found to interact with 
their active target genes simultaneously, thus forming an “active chromatin hub” structure 
containing multiple chromatin loops at a locus (for example, the β-globin (see Figure 1.6) 
and Hox loci (Montavon et al., 2011)). It is speculated that clustering of multiple 
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enhancers could achieve and maintain a high local concentration of transcription factors 
and RNA polymerase for promoting transcription activity.  
 
A. Non-contact model 
?
B. Contact model 
 
Figure 1.3. Mechanistic models for long-range transcription control.   
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Long-range chromatin interactions are not limited to regulatory elements on the same 
chromosome (cis) but have also been observed across different chromosomes (trans) 
although their functions remain largely obscure (Williams et al., 2010). Moreover, 
chromatin looping is also present at repressed genes. For example, upon repression of the 
Kit gene, loss of an enhancer-promoter loop is accompanied by de novo formation of a 
loop within the gene body (Jing et al., 2008). Polycomb group (PcG) protein occupied 
regions can form chromatin loops and maintain key developmental regulatory genes in 
poised, low transcription state in early embryonic cells (Tiwari et al., 2008). The work 
presented here focuses on active chromatin looping in cis.  
1.2.3: Molecular mediators of chromatin looping 
The chromatin looping model presumes that the chromatin fiber is flexible and that 
enhancers and genes are relatively free to move in three dimensions to contact each other 
within the nucleus. However, it is still unknown how enhancers “find” their target genes 
efficiently, how enhancers confine their activity to a specific gene, and what molecular 
forces tie the loops. Chromatin loops can span kilobases to megabases of genomic 
distance, so it appears unlikely that unassisted looping would be either efficient or 
specific (Rippe, 2001). Yet the composition of protein complexes bound to the regulatory 
element and the regulated gene are likely to determine affinity and specificity of long-
range interactions. Cell-type specific transcription factors and their associated co-factors 
are plausible candidates of mediating chromatin loops that are linked to cell-type specific 
transcription. Interactions of specific factor-associated chromatin can be mapped by the 
ChIP-loop assay or ChIA-PET (chromatin interaction analysis by paired-end tag 
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sequencing) on a genome-wide scale (Hakim and Misteli, 2012). The first ChIA-PET 
study in human breast cancer cells reveals that a large portion of remote estrogen receptor 
α (ERα) binding sites with high ChIP signal are juxtaposed with gene promoters through 
long-range chromatin interactions, suggesting ERα regulates transcription activity by 
inducing extensive chromatin looping to bring enhancers and genes together (Fullwood et 
al., 2009). 3C and loss-of-function studies have documented numerous examples that 
DNA-binding transcription factors and their co-factors are required in chromatin loop 
formation (e.g. β-globin locus, see below). However, chromatin binding of transcription 
factors and co-factors are often inter-dependent, making it difficult to determine whether 
chromatin looping is a direct or indirect function of a particular factor, and to determine 
which factor, if any, is sufficient to establish chromatin loops. 
A few ubiquitously expressed nuclear factors have been implicated in mediating 
gene-specific chromatin loops. CCCTC-binding factor (CTCF) is a highly conserved 
DNA binding protein and involved in diverse regulatory functions including transcription 
activation/repression, insulation, and imprinting (Phillips and Corces, 2009). 
Accumulating data by studying specific loci suggest that CTCF functions at least in part 
via mediating long-range chromatin interactions (Hou et al., 2010; Splinter et al., 2006; 
Yoon et al., 2007). Recent genome-wide studies support a primary role for CTCF in 
global organization of chromatin architecture (Handoko et al., 2011). Cohesin and 
Mediator physically interact in murine embryonic stem cells (Kagey et al., 2010). They 
co-occupy numerous active enhancers and promoters that are found to form chromatin 
loops (Kagey et al., 2010). However, it is still not fully understood how these factors are 
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involved in the formation and maintenance of chromatin looping, and how they interact 
with lineage-constrained transcription factors to establish cell-specific chromatin 
interactions.  
 
1.3: β-Globin Regulation ?
1.3.1: Composition of the β-globin locus 
Studies of the β-globin locus have often been at the forefront of revealing new 
mechanisms of gene regulations. The mammalian β-globin loci are highly conserved and 
share similar genomic composition among species. The mouse β-globin locus contains 
four functional globin genes arranged in the order of their temporal expression, with two 
embryonic globin genes, εy and βh1, followed by two adult globin genes, β-major and β-
minor (Figure 1. 4 A). Upstream of the β-globin genes lies a cluster of conserved DNase I 
hypersensitive sites (HSs), called the locus control region (LCR). The HSs of LCR 
function as erythroid-specific enhancers and confer high-level expression of β-globin 
genes in erythroid cells. Additional HSs are found both upstream and downstream of the 
LCR and globin genes (Figure 1. 4 A). The human β-globin locus has similar genomic 
organization as the mouse locus but contains five functional globin genes in the order of 
5’-ε-Gγ-Aγ-δ-β-3’. ε, Gγ and Aγ, δ and β, are expressed in embryonic, fetal and adult 
stages, respectively (Figure 1. 4 B). Point mutations or deletions of the LCR or β-globin 
genes are found in humans and lead to β-thalassemia with a large spectrum of disease 
severity. The first “molecular disease” sickle cell anemia (SCD) is caused by substitution 
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of valine for glutamic acid in the human β-globin chain. The mutant hemoglobin (HbS) 
undergoes polymerization upon deoxygenation, resulting in erythrocyte deformation and 
hemolysis. 
 
(A) 
 
 (B)  
 
Figure 1. 4. The mouse and human β-globin loci (From (Palstra et al., 2008a)). HS, 
DNase I hypersensitive site. OR, olfactory receptor genes. 
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1.3.2: LCR of the β-globin locus 
LCRs are defined by their ability to confer high-level and tissue-specific expression 
of linked genes in a copy number-dependent manner at ectopic chromatin sites (for 
review, see (Li et al., 2002)). The LCR was first identified at the human β-globin locus. 
When the LCR is missing, transcription of β-globin is severely reduced (Bender et al., 
2000). Functions of each HS element at the mouse β-globin locus have been extensively 
studied by gene-targeting in mice (Bender et al., 2012; Bender et al., 1998; Bender et al., 
2001; Fiering et al., 1995). Deletion of individual HS leads to reduction of β-globin 
expression to various extents, ranking as HS2>HS3>HS4>HS1 ((Bender et al., 2012), 
Figure 1.5). HS2 functions as a classical enhancer as it shows activity in transient 
transfection assays. HS5 and HS6 do not show direct roles in β-globin activation 
although HS5 is homologous to the bona fide insulator element, chicken HS4 (Bender et 
al., 2012; Bender et al., 1998). Deletion of multiple HSs shows additive and not 
synergistic effects on transcription (Bender et al., 2012). These findings support that HSs 
of the β-globin LCR function in an additive manner in the mouse.  Although the LCR is 
essential for high-level expression of β-globin, the open chromatin structure (Epner et al., 
1998; Reik et al., 1998), hyperacetylation of histones (Schubeler et al., 2001) and 
developmental gene switching (Bender et al., 2000; Epner et al., 1998) are independent of 
the LCR.  
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Figure 1.5 Effect of single HS deletions on β-globin expression (from (Bender et al., 
2012)). ?
 
1.3.3: Chromatin organization of the β-globin locus?
The LCR resides 20-60 kilobases upstream of β-globin genes. How the LCR exerts its 
function on β-globin transcription over a long genome distance and how such spatial- and 
temporal- regulation is achieved have been long-standing and interesting questions. 
Studies of its chromatin organization have provided valuable insights. Two independent 
studies demonstrated that the β-globin LCR and the active adult β-major globin promoter 
are in close proximity in adult erythroid cells, suggesting that these two regions 
physically interact supporting the chromatin looping model (Carter et al., 2002; Tolhuis 
et al., 2002). In primitive erythroid cells, a development stage when the embryonic globin 
genes are active and the adult globin genes are silent, the LCR interacts specifically with 
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the active embryonic globin genes but not the adult globin genes (Palstra et al., 2003). 
These observations linked the LCR-globin gene interactions with active transcription. 
The flanking upstream and downstream HSs are also found to be in proximity with the 
LCR and the active globin genes, forming an active chromatin hub structure ((Palstra et 
al., 2003), Figure 1.6). The globin genes switch their interaction with the LCR, 
correlating with the switch of their activity during development. Moreover, the spatial 
organization of the β-globin locus is cell type-specific. The β-globin locus adopts a 
seemingly linear conformation in brain cells, but forms a partial chromatin hub structure 
in erythroid progenitor cells before full transcription activation (Figure 1.6).  
 
 
Figure 1.6 The β-globin chromatin hub (From (Palstra et al., 2003)).   
 
A number of nuclear factors are involved in chromatin looping at the β-globin locus. 
CTCF binds multiple HSs flanking the β-globin locus: the upstream HS-85, HS-62/60, 
HS5 and the downstream 3’HS {Splinter, 2006 #1182}. Interactions among these CTCF-
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binding elements are formed prior to full activation of β-globin and participate in the 
ACH in mature erythroid cells (Figure 1.6). Conditional deletion of CTCF or targeted 
deletion of its DNA-binding site in erythroid progenitor destabilizes interactions among 
CTCF-bound HSs, however, LCR-promoter interactions and transcription activation are 
not affected {Splinter, 2006 #1182}. Mechanistic studies defined gene-specific 
transcription factors that establish LCR-β-globin interactions, including the 
hematopoietic-restricted factors GATA1 and its co-factor FOG1 (Vakoc et al., 2005), 
KLF1 (Drissen et al., 2004), and the more broadly expressed protein Ldb1 (Song et al., 
2007). Functional disruption of any of these factors was associated with reduced LCR-β-
globin interactions and diminished β-globin transcription. It is still not fully understood 
how these factors interplay on chromatin and organize the higher-order chromatin 
structure. 
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CHAPTER 2: SCL and Associated Proteins 
Distinguish Active from Repressive GATA 
Complexes 
 
Research presented in this chapter was accomplished in collaboration with a previous 
postdoctoral fellow, Tamara Tripic, with equal contribution. I have contributed to the 
experimental design and execution, and manuscript writing for the publication. I have 
worked together with Tamara to characterize the dynamic association of the SCL 
complex with chromatin at various loci and in multiple hematopoietic cell lineages 
(Figure 2.1-2.8). I have examined chromatin recruitment of the DNA binding mutant 
SCL by GATA1 (Figure 2.9), analyzed the ChIP-chip results with our collaborator Ross 
Hardison laboratory  (Figure 2.10), and investigated effects of LMO2 knockdown to 
GATA1 activity (Figure 2.11).  
This research was originally published in Blood. Tamara Tripic*, Wulan Deng*, 
Yong Cheng, Ying Zhang, Christopher R. Vakoc, Gregory D. Gregory, Ross C. 
Hardison, and Gerd A. Blobel. SCL and associated proteins distinguish active from 
repressive GATA transcription factor complexes. Blood 2009 113:2191-2201. © the 
American Society of Hematology. *equal contribution 
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2.1: Chapter Summary 
GATA1 controls hematopoietic development by activating and repressing gene 
transcription, yet the in vivo mechanisms that specify these opposite activities are 
unknown. To our surprise, we found that active and repressive GATA1 complex cannot 
be distinguished simply by its association with classical co-activator CBP/p300 or co-
repressor NuRD complex. By examining the composition of GATA1 associated protein 
complexes in a conditional erythroid rescue system as well as through the use of tiling 
arrays we detected the SCL, LMO2, Ldb1, E2A complex at all positively acting GATA1-
bound elements examined. Similarly, the SCL complex is present at all activating GATA 
elements in megakaryocytes and mast cells. In striking contrast, at sites where GATA1 
functions as a repressor, the SCL complex is depleted. A DNA-binding defective form of 
SCL maintains association with a subset of active GATA elements indicating that 
GATA1 is a key determinant for SCL recruitment. Knockdown of LMO2 selectively 
impairs activation but not repression by GATA1. ETO-2, an SCL-associated protein with 
the potential for transcription repression is also absent from GATA1-repressed genes but, 
unlike SCL, fails to accumulate at GATA1 activated genes. Together, these studies 
identify the SCL complex as a critical and consistent determinant of positive GATA1 
activity in multiple GATA1-regulated hematopoietic cell lineages. 
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2.2: Introduction 
Most transcription factors can function both as activators and repressors. The context 
that determines transcriptional activity is often unclear. This holds true for GATA1, 
which in erythroid cells activates all known erythroid-specific genes but also contributes 
to the repression of genes associated with the immature, proliferative state. The proper 
balance of GATA1's activating and repressive functions is essential for normal 
hematopoietic cell maturation, and its disruption contributes to diseases with underlying 
GATA1 mutations (Hollanda et al., 2006; Nichols et al., 2000; Wechsler et al., 2002).  
Many co-factors associate with GATA1 and modulate its activity. GATA1 interacts 
with the NuRD complex, a classical co-repressor complex containing histone deacetylase, 
as well as a typical co-activator protein, histone acetyltransferase CBP/p300, leading to a 
simple model in which co-activators and co-repressors might be recruited in a distinct 
fashion to GATA1 activated and repressed genes, respectively. However, ChIP 
experiments surprisingly revealed that chromatin occupancy of neither CBP nor NuRD 
proteins distinguishes GATA1 activity since both proteins are found at active and 
repressive GATA1 elements in vivo ((Grass et al., 2003; Letting et al., 2003; Martowicz 
et al., 2005), and this study). This unexpected pattern of co-factor occupancy suggests 
that the recruitment of these chromatin modifying/remodeling complexes is not the 
pivotal determinant of transcriptional activity at GATA1 target genes. Another aspect of 
GATA1-induced changes in chromatin organization, i.e. the formation of chromatin 
loops occurs at both activated and repressed genes (Jing et al., 2008; Vakoc et al., 2005). 
This suggests that post-translational modifications or additional GATA1-associated 
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proteins might regulate the activities of co-activator and repressor proteins. We therefore 
explored whether other proteins that are known to associate with GATA1 might 
consistently distinguish active from repressive GATA1 complexes. 
A protein complex composed of SCL, LMO2, Ldb1, and E2A can physically and 
functionally associate with GATA1 (see Chapter 1.1.4). Although a few GATA-E-box 
containing erythroid genes have been identified that are regulated by SCL, there are 
several reasons to believe that SCL serves a broader role in transcriptional regulation in 
hematopoiesis, presumably through interaction with other hematopoietic transcription 
factors including GATA1. First, SCL is co-expressed with GATA1 in erythroid, 
magakaryocyte, and mast cell lineages and, like GATA1, is essential for the normal 
maturation of all three lineages (Hall et al., 2003; Mikkola et al., 2003; Salmon et al., 
2007). Second, DNA-binding activity of SCL is dispensable for specification of primitive 
and definitive hematopoiesis, but is required for complete erythroid maturation (Kassouf 
et al., 2008; Porcher et al., 1999). Strikingly, a small fraction of mice homozygous for a 
DNA-binding-defective form of SCL (SCL-RER) survived to adulthood (Kassouf et al., 
2008). Third, SCL can activate transcription in the absence of an E-box through 
association with other transcription factors. For example, SCL together with E47, LMO2, 
and Ldb1 stimulates the promoter of the Kit cytokine receptor gene in a manner requiring 
a Sp1 binding site but not an E-box or GATA element (Lecuyer et al., 2002). Moreover, 
SCL and LMO2 can activate the promoter of the RALDH2 gene in T-ALL cells through 
interaction with GATA3 in the absence of an E-box (Ono et al., 1998). Fourth, forced 
expression of GATA1, SCL and LMO2 displayed strong synergy during induction of 
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blood formation in developing Xenopus embryos (Mead et al., 2001). Fifth, it is 
noteworthy that at HS2 of the β-globin LCR, a GATA site mutation reduces SCL 
recruitment more strongly than does an E-box mutation (Song et al., 2007). This suggests 
that GATA1 plays a critically role in the recruitment of the SCL complex even in the 
absence of neighboring E-boxes.  
To test a general role for the SCL complex in GATA1-dependent transcription 
activation, we determined the occupancy of SCL, LMO2, E2A and Ldb1 at numerous 
regulatory sites where GATA1 functions as an activator or repressor. Using an erythroid 
cell line in which GATA1 can be activated conditionally (G1E-ER4, see Chapter 1.1.2), 
we found that the entire SCL complex is invariably recruited to all sites where GATA1 
activates transcription. In contrast, GATA1 fails to recruit the SCL complex at sites 
where it functions as a repressor. Prior to gene repression by GATA1, the SCL complex 
is frequently found to correlate with the presence of GATA2. The positive correlation of 
the SCL complex with active GATA elements in erythroid cells was extended through 
the use of ChIP-on-chip using high density tiling arrays that cover 66 megabases of 
mouse chromosome 7. Moreover, SCL and GATA1 co-occupy active genes in 
megakaryocytes and mast cells, further demonstrating the general nature of SCL as a 
GATA1-co-activator. The co-repressor ETO-2 was absent from all GATA1/SCL-
activated genes examined. Together, this work demonstrates that in contrast to several 
tissue-specific or general GATA1 co-factors studied previously, the SCL complex is a 
clear indicator of positive transcriptional activity of GATA1 in several hematopoietic 
lineages. 
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2.3: Results  
2.3.1: GATA1 recruits the SCL complex to active erythroid genes  
A working model for GATA1 function predicts that co-activator and co-repressor 
molecules are recruited to active and repressed genes, respectively. Surprisingly, neither 
the classic co-activators such as BRG1 and the histone acetyltransferase CBP (Figure 2.1) 
nor the co-repressor complex NuRD (nucleosome remodeling and deacetylase) or several 
other GATA1-binding factors such as FOG1 are reliable predictors of active versus 
repressive transcription factors complexes (Miccio et al., 2010; Williams et al., 2004). 
Since the SCL complex contains multiple subunits with transcription activating function 
we examined whether it might associate selectively with GATA1-activated genes in 
G1E-ER4 cells that contain an inducible version of GATA1 (see Chapter 1.1). A great 
advantage of G1E-ER4 cells for this study is that genomic occupancy of GATA1 and its 
co-regulators can be examined under dynamic conditions. We performed ChIP assays to 
compare SCL and GATA1 occupancy at GATA1-activated genes in parental G1E cells 
and G1E-ER4 cells treated with estradiol for 24 hours. The reason for choosing parental 
G1E cells for comparison instead of uninduced G1E-ER4 cells is that the latter display a 
certain degree of leakiness with regard to GATA1 occupancy at some sites (Johnson et 
al., 2002). Increases in GATA1 occupancy were accompanied by increases in SCL 
recruitment at positive acting GATA sites including HS2 and HS3 of the LCR and the 
adult β-globin gene (Hbb-b1) promoter (Figure 2.2 A, B). Notably, the Hbb-b1 promoter 
lacks conserved E-boxes, suggesting that SCL recruitment is mediated by GATA1 
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independently of SCL DNA binding. Control experiments showed that neither GATA1 
nor SCL were detected in a region approximately 1 kb upstream of the Hbb-b1 
transcription site that lacks GATA sites (Figure 2.2 A, B). Moreover, SCL recruitment 
was stimulated by GATA1 at additional GATA1-dependent genes, including Band3, Klf1 
(EKLF), and Eraf (AHSP). These results suggest that SCL recruitment is a general 
feature of GATA1 activated genes regardless of the presence of E-box elements. This 
agrees with observations at regulatory regions of the Gata1 gene where SCL complexes 
correlated with the presence of GATA1 even in the absence of E-boxes (Valverde-
Garduno et al., 2004). In the absence of GATA1, SCL occupancy is detected at some but 
not all of the examined sites (Figure 2.2  B) possibly due to the presence of E-boxes (at 
Band3 and Klf1) or GATA2 which is highly expressed prior to its repression by GATA1 
(Weiss et al., 1994). Indeed, when compared to controls, we found substantial enrichment 
for GATA2 at HS3, Band3, Klf1, and Eraf prior to activation by GATA1 (Figure 2.2 C). 
Moreover, at sites of initially high GATA2 occupancy, GATA2 was depleted upon 
GATA1 activation. 
Since SCL is part of a multimeric protein complex we investigated by ChIP whether 
Ldb1, LMO2 and E2A follow a similar pattern. The results in Figure 2.3 show that all 
three molecules are similarly enriched upon GATA1 activation. Western blots of nuclear 
extracts demonstrated that protein levels of all four proteins were essentially unchanged 
following GATA1-ER activation (data not shown), indicating that recruitment rather than 
elevated expression accounts for the increased occupancy of the SCL complex. Thus, at 
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all sites examined so far, SCL, LMO2, Ldb1 and E2A recruitment increases as a result of 
increased GATA1 occupancy. 
To further establish that SCL recruitment is critically determined by GATA1 
occupancy, we performed time course ChIP experiments at the Hbb-b1 promoter in G1E-
ER4 cells treated with estradiol for 4, 8, 12, 16, and 20 hours. We found that the levels of 
SCL occupancy paralleled those of GATA1, suggesting that association with GATA1 
rather than direct DNA binding is essential for SCL recruitment at this site (Figure 2.4). 
We also investigated SCL occupancy at the α-globin locus (Hba) before and after 
GATA1-ER activation, focusing on the distal regulatory sites HS-31, HS-12 and the Hba-
a1 promoter. Notably, prior to GATA1 activation, high levels of SCL, E2A, Ldb1 and 
LMO2 were found at HS-31 and HS-12 (Figure 2.5). In addition, low levels of the SCL 
complex were detected at the Hba-a1 promoter. This generally agrees with previous 
observations in which SCL and Ldb1 were found at the α-globin locus in immature cells 
before the onset of transcription (Anguita et al., 2004) and could be due to the presence of 
GATA2 or E-boxes or a combination of the two. Following activation of GATA1-ER, the 
protein levels of SCL, E2A, Ldb1 and LMO2 decreased slightly but remained very high 
when compared to other GATA1-activated genes (data not shown). This finding is 
consistent with a model in which the SCL complex functions as co-activator for GATA1. 
However, the function of the SCL complex at the inactive α-globin locus is unclear. It is 
possible that the SCL complex is insufficient for transcription or that it actually keeps the 
α-globin locus in its repressed state, perhaps via ETO-2 (Goardon et al., 2006; Meier et 
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al., 2006; Schuh et al., 2005). Our ChIP experiments using antibodies against ETO-2 
support the latter possibility (see below). 
One observation that remains unclear is that the relative amounts of SCL and GATA1 
occupancy vary. For example, at the Klf1, Eraf and Band3 genes, SCL occupancy is 
higher than at the β-globin locus whereas GATA1 occupancy is somewhat higher at the 
β-globin locus (Figure 2.2). Moreover, at the Hba-a1 promoter the ratio of GATA1 to 
SCL is higher than at HS-31 and HS-12. It is likely that additional transcription factors or 
co-factors influence SCL recruitment. Nevertheless, the SCL complex is present at all 
active GATA sites examined.  
To confirm these results in primary cells we performed ChIP experiments using 
erythroid cells from E14.5 fetal livers. SCL, LMO2, and Ldb1 were detected at active 
GATA1 target genes at levels very similar to those found in induced G1E-ER4 cells (data 
not shown). 
2.3.2: SCL and GATA1 co-occupy active genes in megakaryocytes and mast cells 
The normal development of megakaryocytes (MK) and mast cells depends on both 
GATA1 and SCL (Cantor et al., 2008; Hall et al., 2003; Migliaccio et al., 2003; Mikkola 
et al., 2003; Salmon et al., 2007). To determine the relationship between GATA1 and 
SCL occupancy at MK-specific promoters we performed ChIP experiments with the 
murine megakaryocytic cell line L8057. Primer pairs were directed towards the proximal 
promoter sequences of the early expressed αIIb and Mpl genes and the late expressed 
Gplba and Pf4 genes all of which harbor well-characterized GATA elements (Szalai et 
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al., 2006). We found high levels of GATA1 at the proximal promoters of GpIba and Pf4 
and somewhat lower levels at the αIIb and Mpl genes (Figure 2.6 A). GATA1 was 
undetectable at a control region 3 kb upstream of the αIIb transcription start site that is 
devoid of GATA elements. Consistent with our findings in erythroid cells, occupancy 
levels of SCL and Ldb1 correlated with that of GATA1 at megakaryocytic target genes 
(Figure 2.6 A).  
To examine whether the tight correlation between GATA1 and SCL proteins extends 
to mast cells, we performed ChIP experiments in primary cultured bone marrow-derived 
mast cells. We examined regions with known GATA binding sites near the genes 
encoding the mast cell carboxypeptidase A (Mc-Cpa) (Zon et al., 1991), the mast cell-
specific IgE receptor (FcεRI) β-chain (Maeda et al., 2003), the transcription factor PU.1 
(Sfpi1) (Chou et al., 2009), and the Kit gene (Jing et al., 2008; Munugalavadla et al., 
2005). As expected GATA1 was present at the relevant sites but not control regions of all 
four genes (Figure 2.6 B). The occupancy of SCL, Ldb1 and LMO2 followed a very 
similar pattern with the regard to both spatial distribution and amount of detectable 
protein (Figure 2.6 B). The -114kb region of Kit and the FcεRIβ promoter do not harbor 
any E-boxes within at least 100 base pairs of the GATA elements consistent with GATA1 
likely accounting for most of the SCL recruitment at these sites. 
At the promoter of the Mc-Cpa gene the ratio of GATA1 to SCL proteins was lower 
than that found at other sites. In contrast, this ratio was higher at the FcεRI-β promoter. 
The reason for this is unclear but in contrast to mature erythroid cells, mast cells express 
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high levels of GATA2 leading us to speculate that the degree of SCL recruitment might 
reflect combined levels of GATA1 and GATA2. 
Immunoprecipitation experiments suggested that GATA1 associates with distinct 
complexes containing SCL or FOG1 but not both (Rodriguez et al., 2005). However, 
FOG1 is recruited to all activating GATA sites in a manner virtually indistinguishable 
from SCL proteins (Letting et al., 2004; Miccio et al., 2010; Pal et al., 2004). In trying to 
reconcile these observations it is possible that the composition of GATA1-associated 
protein complexes changes over time such that FOG1 is substituted by SCL or vice-versa. 
While preliminary time course ChIP studies in G1E-ER4 cells do not support this model 
(data not shown), very closely spaced time points might be required to reveal differences 
in the kinetics of co-factor assembly. It is also possible that distinct FOG1 and SCL 
containing GATA1 complexes associate in a variegated manner with alleles of the same 
genes. For example, alternate/combinatorial utilization of transcription co-factors has 
been described at estrogen-receptor regulated genes (Metivier et al., 2003). While 
conventional ChIP experiments reflect the sum of protein interactions at all alleles, 
sequential ChIP (double ChIP) experiments might address the issue of variegated protein 
occupancy. Nevertheless, our results demonstrate that the SCL complex is present at all 
active GATA sites examined in erythroid cells, megakaryocytes and mast cells even in 
the absence of conserved E-box sequences, strongly suggesting that the SCL complex 
represents a tissue-specific co-activator complex for GATA1. 
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2.3.3: The SCL complex fails to assemble at GATA1-repressed genes  
If the SCL complex directs positive activity of GATA1, it would be expected that it is 
reduced or absent from genes where GATA1 functions as repressor. To test this 
hypothesis we interrogated the occupancy of the SCL complex at genes directly repressed 
by GATA1 comparing G1E cells to induced G1E-ER4 cells. We examined several 
GATA elements at the Gata2 and Kit genes that were previously shown to be occupied 
by GATA1 during their repression (Grass et al., 2003; Jing et al., 2008; Letting et al., 
2004; Munugalavadla et al., 2005). In induced G1E-ER4 cells, GATA1 occupied GATA 
elements positioned 114kb upstream and 5kb, 58kb and 73kb downstream of the 
transcription start site but not at the promoter of the Kit gene (Figure 2.7 A) in agreement 
with previous results (Jing et al., 2008). Strikingly, all SCL components were depleted 
from all four GATA1-occupied elements at the repressed Kit locus (Figure 2.7 A). 
Similar results were obtained at the Gata2 locus where high levels of GATA1 were 
associated with reduced or lost SCL occupancy 77kb and 2.8 kb upstream and 9.5kb 
downstream of the transcription start site (Figure 2.7 B). Ldb1, LMO2 and E2A followed 
the same trend (data not shown). At the active Kit and Gata2 loci, SCL levels correlated 
well with the presence of GATA2 (Figure 2.7 A, B) (Grass et al., 2006; Jing et al., 2008), 
suggesting that GATA2 might function via SCL to activate Kit and Gata2 expression in 
immature erythroid cells.  
Repression of Kit and Gata2 by GATA1 requires FOG1. To investigate whether 
FOG1 might be required for the depletion of SCL we examined the Lyl1 gene which is 
repressed directly by GATA1 in a FOG1-independent manner (Johnson et al., 2007). We 
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found that SCL levels correlated inversely with GATA1 occupancy but correlated 
positively with GATA2 protein levels (Figure 2.7 C). We also examined three more 
GATA1-repressed genes, Etv6, Sox6 and Tram2 that contain composite GATA-E-box 
elements in their regulatory regions (Wozniak et al., 2008). In the absence of GATA1 we 
found high levels of GATA2 and SCL at all three promoters (Figure 2.7 D). In contrast, 
upon GATA1-induced gene repression, SCL was dramatically reduced again showing 
that despite the presence of conserved E-boxes in these genes, a repressive GATA1-
containing complex is incompatible with the presence of SCL. Together, our results show 
that at all examined GATA1-dependent enhancer elements, the SCL complex co-exists 
with GATA1 in erythroid cells, mast cells and megakaryocytes (Table 2.1). In contrast at 
all 12 sites where GATA1 functions as a repressor, the SCL complex is reduced or absent 
(Table 2.2). Despite the strong correlation between GATA1 and SCL at active genes but 
not repressed genes, we cannot rule out the existence of GATA1-regulated genes where 
this correlation breaks down and other factors control the overall gene activity. Future 
studies spanning the entire genome will address this issue. 
2.3.4: ETO-2 occupancy at GATA1-regulated genes 
Since SCL is largely displaced from genes at which GATA1 represses transcription, 
SCL is unlikely to play a direct role in their repression. However, at genes where SCL is 
present prior to their activation, it is possible that it helps maintaining them in an inactive 
state. For example, at the α-globin locus SCL has been detected prior to its transcriptional 
activation (Anguita et al., 2004). The SCL complex harbors ETO-2, a member of 
ETO/MTG family of corepressor proteins which can bind histone deacetylases (Goardon 
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et al., 2006; Meier et al., 2006; Schuh et al., 2005). Since ETO-2 is a candidate for SCL-
mediated gene repression, we examined its occupancy at GATA1 target genes before and 
after their activation by GATA1. We found significant levels of ETO-2 at the α-globin 
gene in the absence of GATA1 which was dramatically reduced upon GATA1-ER 
activation (Figure 2.8 A). Loss of ETO-2 association with the α-globin gene was not a 
result of reduced ETO-2 protein levels as determined by Western blotting (data not 
shown). ETO-2 was also present at other GATA1 target genes including Band3, Hbb-b1 
and Klf1 prior to their activation. Notably, the amounts of ETO-2 correlated well with 
GATA2 levels (compare with Figure 2.2 C). This suggests that ETO-2 might indeed 
participate in repressing these genes in immature erythroid cells probably via GATA2 
and SCL. Consistent with this interpretation, forced expression of ETO-2 in the erythroid 
cell line MEL reduced α-globin expression, and a dominant interfering form of SCL 
raised α-globin levels in erythroid progenitors (Schuh et al., 2005). However, to our 
surprise, at the active Gata2 and Kit genes we also found high levels of ETO-2 which 
was lost upon repression (Figure 2.8 B, C). ETO-2 levels largely mirrored those of SCL 
and GATA2 (compare with Figure 2.2 A, B) except for the -77kb region of the Gata2 
gene where ETO-2 levels were significantly higher than would have been predicted based 
on the amounts GATA2. Thus, the ratio of ETO-2 to SCL appears to vary not only during 
erythroid maturation (Goardon et al., 2006; Meier et al., 2006; Schuh et al., 2005) but 
also among regulatory elements. From these data we conclude that the mere presence of 
ETO-2 does not predict whether a target gene is active or repressed. This raises the 
possibility that the activity of ETO-2 is regulated such that it "permits" transcription of 
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certain active genes while contributing to the repression of others. Moreover, ETO-2 does 
not appear to contribute to the silencing of Gata2 and Kit expression in G1E-ER4 cells 
since it is removed from these genes along with the SCL core complex. Therefore, it is 
surprising that expression of a dominant negative form of E2A that is defective for ETO-
2 binding can increase Kit expression in differentiating MEL cells (Schuh et al., 2005). 
Perhaps, mature MEL cells maintain residual levels of SCL at the Kit gene to allow E2A 
recruitment or the effects of mutant E2A were indirect.  
2.3.5: SCL recruitment in the absence of DNA binding 
Our results presented thus far support a general role for the SCL complex as a GATA 
factor coactivator consistent with its ability to perform broad functions during 
erythropoiesis even in the absence of direct DNA binding (Kassouf et al., 2008; Lecuyer 
et al., 2002; Ono et al., 1998; Porcher et al., 1999). To evaluate the extent to which DNA 
binding by SCL is dispensable for occupancy at GATA1 target genes we infected G1E-
ER4 cells with retrovirus expressing HA-tagged SCL or a version bearing three point 
mutations in the SCL basic domain that abrogates DNA binding (SCL-RER, (Porcher et 
al., 1999)). Western blots showed comparable expression of HA-SCL and HA-SCL-RER 
(insert in Figure 2.9 A). After 24 hours of estradiol treatment, ChIP assays were 
performed with anti-HA antibodies. Wild-type SCL displayed a pattern of occupancy 
resembling that of endogenous SCL with increasing occupancy at GATA1-activated 
genes (Figure 2.9 A). SCL-RER occupancy was reduced at HS3, HS2, Hbb-b1 and 
Band3, but occurred at virtually normal levels at the Klf1, Eraf, and Hba-a1 genes 
(Figure 2.9 A). Among the genes repressed by GATA1, two sites at the Kit gene (-114 kb 
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and +5kb) displayed reduced occupancy of SCL-RER while at the Gata2, Lyl1 and Rgs18 
genes wild type SCL and SCL-RER were recruited similarly  (Figure 2.9 B). These 
results demonstrate that although direct contacts with DNA contribute to SCL occupancy, 
GATA1-induced SCL recruitment can occur at numerous sites independently of DNA 
binding. Since G1E-ER4 cells are definitive erythroid precursor cells, our results are also 
consistent with the observation that SCL DNA binding is required for normal definitive 
erythropoiesis (Kassouf et al., 2008; Porcher et al., 1999). Based on previous work 
(Porcher et al., 1999) it is predicted that in primitive erythroid cells GATA1 or perhaps 
additional transcription factors might be entirely sufficient for tethering the SCL complex 
to its target genes.  
2.3.6: Widespread association of GATA1 with SCL at enhancers  
To examine the generality of the association between GATA1 and SCL, we 
investigated the co-occupancy of DNA segments by GATA1 and the SCL complex over 
a 66Mb region of mouse chromosome 7. ChIP was performed with antibodies against 
SCL and Ldb1 in G1E-ER4 cells treated with estradiol for 24 hours and parental G1E 
cells lacking GATA1. ChIP material was amplified and hybridized to high density 
NimbleGen custom arrays spanning 66Mb of chromosome 7. Data were analyzed and 
compared to GATA1 ChIP (Cheng et al., 2008). The peak-calling program Tamalpais 
(Bieda et al., 2006) identified 97 GATA1-bound sites in estradiol-treated G1E-ER4 cells  
within regions containing few repetitive sequences ("chipable regions") (Table 2.3 A). 63 
DNA segments were unequivocally found to be occupied by GATA1 as confirmed by 
quantitative PCR (Cheng et al., 2008). Hybridization with SCL and Ldb1 ChIP DNA 
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revealed a strikingly similar pattern of occupancy for these two proteins. Overall, the 
signal intensity for SCL was highly correlated with that for Ldb1 (r = 0.66), and 86% of 
the SCL peaks overlap with Ldb1 peaks. This suggests that in the majority of cases Ldb1 
and SCL are associated.  
SCL and Ldb1 proteins also showed a strong tendency for co-occupancy with 
GATA1. Of the 63 DNA segments validated as occupied by GATA1, 48 (76%) were also 
positive for SCL and Ldb1 occupancy. Almost all of these are associated with enhancer 
activity (see below). Also, considering individual probes in the 63 GATA1-occupied 
DNA segments, the hybridization signals between SCL and Ldb1 ChIPs are tightly 
correlated (r= 0.93), even higher than the correlation for the entire 66Mb target region. 
This higher correlation suggests that all three proteins, GATA1, SCL and Ldb1, tend to 
bind DNA in a complex. 
We identified 247 SCL-occupied sites (Table 2.3 A), which exceeded the number of 
GATA1 peaks. Although the great majority of the validated GATA1-occupied DNA 
segments were co-occupied by SCL and Ldb1, only 20% of the SCL-occupied segments 
are co-occupied by GATA1. This is consistent with SCL having functions that are 
independent of GATA1. 
We next examined whether the DNA segments co-occupied by GATA1, SCL, and 
Ldb1 are active enhancers in vivo. 61 of the 63 GATA1-bound DNA segments were 
added to a luciferase expression plasmid with a HBG1 gene promoter and transfected into 
K562 cells. Based on their activities, the DNA segments were partitioned into a group of 
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27 that have enhancer activity (increased luciferase activity more than 2-fold compared to 
the parental plasmid), a group of 21 with no positive activity (less than 1.5-fold effect), 
and a group of 13 with threshold activities (1.5 to 2-fold effects). All but one of the active 
enhancers were also occupied by SCL and Ldb1 by the ChIP-on-chip data (Figure 2.10). 
The sole exception (activity indicated by the gray box) was in a repeat-rich region that is 
problematic for ChIP-on-chip analysis, and indeed we found that it also was occupied by 
SCL and Ldb1 by quantitative PCR (data not shown). Thus, all GATA1-occupied DNA 
segments with enhancer activity were associated with SCL and Ldb1. In contrast, the 
GATA1-bound DNA segments with no positive activity were co-occupied by SCL and 
Ldb1 much less frequently (10 out of 21). The correlation of co-occupancy with enhancer 
activity was highly significant (p-value = 1.5x10-5 by Fisher’s Exact Test).  
Another important conclusion is that a GATA element (WGATAR) is a better 
predictor of SCL occupancy than is the E-box (CANNTG). We measured the enrichment 
of motifs in bound segments as the proportion of protein-bound DNA segments that 
contain a specified motif divided by the proportion of background DNA segments that 
contain the same motif. The segments occupied by SCL showed very little enrichment for 
the E-box (1.03) but substantial enrichment for the GATA element (1.25) (Table 2.3 A). 
A notable result is that an E-box might not be essential for SCL recruitment. Of the 
48 sites co-occupied by GATA1, SCL, and Ldb1, 47 had a perfect WGATAR motif, as 
expected, but only 25 had an E-box within 20 base pairs of the GATA element (Table 2.3 
B). This suggests that at the remaining sites, SCL recruitment occurred via GATA1 and 
not via direct DNA binding of SCL. However, given the frequent occurrence of E-boxes 
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it remains impossible to discern whether E-boxes that reside further away from the 
GATA1 bound site contribute to SCL recruitment. Nevertheless, our observation of the 
highly dynamic nature of SCL recruitment in response to changes in GATA factor 
occupancy (Figure 2.2) is consistent with a model in which levels of SCL recruitment are 
controlled by GATA1 at GATA1-occupied sites. 
Many of the elements occupied by GATA1 and/or SCL are found at substantial 
distances from the nearest genes making it difficult to assess which of these genes if any 
they control.  However, it is notable that 27 of 48 elements occupied by GATA1, SCL 
and Ldb1 reside closer to activated genes than to repressed genes. Conversely, the 
majority of elements (11 of 15) occupied solely by GATA1 are found closer to genes that 
are repressed. Together the above results are consistent with the notion that the SCL 
complex functions as co-factor for GATA1 during activation but not repression of 
transcription. 
2.3.7: LMO2 is required for activation but not repression of GATA1-dependent genes 
The selective presence of the SCL complex at active GATA1-bound regions is 
consistent with its role as a co-activator. Consequently, loss of SCL or its associated 
proteins is expected to impair GATA1-mediated activation but not repression. To test this 
prediction, we knocked down LMO2 which bridges GATA1 and the SCL complex. An 
LMO2 shRNA was introduced  into G1E-ER4 cells with the retroviral vector 
pMSCV/LTRmiR30-PIG containing GFP. Since we observed significant cell death upon 
infection, we used a derivative of G1E-ER4 cells expressing the anti-apoptotic protein 
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Bcl-XL, which improved viability (Welch et al., 2004). FACS was employed to generate 
pools of GFP-positive cells. LMO2 expression was diminished as determined by Western 
blotting (Figure 2.11 A). SCL levels were unaffected by the LMO2 knock down (data not 
shown). Cells were treated with estradiol or were left untreated for 24 hours, and mRNA 
levels of GATA1-activated and repressed genes were analyzed by quantitative RT-PCR 
using GAPDH as internal standard. We observed a 47% and 36% reduction in the fold-
increase of Hbb-b1 and Eraf, respectively in the LMO2 knockdown cells when compared 
to controls (Figure 2. 11 B). In contrast, the LMO2 knockdown did not diminish the 
GATA1-induced repression of the Kit, Gata2 and Lyl1 genes (Figure 2. 11 C). In the case 
of Gata2, the fold-repression was even increased from 17-fold in control cells to 26-fold 
in the LMO2 knockdown cells. These results are consistent with the SCL complex 
serving selectively as coactivator but not co-repressor of GATA1. There was a trend in 
LMO2 knockdown cells towards a slight reduction in the expression of the Kit, Gata2 
and Lyl1 genes prior to their repression by GATA1, although the results are not 
statistically significant (data not shown). This might reflect a requirement of SCL for the 
expression of these genes through interaction with GATA2. 
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2.4: Discussion 
Here, we demonstrated that SCL and associated proteins function as a tissue-specific 
GATA1-coactivator complex that is present at activating but not repressive GATA1-
bound regulatory elements. The SCL complex can be recruited to chromatin via its 
interaction with GATA1 in the absence of E-boxes, and is specifically required for 
GATA1 mediated gene activation but not repression. Our work identified the SCL 
complex as a critical and consistent determinant of positive GATA1 activity in multiple 
GATA1-regulated hematopoietic cell lineages. These observations have been further 
confirmed with ChIP-seq data sets in our later studies (Cheng et al., 2009). 
The next challenge will be to determine what mechanism accounts for the selective 
presence of SCL proteins at active GATA elements. It is possible that selectivity is 
achieved at the level of recruitment. How such specificity would be achieved is unclear 
but might involve posttranslational modifications of GATA1. Alternatively, the SCL 
complex might be recruited to both active and repressed GATA1-bound genes but 
removed selectively at sites where GATA1 represses transcription. This might involve 
proteasome-mediated turnover of LMO2 or Ldb1 (Ostendorff et al., 2002; Xu et al., 
2007). Indeed, treatment of G1E-ER4 cells with the proteasome-inhibitors MG132 or 
lactacystein blocks removal of SCL from the Kit and Gata2 genes during GATA1-
induced repression (data not shown). However, since the proteasome is also required for 
the exchange of GATA1 for GATA2 (Lurie et al., 2008; Minegishi et al., 2005) further 
work is needed to assess the role, if any, of proteasome-mediated turnover of the SCL 
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complex at GATA1-repressed genes. One prediction from our results is that forced 
constitutive interaction between SCL and GATA1 might impair the ability of GATA1 to 
function as transcriptional repressor. To test this idea, we fused GATA1 in frame to SCL 
or LMO2 and introduced fusion constructs into G1E cells via retroviral transduction. We 
found that the GATA1-SCL and GATA1-LMO2 fusion proteins functioned almost 
indistinguishably from wild-type GATA1 with regard to both activating and repressive 
functions (data not shown). This result might be explained if one or more components of 
the SCL complex are proteolyzed at repressed elements thus allowing repression to 
proceed unimpaired.  
If the presence of the SCL complex specifies activating GATA1, are there tissue-
specific or general GATA1 co-factors that consistently specify repression by GATA1? 
As discussed above, neither the presence of FOG1 nor NuRD are diagnostic for 
repressive GATA1 complexes as they are also found at GATA1-activated genes. 
Candidate GATA1-co-repressor proteins include Gfi-1b which can physically associate 
with GATA1. However Gfi-1b is detected only at a subset of GATA1-repressed genes 
(Rodriguez et al., 2005). Gfi-1b also binds to SCL presumably via ETO-2 but its 
functional role within this complex remains unknown (Schuh et al., 2005). PU.1 directly 
binds to GATA1 and is thought to antagonize its activity in progenitor cells to inhibit 
erythroid development (Nerlov et al., 2000; Rekhtman et al., 1999; Zhang et al., 1999). 
However, PU.1 expression is extinguished during erythroid differentiation and might not 
function during the repression of GATA1-dependent genes in late maturing erythroid 
cells. Considering the available evidence it is possible that repression by GATA1 
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involves distinct co-repressor molecules depending on the cell lineage, promoter context, 
and maturation stage. 
An important question remains as to how SCL augments GATA1 transcriptional 
activity. SCL associates with histone acetyltransferases p300 and P/CAF and is itself 
acetylated, similar to GATA1 (Blobel et al., 1998; Huang et al., 2000; Huang et al., 1999; 
Hung et al., 1999). Increasing the levels of p300 and/or P/CAF might increase the ratio of 
histone acetylases to deacetylases to facilitate transcriptional activation. However, we and 
others have found that the p300 paralog CBP remains associated with some GATA1-
repressed genes. Whether the same is true for P/CAF and p300 remains to be examined. 
Another possibility is that SCL association with GATA1 governs the specific activity or 
substrate recognition of chromatin remodeling/modifying enzymes. An example for this 
possibility was provided by studies of the hematopoietic transcription factor NF-E2 
which enhanced the nucleosome directed acetyltransferase activity of CBP (Chen et al., 
2001). The SCL complex co-localizes with GATA1 on chromatin at many putative 
intergenic enhancer elements as well as the TSS (this study and (Cheng et al., 2009)), 
therefore it is possible that SCL and associated proteins function by promoting enhancer-
promoter communication (see Chapter 3). In any case, the SCL complex fulfills the 
criteria of a bona-fide coactivator in that it can stimulate GATA1 activity and is 
associated with most if not all active but not repressive GATA factor complexes in vivo.  
2.5: Figures 
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Figure 2.1 
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Figure 2.1. CBP levels at GATA-1 regulated genes. ChIP analysis with CBP 
antibodies or isotype-matched control antibodies (IgG) of the indicated sites at the β-
globin (Hbb-b1) locus (top panel), the Kit (middle panel) and Gata2 (bottom panel) 
genes. ChIP experiments were performed in G1E cells and G1E-ER4 cells after E2 
treatment for 21-24h. The data shown are the averages of two independent experiments. 
Error bars represent standard deviations.  
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Figure 2.2 
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Figure 2.2. GATA1 recruits SCL to active erythroid genes.  
ChIP analysis using GATA1 (A), SCL (B) and GATA2 (C) antibodies or isotype 
matched control antibodies (IgG) and primers for indicated sites. Primers for 1 kb 
upstream of the Hbb-b1 promoter (-1 kb) served as negative control. ChIP experiments 
were performed in G1E cells (-GATA1) and G1E-ER4 cells after E2 treatment for 21-
24h (+GATA1). The data are the averages of three or more independent experiments. 
Error bars represent standard deviations. 
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Figure 2.3  
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Figure 2.3. Co-occupancy of Ldb1, LMO2 and E2A at GATA1-activated genes. 
ChIP analysis using Ldb-1, LMO2 and E2A antibodies. Experiments were performed in 
G1E cells and G1E-ER4 cells after E2 treatment for 21-24h. The data are the averages of 
three or more independent experiments. Error bars represent standard deviations.  
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Figure 2.4 
 
Figure 2.4. Time course ChIP of GATA1 and SCL. Anti-GATA-1 and anti-SCL 
antibodies were used to perform ChIP in G1E-ER4 cells at indicated time points 
following treatment with estradiol. Primer pairs were directed against the Hbb-b1 
promoter or as control a region 1 kb upstream. The data shown are the averages of two 
independent experiments. Error bars represent standard deviations. 
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Figure 2.5  
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Figure 2.5. Association of the SCL complex with the α-globin (Hba) locus. ChIP 
analysis using GATA-1, GATA-2, SCL, Ldb-1, LMO2 and E2A antibodies or isotype-
matched control antibodies. ChIP experiments were done in G1E cells and G1E-ER4 
cells after E2 treatment for 21-24h. The data shown are the averages of three or more 
independent experiments. Error bars represent standard deviations. 
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Figure 2.6 
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Figure 2.6 
 
57 
 
Figure 2.6. GATA1, SCL and Ldb1 co-occupy active genes in megakaryocytes 
and mast cells. ChIP analysis using GATA1, SCL, Ldb1, or isotype-matched control 
antibodies in megakaryocytic L8057 cells (A) and primary bone marrow derived mast 
cells (B). The -3 kb region upstream of αIIb served as negative control. The data shown 
are the averages of three or more independent experiments in (A) and two independent 
experiments in (B). Error bars represent standard deviations. 
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Figure 2.7 
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Figure 2.7 
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Figure 2.7 
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Figure 2.7. Depletion of SCL from GATA1 repressed genes. ChIP analysis using 
GATA1, SCL, GATA2, or isotype matched control antibodies at Kit (A), Gata2 (B), the 
FOG-1-independent Lyl1 gene (C), and the GATA-E-box containing genes Etv6, Sox6, 
and Tram2 (D). ChIP experiments were performed as in Figure 1. The data are the 
averages of three or more independent experiments. Error bars represent standard 
deviations. Please note that the difference in absolute signal intensity for the SCL ChIP 
between panels C and the other panels is due to the use of a different batch of SCL 
antibodies. 
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Figure 2.8 
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Figure 2.8. ETO-2 occupancy at GATA1-regulated genes. ChIP analysis using 
ETO-2 or isotype matched control antibodies at indicated GATA1-activated (A) and 
repressed Kit (B) and Gata2 (C) genes. Prom, promoter. ChIP experiments were 
performed as in Figure 1. The data are the averages of three or more independent 
experiments. Error bars represent standard deviations. 
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Figure 2.9 
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Figure 2.9 
 
 
Figure 2.9. SCL recruitment in the absence of DNA binding. Anti-HA or control 
IgG ChIP of GATA1-activated (A) and repressed (B) genes in G1E-ER4 cells expressing 
HA-tagged SCL (HA-SCL) or HA-SCL-RER (HA-SCL*), before and after estradiol (E2) 
treatment for 21-24h. The data shown are the averages of two (Klf1, Gata2 -2.8), three 
(HS3, Hba-a1, -31, Hba-a1 promoter, Lyl1 and Rgs18 promoters) and four (HS2, Hbb-
b1, Hbb-b1 promoter, Band3, Band3 promoter, Kit -114, Kit +5) independent 
experiments. Error bars represent standard deviations. 
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Figure 2.10 
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Figure 2.10. Erythroid enhancers are co-occupied by GATA1, SCL, and Ldb1. 
61 DNA segments occupied in vivo by GATA1 whose enhancer activities were 
determined in (Cheng et al., 2008) were evaluated for co-occupancy by SCL and Ldb1, 
based on the ChIP-on-chip results. The distribution of results after transient transfection 
of K562 cells (range of 8 to 24 determinations for each GATA1-occupied DNA segment) 
is shown as a box-plot, with the internal line indicating the median, the box extending to 
the first and third quartiles, and the whiskers extending to the most extreme data point 
that is no more than 1.5 times the interquartile range. Black boxes represent DNA 
segments co-occupied by GATA1, SCL and Ldb1; white boxes represent sequences that 
are only occupied by GATA1. The gray box shows results for a DNA segment that was 
not called as an SCL peak in ChIP-on-chip but was shown by qPCR to be occupied by 
SCL. The horizontal line is the threshold for determining a DNA fragment as an 
enhancer. The results were partitioned into the DNA segments with clear enhancer 
activity, those clustered around the threshold, and those with no positive effect. 
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Figure 2.11 
 
 
 
Figure 2.11. LMO2 is required for activation but not repression of GATA1-
regulated genes (A) anti-LMO2 Western blot of nuclear extracts from Bcl-XL-
expressing G1E-ER4 cells transduced with vector producing an shRNA against LMO2 or 
empty vector (ctr). β-actin served as loading control. (B, C) Cells were treated with 
estradiol (E2) for 24 hours and mRNA levels of indicated genes were determined by real-
time RT-PCR. Results were normalized to Gapdh mRNA and plotted as fold-change 
when compared to untreated cells. The data are the averages of 4 independent 
experiments. Error bars represent standard deviation.                          
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Table 2.1 GATA1-activated genes 
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Table 2.2 GATA1-repressed genes 
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Table 2.3 Analysis of ChIP-on-chip data 
(A) 
    Occupied by a : 
  Total in 
chipable 
region 
SCL Enrichmentc p-
valueb 
GATA-
1 
Enrichment p-
value 
Number of 
DNA 
segments 
51,079 247     97     
Number of DNA segments with motif: 
WGATAR 36,672 222 1.252 0 90 1.292 0 
CANNTG 48,463 242 1.033 0.005 91 0.989 0.624 
  
Number of DNA segments with motif within 20 bp of WGATAR: 
CANNTG 13,246 107 1.67 0 44 1.749 0 
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(B) 
    Occupied by a : 
  Total in 
chipable 
region 
GATA-
1, SCL, 
Ldb1  
Enrichment p-
value 
GATA-
1 alone 
Enrichment p-
value 
Number of 
DNA 
segments 
51,079 48     15     
Number of DNA segments with motif: 
WGATAR 36,672 47 1.364 0 15 1.393 0 
CANNTG 48,463 47 1.032 0.086 15 1.054 0 
  
Number of DNA segments with motif within 20 bp of WGATAR: 
CANNTG 13,246 25 2.008 0 5 1.285 0.163 
 
aDNA segments occupied by SCL were determined as the central 600 bp of the peaks 
identified by the program Tamalpais, using the most stringent (L1) threshold.  DNA 
segments occupied by GATA-1 were determined by the program Tamalpais, using the L3 
threshold. 
bThe p-value was determined empirically; it is the number of times (out of 1000 
repetitions) that the fraction of a randomly chosen set of intervals that contains a match to 
the designated motif exceeds that observed for the set of occupied DNA segments. The 
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intervals for comparison were randomly selected from the "chipable" region of the 66Mb 
region of chromosome 7. The chipable portion of the 66Mb region is the part that is 
interrogated by hybridization to the high-density tiling array. The "chipable" region is 
repeat-poor (>500 bp without a repeat) and comprises approximately 30647 kilobases. 
cEnrichment is defined as the proportion of protein-bound DNA segments that contain 
a specified motif divided by the proportion of background DNA segments that contain 
the same motif. 
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CHAPTER 3: Controlling Long-range Genomic 
Interactions at a Native Locus 
 
 
Research presented in this chapter was carried out in collaboration with the Ann Dean 
laboratory and Sangamo BioSciences, Inc. Pregnant ΔLCR mice were prepared by 
Jongjoo Lee from the Ann Dean laboratory, and artificial zinc finger proteins were 
designed and optimized in collaboration with Andreas Reik, Jeff Miller and Philip 
Gregory from Sangamo BioSciences. Hongxin Wang provided technical assistance.  
This research was originally published in Cell. Wulan Deng, Jongjoo Lee, Hongxin 
Wang, Jeff Miller, Andreas Reik, Philip D. Gregory, Ann Dean, and Gerd A. Blobel. 
Controlling long-range genomic interactions at a native locus by targeted tethering of a 
looping factor. Cell 2012 vol. 149 (6) pp. 1233-44.  
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3.1: Chapter Summary?
Distal enhancers can activate genes over a long genomic distance. They are found to 
be physically linked with active promoters and therefore chromatin fibers form loop 
structures. However, the molecular architecture of chromatin loops and the cause-effect 
relationship with transcription activation remain unclear. In erythroid cells, the LCR and 
β-globin promoter form a chromatin loop that requires transcription factor GATA1 and 
Ldb1 (Song et al., 2007; Vakoc et al., 2005). From our studies presented in Chapter 2, we 
observed that the Ldb1-containing SCL complex binds numerous putative enhancer 
elements and active promoters that are co-occupied by GATA1, suggesting a general role 
of Ldb1 in promoting GATA1-regulated enhancer-promoter interaction. Here we tested 
whether artificial tethering of Ldb1 to the endogenous β-globin promoter can substitute 
for GATA1 function in chromatin looping and transcription activation. We employed 
artificial zinc fingers (ZF) to tether Ldb1 to the β-globin promoter in GATA1 null 
erythroblasts in which the β-globin locus is relaxed and inactive. In vivo binding of the 
ZF-Ldb1 to its target was verified by ChIP assays. Remarkably, targeting Ldb1 or only its 
self-association domain to the β-globin promoter substantially activated β-globin 
transcription in the absence of GATA1. Chromosome conformation capture (3C) 
experiments showed that expression of ZF-Ldb1 constructs triggered physical association 
between the LCR and the β-globin promoter via interaction with endogenous Ldb1 
complexes at the LCR. ZF-Ldb1 expression induced two additional LCR-dependent 
functions, Pol II recruitment and serine 5 phosphorylation, further supporting the idea 
that ZF-Ldb1 induced a functional LCR-β-globin promoter chromatin loop. Expression of 
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ZF-Ldb1 constructs in primary erythroid precursor cells from mice heterozygous for a 
deletion of the LCR followed by allele-specific qPCR demonstrated that the activation of 
β-globin expression was indeed due to long-range LCR-β-globin promoter interactions 
and not to secondary effects of ZF-Ldb1 expression. In concert, our findings establish 
Ldb1 as a critical effector of GATA1-mediated loop formation and indicate that 
chromatin looping causally underlies cellular gene regulation. In broader terms, this work 
suggests that forced chromatin looping can be employed to regulate the expression of 
endogenous genes.  
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3.2: Introduction 
Gene activity is controlled by a combination of proximal and distal regulatory 
elements that can be separated by up to hundreds of kilobases. Longstanding questions 
have been how these elements interact functionally to regulate gene expression, how gene 
specificity is achieved, and how unwanted effects on nearby irrelevant genes are avoided. 
The use of chromosome conformation capture (3C) and its derivatives has revealed that 
distant chromosomal elements can be juxtaposed to form chromatin loops, thus providing 
one mechanism of long-range enhancer function (Cullen et al., 1993; Dekker et al., 
2002). Chromatin looping has been discovered at numerous gene loci, and reflects a 
widespread organizing principle of the chromatin fiber (Dean, 2011; Kadauke and 
Blobel, 2009; Miele and Dekker, 2008; Schoenfelder et al., 2010a; Sexton et al., 2009). 
Although looping can occur at genes prior to their full activation, the onset of 
transcription is tightly associated with additional looped interactions (Palstra et al., 2003; 
Spilianakis and Flavell, 2004; Vernimmen et al., 2007). However, based on studies using 
pharmacological inhibitors of transcription elongation, it has become clear that ongoing 
transcription is dispensable for sustaining preformed chromatin loops (Mitchell and 
Fraser, 2008; Palstra et al., 2008b). Moreover, chromatin looping is not limited to active 
genes. For example, upon repression of the Kit gene, loss of an enhancer-promoter loop 
is accompanied by de novo loop formation within the gene body (Jing et al., 2008). These 
studies indicate that chromatin loops are highly dynamic and occur at active and 
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repressed genes but leave open the question as to whether these long-range interactions 
are a cause or consequence of dynamic changes in transcription initiation. 
The molecular mechanisms that establish and maintain chromatin loops remain 
incompletely understood. Fundamental insights into these issues arose from studies of the 
mammalian β-globin locus, which is among the first gene clusters at which long-range 
chromosomal interactions between a powerful distal enhancer, the locus control region 
(LCR), and the target β-globin promoters were described (Carter et al., 2002; Tolhuis et 
al., 2002). Mechanistic studies defined gene-specific transcription factors that establish 
LCR-β-globin interactions, including the hematopoietic-restricted factors GATA1 and its 
co-factor FOG1 (Vakoc et al., 2005), KLF1 (Drissen et al., 2004), and the more broadly 
expressed protein Ldb1 (Song et al., 2007). Functional disruption of any of these factors 
was associated with reduced LCR-β-globin interactions and diminished β-globin 
transcription. However, physical interactions among all of these proteins have been 
reported (Cantor and Orkin, 2002), making it difficult to distinguish whether they 
function in linear or parallel pathways. Moreover, whether loss of looping underlies the 
loss of transcription or vice versa remains an open question in these studies.  
 GATA elements are present at the β-globin promoter and LCR, suggesting that 
GATA1 and its co-factors are involved in the juxtaposition of these sites. Restoring 
GATA1 activity in the GATA1 null proerythroblast cell line G1E leads to an GATA1-
dependent activation of β-globin gene transcription with concomitant LCR-β-globin 
looping (Vakoc et al., 2005). The transcription co-factor Ldb1 (also called NLI) does not 
bind DNA directly but is recruited to E-box elements or GATA elements via a multi-
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component complex that includes the TAL1, LMO2, E2A and GATA1 (see Chapter 1.1). 
Chapter 2 and subsequent studies show that GATA1 and Ldb1 display a highly 
overlapping genomic occupancy pattern but notably, Ldb1 association strongly favors 
sites at which GATA1 functions as a transcriptional activator, such as the β-globin locus 
(Cheng et al., 2009; Kassouf et al., 2010; Soler et al., 2010; Tripic et al., 2009; Wu et al., 
2011). Several observations suggest that Ldb1 might be a critical effector of GATA1’s 
looping function. First, knockdown of Ldb1 impairs LCR-β-globin looping (Song et al., 
2007). Second, the Drosophila homolog of Ldb1, Chip, is required for long-range 
enhancer action (Morcillo et al., 1997). Third, like GATA1, Ldb1 co-occupies the β-
globin promoter and LCR and might therefore function by physically linking the two 
(Song et al., 2007; Tripic et al., 2009). Fourth, Ldb1 can form homodimers and even 
higher order oligomers (Cross et al., 2010; Jurata and Gill, 1997), which might underlie 
its role in loop formation.  
Numerous studies indicate that chromatin loops are highly dynamic and associated 
with transcription change. However, these studies are descriptive of correlations by 
nature, and leave open the question as to whether these long-range interactions are a 
cause or consequence of dynamic changes in transcription initiation. Prior studies in 
prokaryotes (for review see (Marenduzzo et al., 2007)) as well as in eukaryotic cells 
using plasmid constructs have succeeded in influencing gene expression through forced 
looping among regulatory elements (Ameres et al., 2005; Mahmoudi et al., 2002; Nolis et 
al., 2009; Petrascheck et al., 2005). However, the use of plasmids with altered chromatin 
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configuration and the relatively short genomic distances might limit inferences with 
regard to long-range chromatin interactions at native gene loci. 
Here we devised a strategy to modulate chromatin looping at an endogenous locus in 
its native environment. This enabled us to address whether forced chromatin looping can 
activate transcription, to examine the hierarchy of transcriptional regulators in chromatin 
looping, and to define the ensuing molecular and functional consequences. For our 
studies we used G1E erythroid cells since they lack transcription factor GATA1 and thus 
fail to establish an LCR-β-globin loop and transcribe β-globin. Ldb1 recruitment to the β-
globin promoter is entirely GATA1 dependent, whereas substantial amounts of the 
Tal1/Ldb1 complex remain associated with LCR in the absence of GATA1 (Figure 2.2 
and 2.3 of Chapter 2 and Figure 3.1 A). Therefore, Ldb1 recruitment by GATA1 to the 
promoter might represent a critical rate-limiting step in juxtaposing the LCR with the 
promoter to form a loop required for transcription initiation  (Figure 3.2 A). We tested 
this hypothesis by using a zinc finger (ZF) targeting approach to tether Ldb1 to the β-
globin promoter in G1E cells (Figure 3.2 A). Notably, promoter bound ZF-Ldb1 was 
capable of inducing a chromatin loop in G1E cells to an extent similar to that achieved by 
GATA1 restoration. ZF-Ldb1 constructs completely restored RNA polymerase II (Pol II) 
recruitment and Pol II serine 5 phosphorylation (Ser5ph), and partially rescued β-globin 
transcription. Genetic experiments in erythroid cells heterozygous for a deletion of the 
LCR confirmed that the ZF-Ldb1 proteins functioned via a long-range looping 
mechanism. These results reveal that forced juxtaposition of regulatory regions can 
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activate transcription and establish Ldb1 as a critical rate-limiting effector of GATA1 
during chromatin looping. 
 
3.3: Results 
3.3.1: Zinc finger-mediated targeting of Ldb1 to the endogenous β-globin locus 
As a strategy to tether potential looping factors to the endogenous β-globin locus we 
chose artificial zinc finger proteins (ZF) since they have been used successfully to target 
preselected genomic sites in vivo (for review see (Klug, 2010)). ZFs were synthesized to 
target the β-major promoter (P-ZF) and DNase1 hypersensitive site 2 (HS2) of the LCR 
(L-ZF) (Figure 3.1 B) as these sites were previously found to be in close physical 
proximity (Carter et al., 2002; Tolhuis et al., 2002). Six zinc fingers were linked in 
tandem to target 18 base pairs of genomic sequence (for review see (Klug, 2010)). Target 
sequences were chosen within the DNase I hypersensitive regions to facilitate access to 
the ZFs but avoid interference with known transcription factor binding sites (Figure 3.1 
B). Binding of the ZFs to their designated DNA sequences was characterized using a 
previously described ELISA-based assay (data not shown) (Bartsevich et al., 2003). ZFs 
were fused to an HA tag and a nuclear localization sequence (NLS), and their chromatin 
binding profiles were examined by chromatin immunoprecipitation (ChIP) following 
introduction into G1E cells (Figures 3.1 C, D and data not shown). ZFs with suitable 
binding properties were fused to Ldb1, and introduced into a retroviral vector containing 
an IRES-GFP or IRES-YFP cassette. Upon infection of G1E cells, populations of 
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GFP/YFP positive cells were purified by fluorescence activated cell sorting (FACS) and 
subjected to anti-HA ChIP. We identified a P-ZF that strongly bound the β-globin 
promoter in G1E cells (Figure 3.1 C). Fusion of Ldb1 with P-ZF (P-Ldb1) retained strong 
binding to the β-globin promoter but was also detectable at low levels at multiple HSs of 
the LCR (Figure 3.2 B). In the absence of the Ldb1 moiety, this ZF bound to these LCR 
sites with lower efficiency (Figure 3.1 C), indicating that the association of P-Ldb1 with 
the LCR is in large part due to its interaction with endogenous Ldb1 complexes at the 
LCR (Tripic et al., 2009). In addition, L-Ldb1 (L-ZF fused to Ldb1) was found to bind to 
HS2 but not the β-globin promoter (Figure 3.2 C), consistent with the lack of endogenous 
Ldb1 complexes in the absence of GATA1 (Figure 3.1 A). Finally, cells co-expressing L-
Ldb1 and P-Ldb1 produced comparable ChIP signals at the LCR and β-major promoter 
(Figure 3.2 D). 
It is noteworthy that ChIP results comparing several ZF proteins in erythroblasts and 
fibroblasts (not shown) revealed that the binding properties of ZFs to naked DNA 
sequences in vitro do not fully predict their binding efficiency in vivo. Nevertheless, we 
were able to identify a ZF pair capable of targeting Ldb1 to the β-globin locus.  
3.3.2: Tethering Ldb1 to the β-globin locus activates transcription in the absence of 
GATA1 
LCR-promoter looping is required for high-level globin gene expression throughout 
erythroid development. Therefore, we examined whether promoter- and/or LCR-tethered 
Ldb1 induces β-globin transcription in G1E cells. Since G1E cells lack GATA1, the β-
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globin promoter is devoid of Ldb1 whereas the LCR retains significant amounts of Ldb1 
mediated by the TAL1 complex bound to E-box elements (Figures 3.1 A). Remarkably, 
expression of P-Ldb1 activated β-globin transcription over a thousand-fold (Figure 3.3 A) 
amounting to approximately 20% of that achieved upon restoration of GATA1 (G1E-ER4 
cells) (Figure 3.3 B). L-Ldb1 alone or ZFs without the Ldb1 moiety displayed little 
activity (Figure 3.3 A). Co-expression of P-Ldb1 and L-Ldb1 failed to further activate β-
globin expression compared to P-Ldb1 by itself (Figure 3.3 A). Because high level β-
globin expression requires the LCR (Bender et al., 2000), these results suggest that 
promoter-bound Ldb1 is sufficient to promote long-range contacts with at the LCR, 
presumably via endogenous Ldb1, to activate transcription (see below). Measurements of 
β-globin expression were confirmed with multiple primer pairs directed against the β-
globin transcript (Figure 3.3 C). Moreover, the effects of ZF-Ldb1 expression were gene-
specific and not simply a consequence of a general differentiation induction since the 
expression of several additional GATA1 activated (Klf1, Eraf, bH1) and repressed 
(Gata2, Kit) genes was unchanged (Figure 3.3 D, and data not shown). The potent 
activation by ZF-Ldb1 fusion proteins of β-globin transcription is particularly remarkable 
since it occurred in the absence of GATA1, which is essential for β-globin transcription. 
The substantial β-globin transcriptional activation by ZF-Ldb1 strongly implicates an 
LCR looping mechanism since β-globin transcription is reduced to ~1% of normal when 
the LCR is deleted (Bender et al., 2000). Moreover, Ldb1 occupancy at the β-globin 
promoter is normal in the absence of the LCR (Song et al., 2010), indicating that 
promoter-bound Ldb1 alone is insufficient for β-globin transcription without the LCR. 
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Although β-globin activation by ZF-Ldb1 fusion proteins was substantial, their effects 
did not match those of GATA1, consistent with GATA1 exerting functions in addition to 
chromatin looping.  
3.3.3: Tethering of the Ldb1 self-association domain is sufficient for β-globin activation 
Ldb1 contains an N-terminal self-association (SA) domain that mediates the assembly 
of higher order molecular complexes and might account for its looping function (Cross et 
al., 2010; Xu et al., 2003), and a C-terminal LIM interaction domain (LID) that confers 
binding to LMO2 and its associated GATA1/TAL1/E2A multi-protein complex. To 
examine whether the SA domain is sufficient for transcription activation, it was fused 
with L-ZF and P-ZF and introduced into G1E cells. P-SA and L-SA showed very similar 
genomic binding profiles as the full-length Ldb1 fusion constructs such that L-SA 
occupied HS2 whereas P-SA bound the β-globin promoter and additionally the LCR 
(Figure 3.4 A). Remarkably, expression of P-SA alone or co-expression of L-SA and P-
SA activated β-globin gene transcription to virtually the same level as did the full-length 
Ldb1 fusion proteins (compare Figures 3.4B with Figure 3.3A). Again, the effects of ZF-
SA were gene-specific and did not globally alter erythroid gene expression (Figure 3.4C). 
These results suggest that the Ldb1 self-association domain is sufficient to induce β-
globin transcription, further supporting the idea that forced juxtaposition between the 
LCR and β-globin promoter underlies transcriptional activation.  
We also considered the possibility that the remaining portions of Ldb1 might 
participate in chromatin looping by nucleating higher order protein complexes. To this 
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end we generated a ZF-Ldb1 fusion protein lacking the SA domain (P-∆SA) but leaving 
the nuclear localization sequence and LID domain intact. P-∆SA was capable of inducing 
β-globin transcription albeit to a significantly lower degree than P-SA (Figure 3.4D). 
Activation never exceeded 50% of that observed with P-SA even under the most optimal 
conditions and expression levels (Figure 3.4D and data not shown). This supports the 
idea that the SA domain is most efficient in nucleating higher order complexes required 
for looping. Nevertheless, these results are also consistent with the possibility that Ldb1 
can engage its partner proteins via distinct domains to produce chromatin loops. 
3.3.4: Tethering of the Ldb1 self-association domain induces LCR-promoter looping 
The strong induction of β-globin transcription by ZF-Ldb1 or ZF-SA implicates an 
involvement of the LCR and hence chromatin looping, since in the absence of the LCR β-
globin transcription is very low (Bender et al., 2000). Therefore, we examined by 3C 
assay whether expression of ZF-SA constructs juxtaposed the LCR with the β-globin 
gene to form a chromatin loop (for 3C assay optimization, see Chapter 3.6). Using HS2 
as the anchor region we found that in parental G1E cells the 3C signals generally 
declined with increasing distance (Figure 3.5A), consistent with our previous 
observations (Vakoc et al., 2005). In particular, there is no interaction between HS2 and 
β-globin. Upon GATA1 restoration, the relative proximity of HS2 with two adjacent 
fragments comprising the β-major globin gene significantly increased (Figure 3.5A). HS2 
interactions with intervening or downstream segments remained low, indicative of a 
GATA1-dependent HS2-β-globin chromatin loop (Vakoc et al., 2005). We next 
determined the chromatin conformation of the β-globin locus in G1E cells expressing ZF-
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SA proteins. Strikingly, expression of P-SA alone but not L-SA produced a strong HS2-
β-globin chromatin loop, recapitulating the chromatin conformation induced by GATA1 
(Figures 3.5 B, C). Thus, recruitment of the SA domain to the β-globin promoter is 
sufficient for juxtaposition with the LCR, likely via interaction with endogenous LCR-
bound Ldb1 (Figures 3.1A, Model in Figure 3.2A). Co-expression of P-SA and L-SA 
triggered juxtaposition of HS2 with the β-globin gene with a similar efficiency as the P-
SA alone (Figure 3.5D). Given the lower levels of occupancy of P-SA at HS2 in 
comparison to L-SA, it was surprising to find that P-SA was as active as the combination 
of L-SA plus P-SA or GATA1. It is possible that the ChIP signal for P-SA at the LCR 
under-represents the amounts of P-SA since proteins indirectly associated with DNA are 
not cross-linked as efficiently. Moreover, P-SA association with multiple regions in the 
LCR via endogenous Ldb1 likely adds to its ability to promote loop formation. 
Nevertheless, forced LCR-β-globin chromatin looping correlated well with activation of 
β-globin transcription. 
In concert, these results show that tethering the SA domain of Ldb1 to the β-globin 
promoter is sufficient to produce an LCR-β-globin chromatin loop that is similar if not 
identical to that generated by GATA1. This strongly suggests that Ldb1 is an essential 
rate-limiting effector of GATA1 during chromatin looping. More generally, juxtaposition 
of an LCR with a promoter causes strong gene activation.  
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3.3.5: ZF-SA expression produces LCR-dependent functions 
Two of the key functions of the β-globin LCR functions are the recruitment of Pol II 
to the β-globin promoter and stimulation of Pol II phosphorylation at serine 5 of its C-
terminal domain, a modification associated with early transcription elongation (Sawado 
et al., 2003). Hence, if ZF-SA proteins activate β-globin transcription by promoting LCR-
 β-globin contacts, they are expected to stimulate Pol II recruitment and serine 5 
phosphorylation (Ser5ph). To examine the extent to which ZF-SA fusion protein restored 
LCR-dependent function, we performed ChIP with antibodies against Ser5ph Pol II, or 
antibodies that react with Pol II regardless of its phosphorylation state. Notably, 
expression of P-SA triggered Pol II recruitment to the β-globin promoter with an 
efficiency similar to that achieved by GATA1 expression (Figure 3.6 A, B). In contrast, 
Pol II levels in the body of the gene amounted to approximately 25% to 30% of those 
found in GATA1 expressing cells corresponding well with the levels of β-globin mRNA 
production (Figure 3.3B). This is consistent with reduced recruitment of the elongation 
complex P-TEFb to the β-globin promoter and the body of the gene when compared to 
GATA1 expressing cells (as measured by anti-CDK9 ChIP, Figure 3.6 C). The amounts 
of Ser5ph Pol II found at the β-globin gene in P-SA expressing cells were 
indistinguishable from those observed in GATA1-expressing cells (Figure 3.7 A). As an 
additional measure of transcription initiation, we determined the level of histone H3 
lysine 4 trimethylation (H3K4me3), and found that P-SA restored this mark to levels 
equal to that produced by GATA1 (Figure 3.7 B). Similar results were obtained in cells 
co-expressing P-SA and L-SA (data not shown). These results demonstrate that two 
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functions of the LCR, i.e. Pol II recruitment to the β-globin promoter and Pol II serine 5 
phosphorylation were completely restored by expression of P-SA, lending additional 
support to the idea that juxtaposition of the LCR with the β-globin promoter underlies the 
activity of P-SA. The failure to fully restore transcription elongation can be explained by 
the lack of GATA1 and its co-factors which exert additional, looping-independent 
functions, possibly including the recruitment and activation of P-TEFb complex (Bottardi 
et al., 2011; Elagib et al., 2008, see Discussion). 
3.3.6: Precocious induction of β-globin transcription by ZF-SA fusion proteins in 
primary erythroblasts 
We examined whether ZF fusion proteins function in primary erythroid progenitor 
cells to activate β-globin expression. The maturation stage of primary erythroid precursor 
cells from E13.5 wild type fetal livers was monitored by flow cytometry measuring the 
expression of the cell surface markers Ter119 and CD71 (Zhang et al., 2003). Cells 
progress through the R1, R2, R3, and R4 stages of maturation (Figure 3.8 A), and 
gradually increase expression of erythroid specific transcription factors (e.g. GATA1, 
KLF1) and repress transcription factors of immature stage (e.g. GATA2, Kit) (Figure 3.8 
B),   and ultimately produce abundant amounts of α-globin and β-globin (Figure 3.8 C) . 
For the expression of ZF-SA proteins we purified Ter119-, CD71-/low cells (R1 population 
in Figure 3.8 A) representing early precursor cells. At this stage, the β-globin genes are 
not yet highly active but cells express low levels of essential regulatory factors, including 
GATA1 and KLF1 (Figure 3.8 C). Following infection with retrovirus expressing ZF-SA 
fusion proteins, cells were cultured in defined medium containing cytokines IL-3, IL6 
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and SCF to preserve the cells in the precursor state. Remarkably, expression of P-SA only 
or P-SA/L-SA, but not L-SA alone precociously activated β-globin transcription (Figure 
3.9 A). Note that the fold-activation over control was not as pronounced as that observed 
in the G1E system, since in contrast to the latter, primary erythroblasts are replete with 
transcription factors and produce higher levels of β-globin even prior to full maturation. 
Nonetheless, these results in essence mirrored those from G1E cells in that the same 
combinations of ZF fusion proteins were capable of activating β-globin expression. The 
effects were specific to the β-globin locus as no other erythroid genes examined were 
altered in their activities (Figure 3.9 A). Moreover, ZF-SA expression did not non-
specifically promote erythroid maturation as determined by flow cytometry using CD71 
and Ter119 surface markers (Figure 3.9 B). Together, these results show that ZF-SA 
fusion constructs can activate β-globin transcription in primary erythroid cells.  
3.3.7: ZF-SA fusion protein induction of β-globin transcription is LCR-dependent 
Targeting of the SA domain to the β-globin locus restores juxtaposition of HS2 with 
the β-globin gene, Pol II recruitment, and Pol II serine 5 phosphorylation, strongly 
suggesting that transcriptional activation is due to LCR- β-globin looping. The prediction 
from these observations is that alleles lacking the LCR would not respond to ZF-SA 
fusion proteins (Figure 3.10 A). Alternatively, if β-globin transcription simply resulted 
from SA-induced transcription factor assembly at the β-globin promoter, ZF-SA should 
activate transcription independently of the LCR. This distinction is especially important 
in light of the positive effects on β-globin transcription exerted by the expression of P-SA 
alone. To definitively distinguish between these possibilities, we examined ZF-SA’s 
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functions in E13.5 fetal liver erythroblasts derived from mice that are heterozygous for a 
deletion of the LCR (∆LCR/+) (Bender et al., 2000). The β-major gene on the ∆LCR 
allele is of the D haplotype whereas that on the wild type allele is of the S haplotype. We 
developed an allele-specific qPCR assay that distinguishes single nucleotide 
polymorphisms between the transcripts of these alleles (Figure 3.11), providing an ideal 
internally controlled experimental setup. 
Next we transduced ∆LCR/+ R1 cells with viral vectors expressing ZF-SA proteins 
and exposed them to erythropoietin (Epo) for 6 hours to promote erythroid maturation. 
Allele-specific RT-qPCR demonstrated that the wild type allele (βmaj-S) was activated in 
cells expressing L-SA together with P-SA, or P-SA alone (Figure 3.10 B, left panel). L-
SA had little or no activity similar to ZFs lacking SA that served as negative controls. In 
striking contrast, the β-major gene on ∆LCR allele (βmaj-D) was expressed at low levels 
and showed very little response to the P-SA/L-SA or P-SA proteins (Figure 3.10 B, 
middle panel). The effects were specific to the β-globin locus as no other erythroid genes 
examined were altered in their activities (Figure 3.10 C). The effects of ZF fusion protein 
expression were the essentially the same in the presence or absence of erythropoietin and 
specific to the β-globin locus as none of the other examined erythroid genes were altered 
in their activities (Figures 3.12). The residual signal produced by the D-allele-specific 
primers was not due to transcription from the D-allele but the result of cross-
hybridization with S-allele cDNA. This was demonstrated by template mixing 
experiments showing that approximately 10% of the signal produced by the D-allele-
specific primers derived from cross-reactivity with the S-allele cDNA (Figure 3.11).  
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Indeed, when homozygous (∆LCR/∆LCR) R1 cells were transduced with P-SA, β-globin 
activation was close to background, establishing that the low signal obtained with D-
specific primers in ∆LCR/wt cells was in fact due to cross-hybridization (Figure 3.10 B, 
right panel). In concert, the results clearly demonstrate that the activity of ZF-SA proteins 
is entirely dependent on the presence of LCR and hence on long-range chromatin 
looping. 
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3.4: Discussion 
Here we employed a ZF targeting strategy to address critical questions concerning the 
higher order organization of the chromatin fiber. Targeting the SA domain of Ldb1 to the 
endogenous β-globin locus compensated to a significant extent for the loss of GATA1, 
strongly suggesting that Ldb1 serves as an effector of GATA1 during chromatin loop 
formation. Forced chromatin looping by ZF-SA proteins at a native gene locus caused 
strong transcriptional activation, indicating that the juxtaposition of an enhancer with a 
promoter causally underlies gene induction.  
Expression of P-SA by itself produced effects very similar to those of P-SA and L-SA 
co-expression. Several independent lines of investigation demonstrate that in P-SA 
expressing cells, forced loop formation accounts for β-globin activation. First, 3C 
experiments clearly showed that tethering the SA domain to the β-globin promoter 
fostered genomic contacts that strongly resembled those induced by GATA1 with regard 
to both their spatial configuration and efficiency. Second, SA domain recruitment 
completely restored several LCR-dependent functions at the β-globin promoter, including 
Pol II recruitment, serine 5 phosphorylation of Pol II, and H3K4 methylation. Third, 
targeted deletion of the LCR dramatically reduced β-globin transcription without 
diminishing the amounts of promoter-bound Ldb1 (Song et al., 2010). Therefore, 
tethering Ldb1 or its SA domain to the promoter is not expected to produce such 
pronounced effects without an involvement of the LCR. Fourth, P-SA and P-SA/L-SA 
induction of β-globin expression was entirely dependent on the LCR, confirming an 
underlying looping mechanism. The ability of P-SA to potently induce loop formation is 
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most likely explained by its ability to interact with endogenous Ldb1-containing 
complexes that reside at the LCR even in the absence of GATA1 (Figure 3.1)(Tripic et 
al., 2009). In contradistinction, Ldb1 association with the β-globin promoter is entirely 
GATA1-dependent, and hence might represent a critical and rate limiting step during 
chromatin looping and high-level transcription. 
The observation that the SA domain is sufficient to induce long-range chromatin 
interaction implies that self-association of Ldb1 is a major molecular force tying together 
anchored chromatin regions. Importantly, the SA domain can form multimers (Cross et 
al., 2010) allowing for the formation of higher order complexes that might serve to 
stabilize interactions between distant chromatin fragments. However, the SA-deleted 
form of Ldb1 was also active, suggesting that the LID domain is also capable, albeit with 
lower efficiency, of recruiting the endogenous Ldb1 complex to promote long-range 
interactions.  
While it is conceivable that in the simplest terms the mere dimerization of DNA 
bound factors should be capable of inducing chromatin loops, we speculate that multiple 
contacts are required to provide the requisite specificities and affinities. Moreover, the 
folding of the chromatin fiber can occur in complex patterns involving simultaneous 
interactions between multiple segments to form what are called chromatin hubs. Simple 
protein dimers might be insufficient to accommodate such complex interaction patterns. 
In agreement, fusion of ZFs with diverse dimerizering domains (lexA, p65NFkB, the 
Argent™ dimerization system) or protein modules that can form multimers, such as the 
POZ domain of GAGA factor failed to efficiently activate β-globin expression 
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(unpublished observations). Thus, Ldb1 might have evolved to promote such interactions 
by forming homo-multimers and by engaging numerous gene-specific transcription 
factors, including the LMO2/TAL1/E2A complex and GATA1. Indeed, a widely used 
and evolutionarily conserved looping function for Ldb1 is suggested by studies in diverse 
organisms and cell lineages (Matthews and Visvader, 2003; Morcillo et al., 1997; Thaler 
et al., 2002). 
The cause-effect relationship between chromatin looping and gene regulation has 
been unclear. By manipulating the chromatin conformation at a native gene locus, we 
found that juxtaposition of an enhancer with its target gene leads to transcription 
activation, indicating that looping is a prerequisite for transcription activation. In 
particular, forced association between the LCR and the β-globin gene sufficed to exert 
two functions ascribed to the LCR, the formation of a pre-initiation complex at the 
promoter and the generation of early elongating Pol II as reflected in serine 5 
phosphorylation (Sawado et al., 2003; Song et al., 2010). On the other hand, our 
observation that ZF-Ldb1 proteins completely rescued chromatin looping but only 
partially restored transcription elongation agrees with the notion that full transcription is 
not required for loop formation (Jing et al., 2008; Mitchell and Fraser, 2008; Palstra et al., 
2008b). We speculate that juxtaposition of the LCR with β-globin promoter increases the 
concentration of nuclear regulators at the promoter above a threshold critical for pre-
initiation complex formation and early transcription elongation  (see model in Figure 
3.13). 
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Ldb1 recruitment in GATA1 null cells completely rescued chromatin looping and 
transcription initiation, but only partially restored transcription elongation, indicating that 
GATA1 contributes additional functions independently of Ldb1 and chromatin looping. 
Indeed, both the recruitment of P-TEFb complex and its distribution along the gene were 
impaired in the absence of GATA1, suggesting GATA1 impacts on P-TEFb regulation at 
multiple levels, perhaps via direct interaction (Bottardi et al., 2011; Elagib et al., 2008) or 
indirectly via proteins of the BET family (Lamonica et al., 2011). In addition, GATA1 
interacts with many other transcription factors and histone modifiers, the lack of which 
might account for inefficient transcription elongation.  
In concert, these results suggest that Ldb1 functions downstream of GATA1 rather 
than in a parallel pathway and highlight the usefulness of this system to interrogate 
protein functions during distinct steps in the transcription cycle. In more general terms, 
this work illustrates a novel strategy to establish hierarchical orders of transcription factor 
function. On the background of a transcription factor deficiency, forced tethering of a 
potential co-factor to a chosen gene can be employed to measure its contribution to 
defined steps in the transcription cycle, such as loop formation, Pol II recruitment, Pol II 
phosphorylation, and productive transcription elongation. We believe that this approach 
is widely applicable for any nuclear factors that can be knocked down or knocked out.  
One key general finding of our study is that a single ZF-Ldb1 protein targeted to the 
β-globin promoter can induce a chromatin loop by interacting with endogenous LCR-
bound factors.  ZFs have previously been linked to activation domains to successfully 
activate gene expression (Klug, 2010). However, the use of ZFs to promote interactions 
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with a potent enhancer or LCR is expected to produce more pronounced transcriptional 
effects. Indeed, we are not aware of any single ZF proteins capable of activating gene 
transcription by a factor of more than a 1000-fold. Another advantage of a forced looping 
approach by a single ZF construct, especially in the context of therapeutic applications, is 
that efficient expression of a single molecule is easier than co-expression of two factors at 
matching levels. 
Finally, specific chromatin loops can occur at repressed genes (Jing et al., 2008), and 
placing an enhancer and promoter on separate loops can isolate the enhancer to render it 
inactive (Ameres et al., 2005; Hou et al., 2008). Thus, in addition to activating 
transcription, we envision that forced chromatin looping could be used to silence gene 
expression for scientific or therapeutic purposes.  
 
3.5: Figures 
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Figure 3.1  
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Figure 3.1. ZFs targeting of the β-globin locus. (A) Anti-GATA1 (top) and anti-TAL1 
(middle and bottom) ChIP-seq tracks encompassing the β-globin locus from parental 
G1E cells (middle) and G1E cells expressing induced GATA1-ER (top, bottom). TAL1 is 
a reliable indicator for the presence of Ldb1 since their occupancy patterns are virtually 
identical (Tripic et al., 2009). Note that in the absence of GATA1, TAL1 is completely 
lost from the β-major globin promoter but not the LCR. (B) L-ZF and P-ZF target HS2 of 
the LCR (red oval) and the β-major promoter (red triangle), respectively. The DNA 
sequences used for ELISA experiments are shown, including 18 nucleotides of ZF 
binding site (uppercase) and the flanking nucleotides (lowercase). Anti-HA ChIP profiles 
of HA tagged P-ZF (C) and L-ZF (D) in G1E cells were shown. N=3; error bars denote 
standard deviation. 
99 
 
Figure 3.2 
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Figure 3.2. ZF-mediated targeting of Ldb1 to the β-globin locus.  (A) Experimental 
model. Top: wild-type scenario in which GATA1 and the TAL1 complex recruit Ldb1 to 
promote chromatin looping. Middle: lack of GATA1 leads to loss of Ldb1 at the 
promoter, impaired looping, and reduced transcriptional activation. Bottom: ZF-mediated 
Ldb1 tethering to the β-globin promoter is examined for its ability to restore looping and 
transcription activation. (B) Top: P-ZF and L-ZF target the β-major promoter  (red 
triangle) and HS2 of the LCR (red oval), respectively. (B-D) Anti-HA ChIP in cells 
expressing P-Ldb1 (B), L-Ldb1 (C), and L-Ldb1+P-Ldb1 (D). L-Ldb1 binds selectively 
to HS2 of the LCR. Of note, P-Ldb1 binds to the promoter but additionally associates 
with HS 1, 2, 3 of the LCR but not to other regions, including the εy, βH1, and βmin 
genes, an intervening region (IVR16) or an inactive gene (CD4). N≥3; error bars denote 
standard deviation.  
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Figure 3.3 
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Figure 3.3. Activation of β-globin transcription in GATA1 null cells by tethered 
Ldb1. (A) β-major mRNA levels as measured by RT-qPCR with primer pairs for exon 2 
in G1E cells and derivatives expressing indicated ZF and ZF-Ldb1 constructs. (B) Data in 
(A) were re-plotted next to those obtained from induced G1E-ER4 cells (G1E+GATA1). 
Note that β−major expression achieved by P-Ldb1 or L-Ldb1+P-Ldb1 amounts to 
approximately 20% of that induced by GATA1. (C) β-major mRNA levels in ZF-Ldb1 
expressing cells as measured by RT-qPCR with primer pairs for exon 2/3 junction, 5UTR 
and 3UTR. (D) Relative expression of indicated erythroid genes as determined by RT-
qPCR. Transcript levels were normalized to β-actin. N≥3; error bars denote standard 
deviation.  
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Figure 3.4 
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Figure 3.4. The self-association domain of Ldb1 is sufficient for sufficient for β-
globin activation. (A) Top: schematic of Ldb1. SA, self association domain, LID, LIM 
interaction domain. Bottom: Anti-HA ChIP profiles in G1E cells expressing L-SA (top), 
P-SA (middle), and L-SA+P-SA (bottom). L-SA binds selectively to HS2 of the LCR. Of 
note, P-SA binds to the promoter and additionally associates with HS 1, 2, 3 of the LCR 
but not to other regions, including the εy, βH1, and βmin genes, an intervening region 
(IVR16) or an inactive gene (mCD4). (B) β-major mRNA levels in G1E cells expressing 
indicated ZF fused to the SA domain of Ldb1. (C) mRNA levels of indicated genes as 
measured by RT-qPCR in G1E cells and derivatives expressing indicated ZF and ZF-SA 
constructs. Note that while β-major is dramatically activated in P-SA or P-SA/L-SA cells, 
mRNA levels of GATA1 repressed (Gata2, Kit) and activated (Eraf) genes were largely 
unchanged by ZF-fusion protein expression. (D) β-major mRNA levels as measured by 
RT-qPCR in G1E cells expressing indicated fusion proteins of ZF with full-length Ldb1, 
SA domain or Ldb1 protein with SA deletion. N=3; error bars denote standard deviation. 
mRNA levels were normalized to β-actin.  
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Figure 3.5 
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Figure 3.5. Chromatin looping by the tethered Ldb1 self-association domain. (A-
D) 3C assay measuring locus wide cross-linking frequencies in G1E cells (blue) or 
induced G1E-ER4 cells expressing GATA1 (A, red), or G1E cells containing P-SA (B, 
red), L-SA (C, red) or L-SA+P-SA (D, red). The murine β-globin locus is depicted on top 
of each graph. The X-axis indicates distances (kb) from the εy gene, which represents 
zero. Black bar denotes the HS2-containing BglII fragment serving as anchor. Grey bars 
denote analyzed BglII fragments. N=3 (A,B,D), and N=2 (C). Error bars indicate 
standard-error-of-mean.  
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Figure 3.6 
 
Figure 3.6. Recruitment of Pol II and CDK9 by ZF-SA expression. (A) Location 
of amplicons (black bars). Prom, promoter; numbers indicate exons. (B, C) ChIP profiles 
with antibodies against total Pol II (B), CDK9 (C) using G1E cells or G1E cells 
expressing GATA1 or P-SA. N=3; error bars denote standard deviation. 
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Figure 3.7 
 
Figure 3.7. Restoration of Pol II serine 5 phosphorylation and H3 lysine 4 tri-
methylation by ZF-SA expression. ChIP profiles with antibodies against total Pol II 
Ser5ph (B), H3K4me3 (C) using G1E cells or G1E cells expressing GATA1 or P-SA. 
N=3; error bars denote standard deviation. 
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Figure 3.8 
 
Figure 3.8. Staging of E13.5 fetal liver erythroid cells.  (A) Isolation and FACS profile 
of E13.5 fetal liver erythroid cells staining with Ter119 and CD71 antibodies. (B, C) 
mRNA level of indicated genes in R1 to R4 populations of fetal liver cells as measured 
by qPCR. N=3; error bars denote standard deviation.  
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Figure 3.9 
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Figure 3.9. ZF-SA specifically enhances β-globin expression in primary early 
progenitor cells. (A) mRNAs from FACS purified R1 cells transduced with ZF 
constructs were examined by RT-qPCR with primers for the indicated genes. Negative 
controls (Neg Ctrl), cells expressing empty vector. Results were normalized to GAPDH. 
N=3; error bars denote standard deviation. (B) Differentiation profiles of R1 cells 
expressing indicated constructs as measured by flow cytometry using Ter119 and CD71 
surface markers.  
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Figure 3.10 
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Figure 3.10. LCR-dependence of β-globin induction by ZF-SA proteins. (A) 
Experimental concept. The LCR deleted allele is on the background of the β-major D 
haplotype while the wild type allele is of the β-major S haplotype. (B) β-major transcript 
levels as measured by allele-specific RT-qPCR in R1 cells from WT/ΔLCR or 
ΔLCR/∆LCR fetal livers expressing indicated ZF-SA proteins. R1 cells were treated with 
erythropoietin (Epo) for 6 hours following transduction with ZF-SA expression 
constructs. (C) mRNA levels of indicated genes in R1 cells from WT/ΔLCR fetal livers 
expressing indicated ZF-SA proteins. Transcript levels were normalized to GAPDH. 
N=3; error bars denote standard deviation. 
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Figure 3.11 
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Figure 3.11. Allele-specific qPCR. (A) β-major mRNA levels of D and S haplotypes as 
measured by qPCR using allele-specific primers βmaj-D and βmaj-S, respectively. cDNA 
from D haplotype or S haplotype was prepared from 129 or BL6 mouse strains, 
respectively. Note that the βmaj-S primer specifically amplified BL6 cDNA but not 129 
cDNA. In contrast, the βmaj-D primer cross-amplified BL6 cDNA with an efficiency ~ 
10% of the βmaj-S primer. Allele specificity was further examined by mixing D-cDNA 
and S-cDNA templates. The observed qPCR signal (C) largely matched the expectation 
(B) for allele-specific qPCR. The βmaj-S signal remained unchanged with increasing 
amount of D cDNA verifying its amplification specificity. However, increasing the 
proportion of S cDNA led to an augmented signal with the D-specific primers indicative 
of cross-reactivity up to ~ 10%. 
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Figure 3.12 
  
Figure 3.12. LCR-dependence of β-globin induction by ZF-SA without Epo 
treatment. mRNA levels of β-major from D or S alleles (A) or indicated genes (B) in R1 
cells from WT/ΔLCR fetal livers expressing indicated ZF-SA proteins. R1 cells were 
transduced with ZF-SA expression constructs without Epo treatment. N=3; error bars 
denote standard deviation. mRNA levels were normalized to GAPDH. N=3; error bars 
denote standard deviation. 
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Figure 3.13 
 
 
Figure 3.13. Hypothetical model functionally integrating chromatin looping and 
transcription activation. Recruitment of Ldb1 to the β-globin promoter either by ZF 
proteins or GATA1 promotes LCR-promoter looping. Forced chromatin looping by ZF-
Ldb1 efficiently restores PIC assembly, Pol II recruitment, Pol II serine 5 
phosphorylation, and transcription initiation. In the absence of GATA1, diminished 
recruitment of P-TEFb and likely additional GATA1 co-factors accounts for inefficient 
transcription elongation. Therefore, chromatin looping can trigger transcription initiation 
and can occur independently of full transcription elongation. 
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3.6: Additional Result: Optimization of 3C assay  
Chromosome conformation capture assay is to analyze the organization of 
chromosomes in the natural state of a cell by measuring relative proximity of paired 
chromatin regions (Figure 3.14). Cells are first cross-linked by formaldehyde to conserve 
the natural conformation of chromosomes. Chromosome DNA is subsequently digested 
by restriction enzymes. Interacting chromatin fragments are in the same chromatin 
particles hence the digested ends of DNA fragments are ligated with a higher efficiency 
than those that are not interacting. qPCR using a primer pair against two digested ends of 
interest is used to measure the amounts of specific ligation products of the two DNA 
molecules. Interacting chromatin fragments have a higher crosslinking frequency, thus 
producing more ligated DNA templates and generating higher qPCR signals.  
3C assay has been wildly used to detect chromatin interactions spanning kilobases to 
megabases, at a much higher resolution than DNA FISH. However, a successful 3C assay 
requires numerous proper controls and protocol optimizations for a particular cell type. It 
is challenging to detect long-range chromatin interactions, because the majority of 
ligation products of a chromatin fragment is from self-ligation to its ends and ligation to 
its neighboring fragments. Ligation of two bona fide interacting chromatin segments, 
such as β-globin locus, occurs at a frequency of less than 1% (Simonis et al., 2007). This 
means there are only a few ligated DNA molecules of interest in a “sea” of DNA 
molecules from a thousand genomes. Hence a sensitive and accurate quantification 
approach is essential. We used taqman qPCR to detect the ligated DNA templates using 
random ligation product of BAC DNA as standard. The quality of primers are assayed as 
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in Figure 3.15 A-C.  There are five major steps of 3C, crosslinking, digestion, ligation, 
DNA purification, and quantification (Hagege et al., 2007). Efficiency of each step 
influences the occurrence of ligation of interacting chromatin fragments. Therefore, 
extensive trials have been done to optimize each of the five major steps. The detailed 
protocol is as below and rationales or caution are also commented.  
                                                 
Figure 3.14. Schematic presentation of 3C assay (adapted from (Kadauke and Blobel, 
2009)). 
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Figure 3.15. 3C quality controls. (A) A representative gel electrophoresis of BAC 
DNA. BAC DNA was purified (lane 2), digested with BglII (lane 3), and ligated with T4 
ligase (lane 4) to generate random ligation products of BglII fragments that served as 
standard DNA for the 3C assay. (B) Linearity of representative 3C primers was tested 
using serially diluted BAC DNA as template. (C) Amplification products of 
representative 3C primers were analyzed by agarose gel electrophoresis to verify primer 
specificity. (D) Digestion efficiencies at HS2 site of a representative 3C experiment.  
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Optimized 3C protocol for G1E cells and comments 
Day0: Preparation 
(1) Make fresh 20% TritonX-100 solution (1ml stock to 4ml water, cover with tin foil and 
rotate to dissolve).   
(2) Prepare cell samples, for example, induce G1E-ER4 cells with 100nM E2.  
Day1: Cross-link and digestion 
1. Count 10X106 log-phase cells, spin down and resuspend in 20ml room temperature 
(RT) PBS and then transfer to a new 50ml tube. Pipette up and down, in order to make 
single cell suspension.  
2. Add 37% formaldehyde 850 ul  (1.5% final). Gently mix and then put in a box and 
shake in horizontally circular motion on the shaker at speed 3, at RT for 10 min. 
[ Test the cross-linking condition for any new cell type. Try 1-2 % formaldehyde for 5-
10 min at RT; Higher formaldehyde is used to detect longer-range interactions, e.g. 
Inter-chromosomal interaction. ] 
3. Quench with 0.4 g Glycine powder ( the final concentration is ~0.25M) . Shake in 
horizontally circular motion on the shaker at speed 3, at RT for 5 min.  Store on ice for 
10 min. 
4. Spin down by swing bucket centrifuge, 2000 rpm (>~400g), 5 min, 4°C.  
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5. Remove carefully the supernatant and wash 10 mL ice-cold PBS, spin down @ 2000 
rpm, 5 min, 4°C. Remove sup.  
[ PBS wash is to remove any residual formaldehyde.] 
6. Resuspend cell pellet in 1.5 ml cold cell lysis buffer with protease inhibitor. Pipette up 
and down to resuspend the pellet. Store on ice for 20 min.  
[ Cell lysis buffer contains 0.2% NP40 that breaks the cytoplasmic membrane but not 
nuclear membrane. ] 
7. Lyse with cold Dounce Pestle A. (10 strokes/sample). Transfer to 1.7mL tube. 
[ Generating homogenous nuclei is essential for the next digestion step. For initial 
rounds of  experiments, take 2 ul sample +2ul H2O +16ul typan blue, and check 
under microscope to ensure cell plasma membrane is lysed well. Nuclei should be 
intact and all stained with typan blue. Otherwise, repeat step 6 and 7. ] 
8. Collect nuclei by swing bucket centrifuge, 2000 rpm (>~800g), 5 min, 4°C. 
9. Resuspend the collected nuclei in 800 ul of cold appropriate 1.2XNEB buffer (buffer 3 
for Bgl II). 
10. Collect nuclei by swing bucket centrifuge, 2000 rpm (>~800g), 5 min, 4°C. 
11. Pipette up and down to resuspend well in 500 ul of 1.2X RE buffer, avoid air 
bubble.  (500 * 1.2= 600 ul in total) 
[ Single nuclei suspension is extremely important! Aggregation of nuclei profoundly 
interferes with the digestion efficiency. ]  
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12. Add 7.5ul of 20% SDS (to a final concentration of 0.3%). Incubate with shaking 
at 950 rpm in a Thermomixer for 1 h at 37°C. 
[ Our and Dekker’s protocol us 0.1% SDS, 65°C for 10 min. However, De Latt’s and 
Fraser’s protocol use 0.3% SDS, 37°C for 1 hour; Chris Vakoc’s protocol (Vakoc et 
al., 2005) was 0.1% SDS, 37°C for 15 min. My understanding is that the purpose of 
this step is to disrupt nuclear membrane, which can be achieved at 37°C, and may 
additionally remove the non-chromatin-bound proteins in the nucleoplasm. ]  
13.  Add 50ul of 20% Triton X-100 (to a final concentration of 1.8%). Incubate with 
shaking at 950 rpm for 1 h at 37°C. 
[ The presence of SDS inhibits enzymatic reaction. In contrast, TritonX-100 is non-
denaturing detergent and its presence doesn’t interfere enzyme activity much. TritonX-
100 can form micelles with SDS and therefore “hide” SDS from proteins. Eight or 
more fold of TritonX-100 over SDS has shown to completely abolish the inhibition of 
enzyme activity by SDS (Russell, 1979). TritonX-100 is light sensitive, so keep it in 
dark and it is essential that working solution is relatively fresh. I always make it fresh 
one day before the experiment. ] 
14. Take out 10 ul as undigested sample. Label as “UND”, store at -20°C. 
15. Add 800 U (16ul 50U/ul) of Bgl II to digest with shaking at 950 rpm overnight at 
37°C. (Bgl II is not active more than 8hrs, add extra enzyme at next morning or after 
8hrs later)  
[ Single nuclei suspension is extremely important! Aggregation of nuclei profoundly 
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interfere digestion efficiency. So make sure to resuspend cells well, and if see 
aggregates during digestion, pipette up and down to resuspend again. ]  
Day 2: Ligation and reverse cross-link 
16. At AM, Add another 400 U (8ul) Bgl II and shake at 950 rpm 37°C, 2 hours. 
[If see aggregates, pipette up and dow to resuspend again. ]  
17. Take 10ul (out of 600ul) as digested sample and label as “DIG”.  Take out the 
UND samples. Add 190ul PK buffer (TE+0.5%SDS), 3ul 20ug/ul proteinase K and 
2ul RNase.  65°C overnight.  
18. Add 40ul of 20% SDS (final 1.6%) incubate in thermalmixer at 65°C,  950rpm, 
25 min.   
[SDS is to deactivate Bgl II, which can not be deactivated by heating. Aggregated 
nuclei particles are dispersed at this point due to SDS.]  
19. Transfer the sample to a 15-mL centrifuge tube, add 750ul 10X Ligase buffer 
(home-made), and 375 ul 20% Triton X-100 (final 1%), and 75ul 10mg/ml BSA, and 
5.7 mL H2O. Incubate at 37°C water bath for 1hr. The total volume is 7.5 ml.  
[Triton is to “hide” SDS from last step. Acetylated BSA is reported to confer stability 
to T4 DNA ligase.] 
20. Chill samples on ice. Add 75 ul of 100mM ATP (final is 1mM).  
[ The pH of ATP stock should be adjusted to pH7.5, and stock solution should be kept 
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in -20°C, after thawed, ATP should be stored on ice. Degradation of ATP can lead to 
inefficient ligation and profound interference of 3C results. ] 
21. Add 4000 U (10ul X 400U/ul) T4 DNA ligase (NEB) and incubate at 16C water 
bath for 4 hrs.   
22. Room temperature for 30 minutes.  
23. Add 160ul of 0.5M EDTA to stop reaction.  
[ T4 ligase can be heat inactivated by 65°C incubation for 10 min, so this step may not 
be necessary. ]  
24. Add 50ul of 20 mg/ml Proteinase K, incubate in 65°C waterbath overnight.  
[ This is to reverse cross-linking.] 
25. Purify “UND” and “DIG” samples with attached protocol (see below). 
Day 3: DNA purification 
26. Add another 25ul proteinase K, 55°C 2hour.  
[ Extra protein digestion time. Proteinase K retains high activity in from pH 6.5-9.5, 
temperature 20-60°C and in the presence of up to 0.5% SDS.] 
27. Cool to RT. Transfer to 50 ml conical tube. Extraction with 10ml pH 8.0 
phenol/chloroform/isoamyl alcohol (PCI), vortex 30 sec, hand shake 1-2min. Spin at 
2,460Xg (3,500rpm) for 10 min at RT. Take supernatant. Extract twice.  
[ Adjust pH of PCI to pH8 because it is optimal for DNA extraction. Pipette as much 
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material as possible close to the interface because the DNA accumulates there during 
the first extraction, but do not carry any interface material into the fresh tube.] 
28. Extraction with 8ml chloroform extraction once. Vortex 30 sec, hand shake 1-
2min.  Spin at 2,460Xg (3,500rpm) for 10 min at RT. 
29. To the supernatant, add ~3ml H2O to bring final volume to 10ml.  Add 1 mL 3M 
NaAc (1/10 Volume, pH5.2), invert to mix, add 25 mL (2.5 volume) RT 100% 
ethanol, invert to mix. Place at -80°C for 20min.  
30. Pellet DNA by spinning in swing bucket at 3500 rpm (2,460Xg ) for 30 min, at 
4°C.  
[ Pellet after this step could be white and big, presumably due to DTT precipitation. 
SDS precipitation is possible too] 
31. Wash with 20 ml 70% ETOH, spinning at 3500 rpm for 20 min, at 4°C.  
32. Air dry for 5 min. Resuspend pellet in 400ul 10mM Tris pH8 buffer.  Add RNase 
2ul , incubate 37°C waterbath for 30 min.  
[ RNA digestion after 1st DNA precipitation is to make RNA digestion more efficient 
and also to reduce the reaction volume.] 
33. Extract with 400ul PCI. Votex 30 sec.  Max spin 5 min. Take aqueous, extract 
again. Extract with 400ul Chloroform. Votex 30 sec.  Max spin 5 min. 
34. Take aqueous, add 40ul Na Acetate and 1.1ml RT 100%ETOH, invert to mix. Put 
on ice for 30 min.  
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35. Spin at max speed for 30 min at 4°C. 
36. Wash with 1ml cold 70% ETOH, for 5 times if needed. 
[ These wash steps are necessary to remove extra salt from DNA pellet. Pellet size 
should reduce obvious after two washes. I usually do 3 times of wash] 
37. Resuspend in 200ul 10mM Tris pH8 buffer. To help DNA to dissolve, incubate in 
55°C waterbath for 10 min, and leave at 4°C fridge overnight.  
38. Run 6 ul (equivalent to 0.3 million cells) on 0.8% agrose gel.  
Day 4: Quantification of 3C 
39. For detailed quality control and qPCR set-up, please refer (Hagege et al., 2007). 
Below are a few additional comments.  
- Digestion efficiency should be at least 60%, preferably ≥ 80%. 
- Dilution of 1:4 or 1:8 usually works well for 3C library from 10 million G1E cells. 
- Setup of PCR reaction: (10ul for 384-well plate) 
2xTaqman master mix             5ul 
Primer (9uM)   1ul 
Probe (2.5uM)   1ul 
3C sample   2ul 
H2O    1ul 
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CHAPTER 4: Conclusions and Future Directions 
 
In this thesis, I have addressed how the activity of GATA1 at its target genes is 
determined, how GATA1 induces long-range chromatin interaction, and more 
importantly what the relationship is of chromatin looping and transcription regulation. I 
have defined a multi-protein complex, SCL/Ldb1/LMO2/E2A, as a critical and consistent 
determinant of positive GATA1 activity in multiple hematopoietic lineages. I have 
uncovered Ldb1 as a potent looping factor that mediates GATA1-induced chromatin 
looping. I have for the first time forced a long-range chromatin interaction at an 
endogenous locus in its native environment, and demonstrated chromatin looping 
causally underlies transcription activation. In the following sections, these conclusions 
will be discussed in greater depth, and follow-up experiments will be suggested to expand 
this work in several new directions.  
4.1. Ldb1 as a looping factor 
The observation that simply anchoring Ldb1 protein to the β-globin promoter is 
sufficient to establish a LCR-β-globin loop demonstrates that Ldb1 functions as a looping 
factor that can build specific physical interactions between distant regulatory elements. 
The SA domain of Ldb1 is functionally equivalent to the full-length Ldb1 in inducing 
chromatin looping, implying that self-association of Ldb1 is a major molecular force 
tying together anchored chromatin segments. Hence it might be possible to induce 
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chromatin loops by targeting interacting domains from heterologous proteins that are not 
normally expressed in erythroid to specific chromatin regions. If successful, this will 
provide important insights into mechanisms of loop formation and functions of chromatin 
looping on transcription regulation since heterologous domains do not interact with 
endogenous proteins and any of their effects on looping and transcription will be direct. 
Our preliminary trials using dimerizing or multimerizing domains from bacteria or yeast 
were not successful in inducing chromatin loops, suggesting Ldb1 might have some 
unique properties to function as a looping factor. Such unique properties may reside in its 
self-association or unknown functions, and this is a direction worth investigating in the 
future. Moreover, we and others found that Ldb1 binds to numerous intergenic regions as 
well as gene promoters in erythroid cells, so it is plausible that Ldb1 might function as a 
general looping factor linking distant chromatin segments. Therefore, we will 
characterize chromatin interactions among Ldb1-bound sites on a genome-wide scale, 
which will in turn help to understand the roles of Ldb1 in chromatin looping.  
4.1.1: Heterologous systems for forcing chromatin loops 
Our studies show that self-association of Ldb1 is likely a major molecular force 
anchoring the LCR-β-globin chromatin loop. To extend our studies, we aim to force 
specific chromatin loops using interacting domains from heterologous proteins. In our 
preliminary studies, targeting diverse dimerizering domains (lexA, p65NFkB, the 
Argent™ dimerization system) or the multimeric POZ domain of GAGA factor to both 
the β-globin promoter and HS2 failed to efficiently activate β-globin expression, 
suggesting that Ldb1 has some unique properties in inducing looping at least in the 
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context of the β-globin locus. First, the unique properties might simply reside in strong 
association affinity of the SA domain. In this regard, further studies to measure the 
association affinity of various interacting domains are required. Second, the SA domain 
of Ldb1 forms dimers, and even larger oligomeric complexes at high concentration 
(Cross et al., 2010). Third, Ldb1 binds multiple HSs of the LCR including HS2. It is 
conceivable that its binding at multiple HSs and oligomerization allow simultaneous 
interactions among HSs of the LCR and the active β-globin promoter that might in turn 
serve to stabilize complex interactions. Thus, in order to improve the design of 
heterologous looping systems, we will target domains that self-associate with high 
affinity to multiple HSs of the LCR and β-globin promoter. We also aim to generate 
inducible chromatin loops using a drug-inducible association system, which, if 
successful, will be critical to isolate roles of chromatin looping and dissect steps of 
transcription activation by time-course studies. To this end, it is worth considering the 
following approaches. 
(i) From ours and others’ studies on artificial ZFs, it is clear that they have a number 
of limitations, including expense, off-target binding, and the requirement for extensive 
screening for the optimal ZFs. In contrast, recently developed DNA binding proteins 
from the plant pathogen Xanthomonas, transactivator-like effector protein (TALE, (Boch 
and Bonas, 2010)) , have been successfully used in gene targeting with high efficiency at 
much lower cost (Cermak et al., 2011; Mahfouz et al., 2011; Miller et al., 2011). TALE 
proteins can be produced conveniently and efficiently using commercially available 
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cloning kits. Hence we will produce TALE proteins targeting multiple HSs of the LCR or 
any sites of interest in future.  
(ii) As mentioned in Chapter 3, besides homodimer domains, we have tested the 
chemically induced proximity (CIP) ArgentTM system that uses FK506 and rapamycin 
analogs to make inducible heterodimers, aiming to produce inducible chromatin loops. 
We observed transient and weak LCR-β-globin interactions but conclusions were limited 
due to toxicity of the dimerizing agent. Very recently, the same group that developed 
rapamycin CIP system developed a potent and non-toxic CIP system that uses the plant 
hormone abscisic acid (ABA) (Liang et al., 2011). We can adopt this system by fusing 
the two heterodimeric domains of the ABA CIP system to ZF or TALE proteins that 
target either the β-globin promoter or HSs of the LCR. The dynamics of loop formation 
will be assessed upon ABA induction of dimerization. If successful, we can further apply 
this system to study other processes that involve long-range chromatin interaction, such 
as transcription repression, insulation, and gene positioning in nucleus.  
4.1.2: Mechanisms of Ldb1 functioning as a looping factor 
Our studies demonstrate Ldb1 or its SA domain is sufficient to induce a chromatin 
loop in the absence of GATA1. The SA domain contains 200 amino acid residues and is 
folded into multiple structural domains (Cross et al., 2010). Yeast two-hybrid analysis of 
SA mutants with deletion of terminal residues show that the first N-terminal 14 residues 
are dispensable for its self-association and any further deletion from its N-terminus or C-
terminus disrupts its self-association (Cross et al., 2010). To further investigate the roles 
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of Ldb1 self-association in chromatin looping, we will systematically make deletions 
within the SA domain and identify a mutant that disrupts self-association with minimal 
deletion. Based on our model that self-association of Ldb1 contributes to chromatin 
looping, the mutant SA domain is expected to be incapable of inducing looping.     
Although we have demonstrated that the SA domain is sufficient to induce chromatin 
loops, the possibility that its interacting factors also contribute to loop formation has not 
been excluded. Ldb1 does not bind to DNA directly but is recruited to chromatin as a 
component of DNA-binding complexes, such as the SCL/LMO2/E2A/GATA complex in 
erythroid cells (Soler et al., 2010). Depletion of Ldb1 or GATA1 reduces LCR-β-globin 
loop formation (Song et al., 2007; Vakoc et al., 2005). However, GATA1 per se might 
not be sufficient to induce chromatin loop as suggested by studies of mice containing a 
hypomorphic allele of the chromatin remodeler Brg1. In fetal liver cells of these mutant 
mice, β-globin looping and transcription are defective although GATA1 binds to β-globin 
promoter and the LCR at the same level as wild type (Kim et al., 2007; Kim et al., 2009). 
Depletion or mutation of Brg1 interferes with chromatin occupancy of SCL but not 
GATA1, (Hu et al., 2011; Kim et al., 2007), suggesting reduced β-globin looping 
observed in the Brg1 mutant mice attributes to deficient chromatin binding of the SCL 
complex.  
It is notable that in genome-wide occupancy studies in different cell types, the great 
majority of long-range enhancer-promoter interactions appear to involve CTCF, 
mediator, and cohesin (Dixon et al., 2012; Kagey et al., 2010). It is therefore possible that 
Ldb1 directly or indirectly associates with these proteins. Prior conventional Ldb1 
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affinity purification/mass spectrometry studies have failed to uncover any of these 
proteins and mostly identified the previously known Ldb1 partners (the SCL complex) 
(Meier et al., 2006). It is possible that specific interactions with any of the other 
molecules involved in looping might have been obscured by background or non-specific 
interactions, especially if their stoichiometry is lower than that of the direct binding 
partners. It is also possible that these interactions might occur stably only in the context 
of chromatin and are disrupted upon lysis and harsh nuclear extraction. Therefore, future 
efforts to identify unknown partners of Ldb1 require a sensitive approach to identify 
weak interacting partners.  
4.1.3: Interactome of Ldb1-bound chromatin 
Ldb1 binds to numerous intergenic sites as well as proximal promoters, suggesting 
that it coordinates long-range genomic interactions at many gene loci (Soler et al., 2010). 
In agreement, knockdown of Ldb1 impairs enhancer-promoter looping and reduces 
expression of the Myb (Stadhouders et al., 2012) and the α-globin genes (Song et al., 
2010). Moreover, ChIP-seq and limited-scale 3C-on-chip studies showed that binding 
sites of the Ldb1-containing complex partially overlap with chromatin regions that 
physically interact with the active β-globin promoter, including genes with similar 
expression patterns (e.g. Uros) as well as widely expressed genes (e.g.Tspan32, 
Suv420h2 and Cox6b2) (44).  Thus, in mature erythroid cells Ldb1 might spatially 
connect regulatory sites that are bound by the SCL/GATA1 complex. Together with 
studies of Drosophila Chip, these observations suggest that Ldb1 coordinates chromatin 
organization on a broad scale as part of a conserved function. Note that the SCL complex 
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largely favors activated over repressed genes (Cheng et al., 2009; Soler et al., 2010; 
Tripic et al., 2009), suggesting that Ldb1 functions by juxtaposing positive regulatory 
elements.?Interestingly, ~22% of Ldb1 occupied sites are not bound by GATA1 or SCL 
(Soler et al., 2010), suggesting additional mechanism of Ldb1 recruitment and possibly 
involvement in GATA1-independent loop formation. These observations suggest that 
Ldb1 might function in multiple distinct modes of organizing chromatin throughout the 
genome. Therefore, to reveal Ldb1’s functions in chromatin organization, it is crucial to 
delineate the chromatin interaction profile established by Ldb1. 
To paint a complete picture of Ldb1 associated chromatin interactions (“chromatin 
interactome”) we plan to perform Ldb1 ChIA-PET in erythroid cells. ChIA-PET 
combines chromatin IP with antibodies against a factor of interest (e.g. Ldb1) with 3C 
ligation and massive parallel sequencing (Fullwood et al., 2010; Fullwood et al., 2009). It 
depicts the interaction profiles of chromatin segments bound by the factor of interest on a 
genome-wide scale (Fullwood et al., 2010). ChIA-PET profiles  of Ldb1 will be analyzed 
in GATA1-null G1E cells and induced G1E-ER4 cells expressing active GATA1 to 
identify Ldb1’s functions in GATA1-dependent loop formation. The following questions 
will be addressed. (1) Is Ldb1 broadly involved in looping? ChIA-PET results can be 
used to compare genome-wide chromatin interactions with Ldb1 genomic binding 
patterns. Large overlap of these two would suggest a general role of Ldb1 in mediating 
chromatin loops. (2) What are the characteristics of chromatin loops regulated by Ldb1? 
We can characterize loop size, locations in the genome, cis or trans, and their 
relationships with transcription activity. (3) Which elements/factors utilize Ldb1 to form 
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chromatin loops? We anticipate that chromatin interactions may occur between two Ldb1 
bound sites (e.g. the LCR and promoter at the β-globin locus) or between an Ldb1 bound 
and an unbound site. For example, at the Myb locus, multiple Ldb1-occupied distal 
enhancers contact the Myb promoter that lacks Ldb1 (Stadhouders et al., 2012). Genomic 
sites to which Ldb1-occupied elements loop that do not bind Ldb1 might identify new 
nuclear proteins that utilize Ldb1 for looping. Motif finder programs such as MEME and 
DREME can be employed to examine contact regions for known or new cis-elements 
enriched in Ldb1 associated regions. By combining these analyses with existing Ldb1 
ChIP-seq data, knock-downs, and transcriptome studies, we expect to identify new 
factors that function via Ldb1 recruitment. Some of these might be amenable to 
regulation by targeted tethering of Ldb1, similar to the studies of the globin locus. (4) To 
what extent does Ldb1 regulate the chromatin interactome in erythroid cells?  In other 
words, are co-regulated genes or genes that depend on Ldb1 co-localized in the nucleus, 
similar to what has been proposed for Klf1 regulated genes (Schoenfelder et al., 2010b)? 
Select chromatin interactions will be validated by conventional 3C and/or DNA-FISH. 
Their dependence on Ldb1 will be investigated by Ldb1 knockdown experiments.  
Ldb1 is essential for cell fate determination and cell differentiation in many tissues. It 
is possible that Ldb1 is employed by DNA-binding transcription factors in various cell 
types to mediate specific chromatin loops and hence regulate the transcription program. 
This aspect can be further explored in HSC and many other hematopoietic lineages in the 
future.  
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These proposed studies would provide important insights on the mechanisms of 
chromatin loop formation and how a non-DNA-binding co-factor can be employed by 
tissue-specific transcription factors to facilitate chromatin looping.  
4.2. Modulate gene activity by forced chromatin looping 
In our studies, forced chromatin looping of β-globin with the LCR leads to Pol II 
recruitment and transcription activation in the absence of GATA1. Therefore, forcing 
chromatin looping can possibly be used to modulate gene activity in cells. We envision 
that linking a gene with its native enhancers would lead to potent gene activation that is 
likely superior to existing strategies that simply targets a heterologous activator to the 
gene (Sera, 2009). This would be useful for controlling gene expression for research and 
therapeutic purposes. 
4.2.1: Developmental reprogramming of the murine β-globin locus 
Activity of β-globin locus is under tight temporal and spatial control such that 
erythroid cells at different developmental stages, including embryo, fetus and adult, 
abundantly express stage-specific β-globins with other globin genes silenced (Chapter 
1.3). The LCR switches its interactions with the β-globin genes and confers high-level 
expression of the stage-appropriate globin genes (Palstra et al., 2003). For example, in 
adult murine erythroid cells, β-major and β-minor globin genes are active and form 
chromatin loops with the LCR, while the embryonic globin genes, εy and βh1, are in a 
repressed state and looped out (Figure 1.6). A few recent studies provide new insights 
into the molecular mechanisms that mediate this developmental switch by showing that 
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transcription factors KLF1 and BCL11a are important regulators of this process (Borg et 
al., 2010; Sankaran et al., 2008). Can forced loop formation be used to alter the 
developmental expression pattern of the β-globin genes? In other words, can forced loop 
formation override the repression mechanisms at the silent globin gene?  
To answer these questions, we will examine whether targeting the SA domain to the 
silent embryonic globin genes in adult erythroid cells can redirect the LCR from adult to 
embryonic globin genes, and whether it can re-activate transcription of the embryonic 
globin genes. Specific ZF or TALE proteins that target the embryonic βh1 gene will be 
designed (Figure 4.1 A) and fused with the SA domain of Ldb1. The fusion protein will 
be expressed in G1E or G1E-ER4 cells and their effects on chromatin looping and 
transcription activation will be studied.  
Below are some preliminary results of the experiments proposed above.  
We first engineered ZF proteins to target the βh1 promoter (βh1 P) in collaboration 
with Sangamo Biosciences and screened for the specific ZFs by ChIP. βh1 P-SA binds to 
the βh1 promoter but not the βmaj promoter or any of the HSs of the LCR (Figure 4.1).  
P-SA and L-SA (ZF-SA targeting HS2 of the LCR) were expressed alone or together in 
G1E cells or G1E-ER4 cells. Our first experiments are promising. βh1 transcription was 
activated about 200-fold over background when βh1 P-SA is expressed alone or in 
combination with L-SA (Figure 4.2 A). L-SA does not affect βh1 expression as we have 
observed before. Activation of βh1 by ZF-SA is also observed in G1E-ER4 cells induced 
with estradiol (Figure 4.2 B). Note that βh1 transcript levels are much higher in induced 
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G1E-ER4 cells than those in G1E cells (compare the y axis value of Figure 4.2 A and B), 
indicating ZF-SA activates βh1 transcription together with GATA1. βh1 activation by 
ZF-SA protein is substantial as the βh1: total globin ratio is elevated from less than 1% to 
about 20% (compare left and right panels of Figure 4.2 C). This result is remarkable since 
it shows that redirecting the LCR to the βh1 promoter at least partially overrides the 
strong constraints that repress the βh1 gene in normal adult erythroid cells. Future work 
on optimizing expression levels and testing of additional ZFs or TALE proteins might 
further enhance βh1 activation.  
The β-globin promoters compete for the actions of the LCR (Stamatoyannopoulos, 
2005). It follows that if βh1 transcription is increased in the adult definitive erythroid, a 
corresponding decrease in β-major expression is expected, reflecting reduction of 
interaction with the LCR. Indeed, β-major expression is reduced compared to controls 
(compare the left and right panels in Figure 4.2 C), however at this point we have not 
resolved whether this is indeed due to alternate loop formation or a non-specific effect on 
cellular differentiation due to βh1 P-SA expression. Follow-up studies will address these 
questions. 
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Figure 4.1. ZF targeting the βh1 promoter.  
(A) Schematic presentation of the murine β-globin locus and the target site of βh1 P-
ZF.  (B) ChIP profile of the flag tagged βh1 P-SA (named as 86SA in the figure) in G1E 
cells.  
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Figure 4.2. Re-activation of βh1 in adult erythroid cells by ZF-SA fusion protein.  
(A) βh1 transcript level in G1E cells expressing indicated constructs. (A) βh1 
transcript level in estradiol-induced G1E-ER4 cells (estradiol treatment for 48 hours) 
expressing indicated constructs. (C). βmaj and βh1 transcript levels in G1E or induced 
G1E-ER4 cells expressing empty construct or L-SA+P-SA are plotted in the form of 
stacked column charts. Transcript levels are normalized to β-actin.  
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4.2.2: Re-activation of the human fetal globin gene 
The β-globin disorders, sickle cell disease (SCD) and β-thalassemia, are the most 
common genetic disorders in the world. However, there are numerous challenges and 
limitations with current treatments (Sankaran, 2011). A series of important natural 
observations demonstrated that increased production of fetal hemoglobin, composed of γ-
globin and α-globin, could ameliorate the severity of SCD and certain forms of β-
thalassemia. Therefore, understanding the regulatory mechanisms of the β-globin locus 
and re-activating the fetal γ-globin genes in adult human erythroid cells have been the 
major goals in the field in the past few decades. In our preliminary studies, targeting the 
SA domain to the βh1 promoter re-activated βh1 transcription up to ~20% of total β-
globin. This is very encouraging since ~15 to 20% of fetal hemoglobin is thought to be 
necessary to virtually eliminate SCD phenotypes in patients (Platt et al., 1994).  
Therefore, our goal is to investigate whether a forced chromatin loop can be used to 
re-activate γ-globin expression in adult human erythroid cells, with the hope to eventually 
provide better therapy for SCD and β-thalassemia. To this end, we will first perform 
proof-of-principle experiments using human CD34+ HSCs isolated from healthy bone 
marrow aspirates, mobilized peripheral blood, or from umbilical cord blood from healthy 
newborns. Human HSCs can be expanded for several days and differentiated into 
erythroid cells in liquid culture with proper cytokines. TALE or ZF proteins will be 
designed and tested to target the human γ-globin promoters. Suitable TALE or ZF 
proteins will be fused with the SA domain and introduced into primary human HSCs 
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followed by in vitro differentiation into erythroid lineage. Their activities on transcript 
and protein levels of hemoglobin will be measured by RT-qPCR and HPLC respectively. 
If successful, re-activation of γ-globin can be further studied in various mouse models 
carrying the wild type or mutant human β-globin locus as a transgene (Miccio and 
Blobel, 2010).  
In summary, we hope to be able to demonstrate that forced chromatin looping can be 
used to reprogram the murine and human β-globin loci.  
 
Concluding Remarks 
This work studied basic mechanisms of transcription regulation using the 
hematopoietic system as a model. It demonstrates how numerous transcription factors 
interplay on the chromatin to concertedly control transcription activity of genes, and how 
each factor plays distinct roles in building a hierarchy of transcription regulation events. 
It also shows a vivid example of how novel technologies can be taken advantage of to 
study fundamental biological questions. Importantly, it showcases how knowledge 
learned from basic research can provide strategies for rational designed therapy.   
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CHAPTER 5: Material and Methods 
 
Cell culture of cell lines 
G1E cells, G1E-ER4 cells and derivatives expressing Bcl-XL were maintained as 
described (Weiss et al., 1997). Where indicated, G1E-ER4 cells were treated with 100nM 
estradiol (E2) for 21 hours (3C assays) or 24 hours (RT-qPCR and ChIP assays) to 
activate GATA1-ER (indicated as G1E+GATA1 in figures). The murine megakaryocytic 
line L8057  (Ishida et al., 1993) was obtained from Dr. Katya Ravid (Boston University 
School of Medicine) and maintained in F-12 nutrient mixture (Invitrogen)  with 100U/mL 
penicillin, 100 U/mL streptomycin, 2 mM L-glutamine and 10% fetal bovine serum 
(HyClone, Logan, UT).  
MEL cells, PlatE cells, and 293T cells were cultured in DMEM with 10% fetal bovine 
serum, 2% penicillin-streptomycin, 1% glutamine, and 1% Na pyruvate. MEL 
differentiation was performed by adding 1.5% DMSO to the growth medium for 72 hr.  
Isolation and culture of BMMC 
Murine bone marrow mast cells (BMMC) were obtained from bone marrow harvested 
from 5- to 6-week-old mice and differentiated with 5 ng/ml recombinant IL-3 and 12.5 
ng/ml SCF in complete RPMI medium (15% heat-inactivated FBS, 2 mM glutamine, 1% 
penicillin-streptomycin, 1 mM sodium pyruvate, and 50 mM 2-β-ME). At 6–8 weeks of 
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culture, these populations were almost (>95%) pure mast cells as assessed by KIT and 
FcεRI expression and toluidine blue staining (Gregory et al., 2006).  
Fetal liver erythroblasts 
Wild type fetal liver erythroid cells were obtained from CD1 mice (Charles River 
Laboratories). ∆LCR/∆LCR mice (129 strain) were described (Bender et al., 2000). To 
generate ∆LCR/wt mice, ∆LCR/∆LCR male animals were bred with wild type female 
mice (BL6 strain). E13.5 fetal liver cells were harvested, stained with PE-conjugated 
anti-CD71 and APC-conjugated anti-Ter119 antibodies and sorted by FACS. The R1 
(Ter119-, CD71 -/low) populations were isolated, infected with desired retrovirus and 
cultured for 24 h in proliferation medium containing Iscove’s DMDM supplemented with 
15% fetal bovine serum, 1% penicillin-streptomycin, 1% glutamine, 10 ng/mL mIL3, 20 
ng/mL m/h IL6, 50 ng/mL mSCF, and 10 ng/mL m/h FLT3L from Peprotech. Where 
indicated, cells were induced to differentiate by cultured in Iscove’s DMDM 
supplemented with 15% fetal bovine serum, 1% penicillin-streptomycin, 1% glutamine, 
50 ug/mL ascorbic acid, 200 ug/mL holotransferrin (Sigma), and 2 U/mL Erythropoietin 
ALFA (Epogen).  
Transient transfections 
K562 cell transfections and firefly luciferase reporter assays were performed as described 
previously (Wang et al., 2006). Samples were tested in quadruplicate and each construct 
was tested in at least two independent experiments. 
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Retrovirus production and cell infections 
Retroviruses were packaged using ecotropic packaging plasmids (pCL-Eco, containing 
Gag, Pol and Env genes) in PlatE cells or 293T cells. The virus-packaging PlatE cells 
(provided by Dr. Mitchell Weiss) at 80% confluence were transfected by use of 
Lipofectamine 2000. Forty-eight hours after transfection, the viral supernatant was 
collected, and 5 ml of viral supernatant was mixed with 4 × 106 of G1E-ER4 cells in the 
presence of 8 µg/ml polybrene and 10 mM HEPES and spun at 3200 g for 1.5 hours at 
room temperature. Cells were then incubated at 37°C for 3 hrs and additional 5 ml of 
fresh media was added. After 48 hrs GFP-positive G1E-ER4 cells were purified by 
FACS.  Cultures were harvested 3-4 days after infection.  
The early passage 293T cells at 80% confluence were transfected by use of calcium 
phosphate transfection reagent. Viral supernatant was collected twice at 24- and 48- 
hours after transfection. 0.5-2 mL viral supernatant was mixed with up to 4 million G1E 
cells or fetal liver cells using 6-well plate in the presence of 8 µg/ml polybrene and 10 
mM HEPES and spun at 3200 g for 1.5 hours at room temperature. For isolated primary 
fetal liver cells, spin-infection condition was modified to 2,000 rpm at room temperature 
for 1 hour, and cells were switched to fresh medium immediately after infection.  
ChIP and ChIP-on-chip assays 
ChIP was performed as described (Letting et al., 2003). DNA was quantified by using 
real-time PCR with SYBR Green dye on an ABI Prism 7900 system (PE Applied 
Biosystems). Primer sequences are listed in Supplemental Materials. Results were 
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normalized to unprecipitated chromatin (input). All data shown are the averages of three 
or more independent experiments. Error bars represent standard deviations. 
For ChIP-on-chip analysis, 10 ng of immunoprecipitated DNA or, as control, 
unprecipitated chromatin from parental G1E cells and estradiol-treated (24 hr) G1E-ER4 
cells was amplified by ligation-mediated PCR using the Whole Genome Amplification 
Kit 2 (Sigma). Real time PCR was employed to confirm that the amplification was linear 
and had not distorted the proportion among the signals (not shown). Samples from three 
independent ChIP experiments were pooled and hybridized to the NimbleGen array 16 
from the mm6 version of the high density tiling array (1 array per sample). The 
microarray covered 66 Mb of mouse chromosome 7 (positions 63331168 to 129534093 
(according to the March 2005 annotation) at 100 bp resolution such that the beginning of 
each 50 nucleotide probe is 100 bp away from the start of the adjacent probe in 
chromosomal coordinates.  
The hybridization signals were analyzed with two peak-calling programs, Mpeak (Zheng 
et al., 2007) and Tamalpais (Bieda et al., 2006), at their highest stringencies (3 standard 
deviations above the mean for all hybridization signals and L1, respectively). The signal 
intensities are also displayed as custom tracks in the UCSC Genome Browser for analysis 
by inspection (Kent et al., 2002). The correlations between signal intensities were 
computed using the R statistical package (http://www.r-project.org/index.html), and 
analysis of peaks was done with tools in Galaxy (Blankenberg et al., 2007). 
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RT-qPCR  
RNA was extracted with Trizol (Invitrogen) from 105-106 cells. RNase-free glycogen 
(Invitrogen) was added to aid RNA precipitation. Reverse transcription reactions were 
performed with random hexamers using Superscript II (Invitrogen). Results were 
quantified by using real-time PCR with SYBR Green dye on ABI Prism 7000 system. 
Allele-specific qPCR was carried out at annealing temperature 62°C (60°C for 
conventional qPCR as default setting). Data were normalized to β-actin or GAPDH, both 
producing similar results. 
3C assay 
Detailed 3C protocol is presented in Chapter 3.6. Briefly, the 3C assay was performed as 
described (Jing et al., 2008; Vakoc et al., 2005) with the following modifications. 1x107 
cells were crosslinked with 1.5% formaldehyde at room temperature for 10 min, followed 
by glycine quenching, cell lysis, Bgl II digestion and T4 ligation. 3C ligation products 
were quantified in triplicates by quantitative TaqMan real-time PCR. Probes and primers 
were designed using Primer Express 2.0 software (Applied Biosystems) and tested by 
serial dilution and gel electrophoresis to ensure specific and linear amplification. 
Digestion efficiencies were monitored by SybrGreen qPCR with primer pairs that 
amplify genomic regions containing or devoid of BglII digestion sites. A BAC clone 
containing the entire murine β-globin locus of 129 origin (SourceBioscience, Clone # 
BMQ433I10) was digested with BglII and re-ligated to generate random ligation products 
of BglII fragments. The DNA was serially diluted and used to generate a standard curve 
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to which all 3C products were normalized. The 3C signals at the β-globin locus were 
further normalized to those from four intervening regions or, alternatively that of a 
control locus ERCC3, both producing similar results.  
Antibodies 
The following antibodies were used: GATA1 (sc-265; Santa Cruz), GATA2 (sc-9008), 
CBP (sc-369), Ldb1 (sc-11198; Santa Cruz), E2A (sc-349; Santa Cruz), ETO-2 (sc 9739 
and sc 9741; Santa Cruz), LMO2 (R&D Systems), pan-Pol II (sc-899, Santa Cruz), 
CDK9 (sc-484, Santa Cruz), Ser5ph (MS-134R, Covance), H3K4me3 (07-473, 
Millipore), anti-HA monoclonal antibody was clone 12CA5. SCL was a gift from Dr. C. 
Porcher (University of Oxford) or SCL (sc-12984; Santa Cruz).  
Artificial zinc finger design 
ZFs each containing six Cys2-His2 zinc finger domains and targeting 18-19 bp sites 
within either the β-major promoter or DNase1 hypersensitive site 2 of the mouse LCR 
were designed and assembled from two-finger units as previously described (Bartsevich 
et al., 2003). 
Constructs 
Retroviral vectors with HA-SCL and HA-SCL(RER) (provided by C. Porcher) were 
inserted into MSCV MIGR1-GFP (Pear et al., 1993). The LMO2 shRNA expression 
construct:  pSM2 plasmids containing the shRNA against LMO2 was obtained from 
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Open Biosystems: Clone Id V2MM_29885. shRNA encoding fragment was transferred 
into pMSCV/LTRmiR30-PIG using XhoI/EcoRI restriction sites.  
Individual zinc finger protein coding sequences were cloned into MigR1 retroviral vector 
with three HA tags and a nuclear localization signal (NLS) at their N-termini. Full length 
Ldb1 or the SA domain containing amino acids 1-200 of Ldb1 was cloned in frame C-
terminal to the ZF.  P-∆SA was generated by deleting the first 256 amino acids of Ldb1. 
ChIP qPCR primers 
HS3  
Forward 5′-CTAGGGACTGAGAGAGGCTGCTT-3′  
Reverse 5′-ATGGGACCTCTGATAGACACATCTT-3′  
 
HS2 
Forward 5′-GGGTGTGTGGCCAGATGTTT-3’ 
Reverse 5′-CACCTTCCCTGTGGACTTCCT-3’ 
 
HS1 
Forward 5′-CAGATCCTCAAACACTCTCCCATAA-3’ 
Reverse 5′-TGCCTTCTTTGTCCCATCATT-3’ 
 
ey promoter  
Forward 5′-ATGACCTGGCTCCACCCAT-3′  
Reverse 5′-TCTTTGAAGCCATTGGTCAGC-3′  
 
βh1 promoter  
Forward 5′-AGGTCCAGGGTGAAGAATAAAAGG-3′  
Reverse 5′-ATCTCAAGTGTGCAAAAGCCAGA-3′  
 
βmaj promoter  
Forward 5′-CAGGGAGAAATATGCTTGTCATCA-3′  
Reverse 5′-GTGAGCAGATTGGCCCTTACC-3′  
 
βmaj exon 2 
Forward 5'-AACGATGGCCTGAATCACTTG-3' 
Reverse 5'-AGCCTGAAGTTCTCAGGATCC-3' 
 
βmaj intron 2  
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Forward 5’-CTTCTCTCTCTCCTCTCTCTTTCTCTAATC-3’ 
Reverse 5′-AATGAACTGAGGGAAAGGAAAGG -3’ 
 
βmaj 3UTR 
Forward 5’- GCCCTGGCTCACAAGTACCA -3’ 
Reverse 5′- TTCACAGGCAAGAGCAGGAA -3’ 
 
βmaj -1kb  
Forward 5’-GTATGCTCAATTCAAATGTACCTTATT-3’ 
Reverse 5′-TTACCTCTTTATTTCACTTTTACACAT-3’ 
 
βmin promoter  
Forward 5′-GAGCCAGCATTGGGTATATAAAGC-3′  
Reverse 5′-ACAGACTCAGAAGCAAACGTAAGAAG-3′  
 
IVR16  
Forward 5′-TGGCCATTTTTACTATGTTAATTTTGC-3′  
Reverse 5′-TAGACTTGTCATGGTTATGGATTGG-3′  
 
mCD4 
Forward 5′-CCAGAACATTCCGGCACATT-3′  
Reverse 5′-GGTAAGAGGGACGTGTTCAACTTT-3′  
 
Band 3 promoter  
Forward 5′-CTGAGCAGTCAAGCCTTAGTTCAC-3′  
Reverse 5′-CCTGTCCAGTCCCTAAGGTCTTT-3′  
 
KLF1 promoter  
Forward 5′-TCTGCTCAAGGAGGAACAGAGCTA-3′  
Reverse 5′-GGCTCCCTTTCAGGCATTATCAGA-3′  
 
Eraf promoter  
Forward 5′-TGCCTGCGTCTCGCTTAGT-3′  
Reverse 5′-GCTGAGCCCGCCTCATC-3′  
 
Hba-a1 -31kb 
Forward 5′- TTCTGACCTCACCTCAGCTAAGC-3′ 
Reverse 5′- TGTGTGGGCAGAGGACACA-3′ 
 
Hba-a1 -12kb 
Forward 5′-AACCCTGACTCAAAACAACAAAGTAA-3′ 
Reverse 5′- GGTTTCTGAGTTTCCTTATCTGCAA-3′ 
 
Hba-a1 promoter 
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Forward 5′- TGACCAAGGTAGGAGGATACTAACT-3′ 
Reverse 5′- TTGCCCGGACACACTTCTTAC-3′ 
 
 
Kit -114kb  
Forward 5′- GCACACAGGACCTGACTCCA-3′  
Reverse 5′- GTTCTGAGATGCGGTTGCTG -3′  
 
Kit promoter 
Forward 5′-CACCTCCACCATAAGCCGAAT-3′ 
Reverse 5′-CTCCTAGACAATAAAGGACAACCA-3′ 
 
Kit +5kb 
Forward 5′-GGCTGGAAACCACTGCCTTA-3′ 
Reverse 5′- AGCCTTGCCTGTGCTTAAAGC -3′ 
 
Kit +58kb 
Forward 5′-GGAGGAGTTAGGGAATATGTCGATAG-3′ 
Reverse 5′-GCAGTTCTCCAGGTTGAGTCAGA-3′ 
 
Kit +73kb 
Forward 5′-AACTGAAGCGAGTACAGCATTCC-3′ 
Reverse 5′-TGCTTTTGCTTGTGTACTGTTAACTG-3′ 
 
Gata2 -77kb 
Forward 5′-TGGGCCACCTTCTTTACCAC-3′ 
Reverse 5′-CCGGAATTCATGCAATGCT-3′ 
 
Gata2 -3.9kb 
Forward 5′-GAGATGAGCTAATCCCGCTGTA-3′ 
Reverse 5′-AAGGCTGTATTTTTCCAGGCC-3′ 
 
Gata2 -2.8kb 
Forward 5′-GCCCTGTACAACCCCATTCTC-3′ 
Reverse 5′-TTGTTCCCGGCGAAGATAAT-3′ 
 
Gata2 1S promoter 
Forward 5′-CCCCTCGAAGTGATGTCGAA-3′ 
Reverse 5′-TCTGGCTGTCTCTCGGTTCC-3′ 
 
Gata2 +9.5kb 
Forward 5′- ACATCTGCAGCCGGTAGATAAG-3′ 
Reverse 5′-CATTATTTGCAGAGTGGAGGGTATTA-3′ 
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Lyl1 promoter 
Forward 5′- TTTCCCCTTTGCACACGTTT-3′ 
Reverse 5′-AAGACCCCCCAACCCTCA-3′ 
 
Rgs18  promoter 
Forward 5′- AGATTGGTCTTGTACTGAATTGTTGAA-3′ 
Reverse 5′-ACGCTGTGGTAATACCAGCTTTTA-3′ 
 
Etv6  
Forward 5′- TGCCAAAACAAATGTAAGAGAGTGA-3′ 
Reverse 5′- TCCACAGGAAGTTCCCAAGATCT-3′ 
 
Sox6 
Forward 5′- CCCACCAGTCAGCAGATGT-3′ 
Reverse 5′- CTGCATCCATTTTGCTGGT-3′ 
 
Tram2 
Forward 5′- TCATTATCTTGCCTGAACAGATG-3′ 
Reverse 5′- ATGTGTTCTGTTTTCACTGAGGAT-3′ 
 
GPIb  promoter 
Forward 5'-TGGTGGCTAGTAGCTGCAAAGTC-3' 
Reverse 5'-TTATCAGCTCTCTGCACAGCATTC-3' 
 
PF4 promoter 
Forward 5'-GCTGCTGGCCTGCACTTAAG-3 
Reverse 5'-GCCACTGGACCCAAAGATAAAG-3 
 
cMpl promoter 
Forward 5′-CTGCCAACAGAAGGCTCATG-3' 
Reverse 5′-CTGTCAGATACAGCCCCACGT-3' 
 
IIb promoter 
Forward 5′-GCCATGAGCTCCAGTCTGATAA-3' 
Reverse 5′-AGCTCTTTCCCTTTCCCTGAA-3' 
 
IIb -3kb 
Forward 5'-AAATAGATGTCAAGTTGGCATAAACCT-3' 
Reverse 5'-TGCCAGCGTTCAAGTACAAAA-3' 
 
Mc-cpa promoter 
Forward 5'-GGCTTGATCTGACCCCTATACG-3' 
Reverse 5'-CCCAGGAACCACAAAGGAAA-3' 
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Mc-cpa +3kb 
Forward 5'-TGTGGAAGAGAGGGAAGAAGAACT-3' 
Reverse 5'-TTGTGTCTAGAAGTGACAGTCTTGCA-3' 
 
Sfpi1 -8kb 
Forward 5'-GAAATCCCCACCTCCTAACC-3' 
Reverse 5'-TAGGGACCTCAGGCTCTTTGTC-3' 
 
Sfpi1 promoter 
Forward 5'-TTCCTGTAGCGCAAGAGATTTATG-3' 
Reverse 5'- GCAGGGCCAGCACAAGTTCC-3' 
 
Fc RI-β  promoter 
Forward 5'-ACAGCAAGAGAAAGGAGTCACTGAT-3' 
Reverse 5'-CATGCGGAACCTACTTGTCAGA-3' 
 
Fc RI-β  +7kb 
Forward 5'-GAAGGTAGTCAATGGGAATGACAA-3' 
Reverse 5'-TGTGCTGAGATTCTAGGCAAACA-3' 
 
Transcript qPCR primers 
βmaj 5 UTR  
Forward 5'-CAACCCCAGAAACAGACATC-3' 
Reverse 5'- CAACTTCATCGGCGTTCA-3' 
 
βmaj exon 2 
Forward 5'-AACGATGGCCTGAATCACTTG-3' 
Reverse 5'-AGCCTGAAGTTCTCAGGATCC-3' 
 
βmaj-D 
Forward 5'-GCCTGTGGGGAAAGGTGAACT -3' 
Reverse 5'-CCATCGTTAAAGGCAGTTATCACC -3' 
 
βmaj -S 
Forward 5'- GCCTGTGGGGAAAGGTGAACG-3' 
Reverse 5'- GCCATCGTTAAAGGCAGTTATCACT -3' 
 
βmaj intron 2  
Forward 5’-CTTCTCTCTCTCCTCTCTCTTTCTCTAATC-3’ 
Reverse 5′-AATGAACTGAGGGAAAGGAAAGG -3’ 
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βmaj exon 2/3 
Forward 5'- AGCTCCACTGTGACAAGCTG -3' 
Reverse 5'- CCAGCACAATCACGATCATA -3' 
 
βmaj 3UTR 
Forward 5’- GCCCTGGCTCACAAGTACCA -3’ 
Reverse 5′- TTCACAGGCAAGAGCAGGAA -3’ 
 
βh1 
Forward 5’- AGGCAGCTATCACAAGCATCTG -3’ 
Reverse 5′- AACTTGTCAAAGAATCTCTGAGTCCA -3’ 
 
Hba 
Forward 5'- GTGGATCCCGTCAACTTCAAG -3' 
Reverse 5'- CAAGGTCACCAGCAGGCAGT -3' 
 
Slc4a1 
Forward 5'-TGGAGGCCTGATCCGTGATA-3' 
Reverse 5'-AGCGCATCGGTGATGTCA-3' 
 
Alas2 
Forward 5'-CCATCTTAAGGCAACCAAGGC -3' 
Reverse 5'- ACAGCATGAAAGGACAATGGC-3' 
 
Klf1 
Forward 5'-TTCCGGAGAGGACGATGAGA-3' 
Reverse 5'-AACCTGGAAAGTTTGTAAGGAAAAGA-3' 
 
Gata1 
Forward 5'- GCCCAAGAAGCGAATGATTG-3' 
Reverse 5'- GTGGTCGTTTGACAGTTAGTGCAT-3' 
 
Gata2 
Forward 5'-CACCCCTAAGCAGAGAAGCAA-3' 
Reverse 5'-TGGCACCACAGTTGACACACT-3' 
 
Kit 
Forward 5'-AGCAGATCTCGGACAGCACC-3' 
Reverse 5'-TGCAGTTTGCCAAGTTGGAG-3' 
 
Gapdh 
Forward 5'- GATGCCCCCATGTTTGTGAT-3' 
Reverse 5'-GGTCATGAGCCCTTCCACAAT-3' 
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β-actin 
Forward 5'- ACACCCGCCACCAGTTC -3' 
Reverse 5'- TACAGCCCGGGGAGCAT -3' 
 
Lyl1 
Forward 5'-CCTGACCTGGACTGACAAACCT-3' 
Reverse 5'-CACATGGACCCCACGGATA-3' 
 
Rgs18 
Forward 5'-TAATGCATGGGTCAGGGAAAG-3' 
Reverse 5'-TCAGGCCTCTGTAGGAGAAGACTTAG-3' 
 
Pabpc1 
Forward 5'-CTACCAGCCAGCACCTCCTT-3' 
Reverse 5'-TGCAGCACGGTTCTGAGTCT-3' 
LMO2 shRNA ‘sense’ sequences 
5’-CCCAGCCCTTAGAGAGAATTTA-3' 
3C probes and primers 
β-globin locus 
LCR-HS2 probe     56-FAM/TCT GCC TGT CCC TGC CTC GTG A/36-TAMSp 
Anchor primer (rHS2)       5'- CAGCGTTTTAGTTGGATATAGAGTGAA-3' 
 
I (rHS1)                  5'- GAACTTGTCAGGGAATTACCTAGTACAG -3' 
II (rbh1ey)            5'- GATCCCTATTGTCTACTTTTGCCAG-3' 
III (rbh1)               5'- CCCATGTTACACCCCATTACAAG-3'   
IV (rβmaj)              5'- GGCTGGAACATCACTGGAATAAAT-3' 
V (rβmaj-frag2)     5'- CAGTCGAGGAATGCAACTGTGA-3' 
VI (rIVR3)             5'-AAGACTAAAAATCCCAGATTGATTCC-3' 
VII (rbmin)            5'-GCCAAATCAGGACCCTAACATT-3' 
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VIII (rIVR2)          5'-CCAAGTCTCTCAAGAAAGAAATCGA-3'       
X (rIVR1)              5'-CAAACATAAGACCATAAGCAACAGAAA-3' 
XI (r3HS1)            5'- ACTACCTAACTCTCAAAAATCTGTGTGA-3' 
XII (r3OR)            5'-GAAAAAATGTGTACGCATCATTAGTTATG-3' 
 
ERCC3 locus 
ERCC3 probe     56-FAM/TCTAGAGCCAAACTCTCCAGCCACCACTTC/36-TAMSp 
rERCC3_3    5'-GCAGTGAAAACACAACACAGTTAATATG-3' 
rERCC3_5    5'-GCAGCCACCGACTTGGAT-3' 
Primers for 3C digestion efficiency 
HS2 BglII cut #1 
Forward 5′- TGTAGATCAGGATTGACTGGTAC -3’ 
Reverse 5′- CAGCGTTTTAGTTGGATATAGAGTGAA -3’ 
 
HS2 BglII uncut #1 
Forward 5′-GGGTGTGTGGCCAGATGTTT-3’ 
Reverse 5′-CACCTTCCCTGTGGACTTCCT-3’ 
 
HS2 BglII cut #2 
Forward 5′- GCGTTTTAGTTGGATATAGAGTGAAGG -3’ 
Reverse 5′- TGCTATCATGGAACATACTATGTAGATCA -3’ 
 
HS2 BglII uncut #2 
Forward 5′- AGGAACAGGCAAGGCAGCTT -3’ 
Reverse 5′- TCACTGGTACCCTGTTTCCTTATCT -3’ 
 
157 
 
References 
 
 
 
 
Ameres, S.L., Drueppel, L., Pfleiderer, K., Schmidt, A., Hillen, W., and Berens, C. 
(2005). Inducible DNA-loop formation blocks transcriptional activation by an SV40 
enhancer. Embo J 24, 358-367. 
Anderson, K.P., Crable, S.C., and Lingrel, J.B. (1998). Multiple proteins binding to a 
GATA-E box-GATA motif regulate the erythroid Kruppel-like factor (EKLF) gene. J 
Biol Chem 273, 14347-14354. 
Anguita, E., Hughes, J., Heyworth, C., Blobel, G.A., Wood, W.G., and Higgs, D.R. 
(2004). Globin gene activation during haemopoiesis is driven by protein complexes 
nucleated by GATA-1 and GATA-2. Embo J 23, 2841-2852. 
Barolo, S. (2012). Shadow enhancers: frequently asked questions about distributed cis-
regulatory information and enhancer redundancy. Bioessays 34, 135-141. 
Bartsevich, V.V., Miller, J.C., Case, C.C., and Pabo, C.O. (2003). Engineered zinc finger 
proteins for controlling stem cell fate. Stem Cells 21, 632-637. 
Begley, C.G., and Green, A.R. (1999). The SCL gene: from case report to critical 
hematopoietic regulator. Blood 93, 2760-2770. 
Bender, M.A., Bulger, M., Close, J., and Groudine, M. (2000). Beta-globin gene 
switching and DNase I sensitivity of the endogenous beta-globin locus in mice do not 
require the locus control region. Mol Cell 5, 387-393. 
Bender, M.A., Ragoczy, T., Lee, J., Byron, R., Telling, A., Dean, A., and Groudine, M. 
(2012). The hypersensitive sites of the murine beta-globin locus control region act 
independently to affect nuclear localization and transcriptional elongation. Blood 119, 
3820-3827. 
158 
 
Bender, M.A., Reik, A., Close, J., Telling, A., Epner, E., Fiering, S., Hardison, R., and 
Groudine, M. (1998). Description and targeted deletion of 5' hypersensitive site 5 and 6 
of the mouse beta-globin locus control region. Blood 92, 4394-4403. 
Bender, M.A., Roach, J.N., Halow, J., Close, J., Alami, R., Bouhassira, E.E., Groudine, 
M., and Fiering, S.N. (2001). Targeted deletion of 5'HS1 and 5'HS4 of the beta-globin 
locus control region reveals additive activity of the DNaseI hypersensitive sites. Blood 
98, 2022-2027. 
Bieda, M., Xu, X., Singer, M.A., Green, R., and Farnham, P.J. (2006). Unbiased location 
analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human 
genome. Genome Res 16, 595-605. 
Blackwood, E.M., and Kadonaga, J.T. (1998). Going the distance: a current view of 
enhancer action. Science 281, 60-63. 
Blankenberg, D., Taylor, J., Schenck, I., He, J., Zhang, Y., Ghent, M., Veeraraghavan, 
N., Albert, I., Miller, W., Makova, K.D., et al. (2007). A framework for collaborative 
analysis of ENCODE data: making large-scale analyses biologist-friendly. Genome Res 
17, 960-964. 
Blobel, G.A., Nakajima, T., Eckner, R., Montminy, M., and Orkin, S.H. (1998). CREB-
binding protein (CBP) cooperates with transcription factor GATA-1 and is required for 
erythroid differentiation. Proc Natl Acad Sci USA 95, 2061-2066. 
Boch, J., and Bonas, U. (2010). Xanthomonas AvrBs3 family-type III effectors: 
discovery and function. Annu Rev Phytopathol 48, 419-436. 
Borg, J., Papadopoulos, P., Georgitsi, M., Gutierrez, L., Grech, G., Fanis, P., Phylactides, 
M., Verkerk, A.J., van der Spek, P.J., Scerri, C.A., et al. (2010). Haploinsufficiency for 
the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. 
Nat Genet 42, 801-805. 
Bottardi, S., Zmiri, F.A., Bourgoin, V., Ross, J., Mavoungou, L., and Milot, E. (2011). 
Ikaros interacts with P-TEFb and cooperates with GATA-1 to enhance transcription 
elongation. Nucleic Acids Res 39, 3505-3519. 
Boyes, J., Byfield, P., Nakatani, Y., and Ogryzko, V. (1998). Regulation of activity of the 
transcription factor GATA-1 by acetylation. Nature 396, 594-598. 
159 
 
Bresnick, E.H., Lee, H.Y., Fujiwara, T., Johnson, K.D., and Keles, S. (2010). GATA 
switches as developmental drivers. J Biol Chem 285, 31087-31093. 
Bulger, M., and Groudine, M. (1999). Looping versus linking: toward a model for long-
distance gene activation. Genes Dev 13, 2465-2477. 
Bulger, M., and Groudine, M. (2011). Functional and mechanistic diversity of distal 
transcription enhancers. Cell 144, 327-339. 
Cantor, A.B., Iwasaki, H., Arinobu, Y., Moran, T.B., Shigematsu, H., Sullivan, M.R., 
Akashi, K., and Orkin, S.H. (2008). Antagonism of FOG-1 and GATA factors in fate 
choice for the mast cell lineage. J Exp Med 205, 611-624. 
Cantor, A.B., and Orkin, S.H. (2002). Transcriptional regulation of erythropoiesis: an 
affair involving multiple partners. Oncogene 21, 3368-3376. 
Carter, D., Chakalova, L., Osborne, C.S., Dai, Y.F., and Fraser, P. (2002). Long-range 
chromatin regulatory interactions in vivo. Nat Genet 32, 623-626. 
Cermak, T., Doyle, E.L., Christian, M., Wang, L., Zhang, Y., Schmidt, C., Baller, J.A., 
Somia, N.V., Bogdanove, A.J., and Voytas, D.F. (2011). Efficient design and assembly of 
custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic 
Acids Res 39, e82. 
Chen, C.J., Deng, Z., Kim, A.Y., Blobel, G.A., and Lieberman, P.M. (2001). Stimulation 
of CREB binding protein nucleosomal histone acetyltransferase activity by a class of 
transcriptional activators. Mol Cell Biol 21, 476-487. 
Cheng, Y., King, D.C., Dore, L.C., Zhang, X., Zhou, Y., Zhang, Y., Dorman, C.M., 
Abebe, D., Kumar, S.A., Chiaromonte, F., et al. (2008). Transcriptional enhancement by 
GATA1-occupied DNA segments is strongly associated with evolutionary constraint on 
the binding site motif. Genome Res. 
Cheng, Y., Wu, W., Kumar, S.A., Yu, D., Deng, W., Tripic, T., King, D.C., Chen, K.B., 
Zhang, Y., Drautz, D., et al. (2009). Erythroid GATA1 function revealed by genome-
wide analysis of transcription factor occupancy, histone modifications, and mRNA 
expression. Genome Res 19, 2172-2184. 
Chou, S.T., Khandros, E., Bailey, L.C., Nichols, K.E., Vakoc, C.R., Yao, Y., Huang, Z., 
Crispino, J.D., Hardison, R.C., Blobel, G.A., et al. (2009). Graded repression of 
160 
 
PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate. Blood 
114, 983-994. 
Cremer, T., Cremer, M., Dietzel, S., Muller, S., Solovei, I., and Fakan, S. (2006). 
Chromosome territories--a functional nuclear landscape. Curr Opin Cell Biol 18, 307-
316. 
Crispino, J.D. (2005). GATA1 in normal and malignant hematopoiesis. Semin Cell Dev 
Biol 16, 137-147. 
Cross, A.J., Jeffries, C.M., Trewhella, J., and Matthews, J.M. (2010). LIM domain 
binding proteins 1 and 2 have different oligomeric states. J Mol Biol 399, 133-144. 
Cullen, K.E., Kladde, M.P., and Seyfred, M.A. (1993). Interaction between transcription 
regulatory regions of prolactin chromatin. Science 261, 203-206. 
Dean, A. (2011). In the loop: long range chromatin interactions and gene regulation. 
Brief Funct Genomics 10, 3-10. 
Dekker, J., Rippe, K., Dekker, M., and Kleckner, N. (2002). Capturing chromosome 
conformation. Science 295, 1306-1311. 
Dixon, J.R., Selvaraj, S., Yue, F., Kim, A., Li, Y., Shen, Y., Hu, M., Liu, J.S., and Ren, 
B. (2012). Topological domains in mammalian genomes identified by analysis of 
chromatin interactions. Nature 485, 376-380. 
Drissen, R., Palstra, R.J., Gillemans, N., Splinter, E., Grosveld, F., Philipsen, S., and de 
Laat, W. (2004). The active spatial organization of the beta-globin locus requires the 
transcription factor EKLF. Genes Dev 18, 2485-2490. 
El Omari, K., Hoosdally, S.J., Tuladhar, K., Karia, D., Vyas, P., Patient, R., Porcher, C., 
and Mancini, E.J. (2011). Structure of the leukemia oncogene LMO2: implications for the 
assembly of a hematopoietic transcription factor complex. Blood 117, 2146-2156. 
Elagib, K.E., Mihaylov, I.S., Delehanty, L.L., Bullock, G.C., Ouma, K.D., Caronia, J.F., 
Gonias, S.L., and Goldfarb, A.N. (2008). Cross-talk of GATA-1 and P-TEFb in 
megakaryocyte differentiation. Blood 112, 4884-4894. 
Epner, E., Reik, A., Cimbora, D., Telling, A., Bender, M.A., Fiering, S., Enver, T., 
Martin, D.I.K., Kennedy, M., Keller, G., et al. (1998). The β-globin LCR is not necessary 
161 
 
for an open chromatin structure or developmentally regulated transcription of the native 
mouse β-globin locus. Mol Cell 2, 447-455. 
Fiering, S., Epner, E., Robinson, K., Zhuang, Y., Telling, A., Hu, M., Martin, D.I., Enver, 
T., Ley, T.J., and Groudine, M. (1995). Targeted deletion of 5'HS2 of the murine beta-
globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. 
Genes Dev 9, 2203-2213. 
Fujiwara, T., O'Geen, H., Keles, S., Blahnik, K., Linnemann, A.K., Kang, Y.A., Choi, K., 
Farnham, P.J., and Bresnick, E.H. (2009). Discovering hematopoietic mechanisms 
through genome-wide analysis of GATA factor chromatin occupancy. Mol Cell 36, 667-
681. 
Fujiwara, Y., Browne, C.P., Cunniff, K., Goff, S.C., and Orkin, S.H. (1996). Arrested 
development of embryonic red cell precursors in mouse embryos lacking transcription 
factor GATA-1. Proc Natl Acad Sci USA 93, 12355-12358. 
Fullwood, M.J., Han, Y., Wei, C.L., Ruan, X., and Ruan, Y. (2010). Chromatin 
interaction analysis using paired-end tag sequencing. Curr Protoc Mol Biol Chapter 21, 
Unit 21 15 21-25. 
Fullwood, M.J., Liu, M.H., Pan, Y.F., Liu, J., Xu, H., Mohamed, Y.B., Orlov, Y.L., 
Velkov, S., Ho, A., Mei, P.H., et al. (2009). An oestrogen-receptor-alpha-bound human 
chromatin interactome. Nature 462, 58-64. 
Goardon, N., Lambert, J.A., Rodriguez, P., Nissaire, P., Herblot, S., Thibault, P., 
Dumenil, D., Strouboulis, J., Romeo, P.H., and Hoang, T. (2006). ETO2 coordinates 
cellular proliferation and differentiation during erythropoiesis. Embo J 25, 357-366. 
Grass, J.A., Boyer, M.E., Pal, S., Wu, J., Weiss, M.J., and Bresnick, E.H. (2003). GATA-
1-dependent transcriptional repression of GATA-2 via disruption of positive 
autoregulation and domain-wide chromatin remodeling. Proc Natl Acad Sci U S A 100, 
8811-8816. 
Grass, J.A., Jing, H., Kim, S.I., Martowicz, M.L., Pal, S., Blobel, G.A., and Bresnick, 
E.H. (2006). Distinct functions of dispersed GATA factor complexes at an endogenous 
gene locus. Mol Cell Biol 26, 7056-7067. 
Gregory, G.D., Raju, S.S., Winandy, S., and Brown, M.A. (2006). Mast cell IL-4 
expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE. 
J Clin Invest 116, 1327-1336. 
162 
 
Hagege, H., Klous, P., Braem, C., Splinter, E., Dekker, J., Cathala, G., de Laat, W., and 
Forne, T. (2007). Quantitative analysis of chromosome conformation capture assays (3C-
qPCR). Nat Protoc 2, 1722-1733. 
Hakim, O., and Misteli, T. (2012). SnapShot: Chromosome confirmation capture. Cell 
148, 1068 e1061-1062. 
Hall, M.A., Curtis, D.J., Metcalf, D., Elefanty, A.G., Sourris, K., Robb, L., Gothert, J.R., 
Jane, S.M., and Begley, C.G. (2003). The critical regulator of embryonic hematopoiesis, 
SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in 
CFU-S12. Proc Natl Acad Sci U S A 100, 992-997. 
Handoko, L., Xu, H., Li, G., Ngan, C.Y., Chew, E., Schnapp, M., Lee, C.W., Ye, C., 
Ping, J.L., Mulawadi, F., et al. (2011). CTCF-mediated functional chromatin interactome 
in pluripotent cells. Nat Genet 43, 630-638. 
Hattangadi, S.M., Wong, P., Zhang, L., Flygare, J., and Lodish, H.F. (2011). From stem 
cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, 
and chromatin modifications. Blood 118, 6258-6268. 
Hollanda, L.M., Lima, C.S., Cunha, A.F., Albuquerque, D.M., Vassallo, J., Ozelo, M.C., 
Joazeiro, P.P., Saad, S.T., and Costa, F.F. (2006). An inherited mutation leading to 
production of only the short isoform of GATA-1 is associated with impaired 
erythropoiesis. Nat Genet 38, 807-812. 
Hong, W., Nakazawa, M., Chen, Y.Y., Kori, R., Vakoc, C.R., Rakowski, C., and Blobel, 
G.A. (2005). FOG-1 recruits the NuRD repressor complex to mediate transcriptional 
repression by GATA-1. Embo J 24, 2367-2378. 
Hou, C., Dale, R., and Dean, A. (2010). Cell type specificity of chromatin organization 
mediated by CTCF and cohesin. Proc Natl Acad Sci U S A 107, 3651-3656. 
Hou, C., Zhao, H., Tanimoto, K., and Dean, A. (2008). CTCF-dependent enhancer-
blocking by alternative chromatin loop formation. Proc Natl Acad Sci U S A 105, 20398-
20403. 
Hu, G., Schones, D.E., Cui, K., Ybarra, R., Northrup, D., Tang, Q., Gattinoni, L., Restifo, 
N.P., Huang, S., and Zhao, K. (2011). Regulation of nucleosome landscape and 
transcription factor targeting at tissue-specific enhancers by BRG1. Genome Res 21, 
1650-1658. 
163 
 
Huang, S., Qiu, Y., Shi, Y., Xu, Z., and Brandt, S.J. (2000). P/CAF-mediated acetylation 
regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL. Embo 
J 19, 6792-6803. 
Huang, S., Qiu, Y., Stein, R.W., and Brandt, S.J. (1999). p300 functions as a 
transcriptional coactivator for the TAL1/SCL oncoprotein. Oncogene 18, 4958-4967. 
Hung, H.-L., Lau, J., Weiss, M.J., and Blobel, G.A. (1999). CREB-Binding Protein 
(CBP) acetylates hematopoietic transcription factor GATA-1 at functionally important 
sites. Mol Cell Biol 19, 3496-3505. 
Ishida, Y., Levin, J., Baker, G., Stenberg, P.E., Yamada, Y., Sasaki, H., and Inoue, T. 
(1993). Biological and biochemical characteristics of murine megakaryoblastic cell line 
L8057. Experimental Hematolgy 21, 289-298. 
Jing, H., Vakoc, C.R., Ying, L., Mandat, S., Wang, H., Zheng, X., and Blobel, G.A. 
(2008). Exchange of GATA factors mediates transitions in looped chromatin organization 
at a developmentally regulated gene locus. Mol Cell 29, 232-242. 
Johnson, K.D., Boyer, M.E., Kang, J.A., Wickrema, A., Cantor, A.B., and Bresnick, E.H. 
(2007). Friend of GATA-1-independent transcriptional repression: a novel mode of 
GATA-1 function. Blood 109, 5230-5233. 
Johnson, K.D., Grass, J.A., Boyer, M.E., Kiekhaefer, C.M., Blobel, G.A., Weiss, M.J., 
and Bresnick, E.H. (2002). Cooperative activities of hematopoietic regulators recruit 
RNA polymerase II to a tissue-specific chromatin domain. Proc Natl Acad Sci U S A 99, 
11760-11765. 
Jurata, L.W., and Gill, G.N. (1997). Functional analysis of the nuclear LIM domain 
interactor NLI. Mol Cell Biol 17, 5688-5698. 
Kadauke, S., and Blobel, G.A. (2009). Chromatin loops in gene regulation. Biochim 
Biophys Acta 1789, 17-25. 
Kagey, M.H., Newman, J.J., Bilodeau, S., Zhan, Y., Orlando, D.A., van Berkum, N.L., 
Ebmeier, C.C., Goossens, J., Rahl, P.B., Levine, S.S., et al. (2010). Mediator and cohesin 
connect gene expression and chromatin architecture. Nature 467, 430-435. 
Kassouf, M.T., Chagraoui, H., Vyas, P., and Porcher, C. (2008). Differential use of 
SCL/TAL-1 DNA-binding domain in developmental hematopoiesis. Blood. 
164 
 
Kassouf, M.T., Hughes, J.R., Taylor, S., McGowan, S.J., Soneji, S., Green, A.L., Vyas, 
P., and Porcher, C. (2010). Genome-wide identification of TAL1's functional targets: 
insights into its mechanisms of action in primary erythroid cells. Genome Res 20, 1064-
1083. 
Kent, W.J., Sugnet, C.W., Furey, T.S., Roskin, K.M., Pringle, T.H., Zahler, A.M., and 
Haussler, D. (2002). The human genome browser at UCSC. Genome Res 12, 996-1006. 
Kim, S.I., Bultman, S.J., Jing, H., Blobel, G.A., and Bresnick, E.H. (2007). Dissecting 
molecular steps in chromatin domain activation during hematopoietic differentiation. Mol 
Cell Biol 27, 4551-4565. 
Kim, S.I., Bultman, S.J., Kiefer, C.M., Dean, A., and Bresnick, E.H. (2009). BRG1 
requirement for long-range interaction of a locus control region with a downstream 
promoter. Proc Natl Acad Sci U S A 106, 2259-2264. 
Klug, A. (2010). The discovery of zinc fingers and their applications in gene regulation 
and genome manipulation. Annu Rev Biochem 79, 213-231. 
Lahlil, R., Lecuyer, E., Herblot, S., and Hoang, T. (2004). SCL assembles a multifactorial 
complex that determines glycophorin A expression. Mol Cell Biol 24, 1439-1452. 
Lamonica, J.M., Deng, W., Kadauke, S., Campbell, A.E., Gamsjaeger, R., Wang, H., 
Cheng, Y., Billin, A.N., Hardison, R.C., Mackay, J.P., et al. (2011). PNAS Plus: 
Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin 
occupancy at erythroid target genes. Proc Natl Acad Sci U S A 108, E159-168. 
Lamonica, J.M., Vakoc, C.R., and Blobel, G.A. (2006). Acetylation of GATA-1 is 
required for chromatin occupancy. Blood 108, 3736-3738. 
Lecuyer, E., Herblot, S., Saint-Denis, M., Martin, R., Begley, C.G., Porcher, C., Orkin, 
S.H., and Hoang, T. (2002). The SCL complex regulates c-kit expression in 
hematopoietic cells through functional interaction with Sp1. Blood 100, 2430-2440. 
Lecuyer, E., and Hoang, T. (2004). SCL: from the origin of hematopoiesis to stem cells 
and leukemia. Exp Hematol 32, 11-24. 
Letting, D.L., Chen, Y.Y., Rakowski, C., Reedy, S., and Blobel, G.A. (2004). Context-
dependent regulation of GATA-1 by friend of GATA-1. Proc Natl Acad Sci U S A 101, 
476-481. 
165 
 
Letting, D.L., Rakowski, C., Weiss, M.J., and Blobel, G.A. (2003). Formation of a 
Tissue-Specific Histone Acetylation Pattern by the Hematopoietic Transcription Factor 
GATA-1. Mol Cell Biol 23, 1334-1340. 
Li, L., Jothi, R., Cui, K., Lee, J.Y., Cohen, T., Gorivodsky, M., Tzchori, I., Zhao, Y., 
Hayes, S.M., Bresnick, E.H., et al. (2011). Nuclear adaptor Ldb1 regulates a 
transcriptional program essential for the maintenance of hematopoietic stem cells. Nat 
Immunol 12, 129-136. 
Li, Q., Peterson, K.R., Fang, X., and Stamatoyannopoulos, G. (2002). Locus control 
regions. Blood 100, 3077-3086. 
Liang, F.S., Ho, W.Q., and Crabtree, G.R. (2011). Engineering the ABA plant stress 
pathway for regulation of induced proximity. Sci Signal 4, rs2. 
Lieberman-Aiden, E., van Berkum, N.L., Williams, L., Imakaev, M., Ragoczy, T., 
Telling, A., Amit, I., Lajoie, B.R., Sabo, P.J., Dorschner, M.O., et al. (2009). 
Comprehensive mapping of long-range interactions reveals folding principles of the 
human genome. Science 326, 289-293. 
Luger, K., Mader, A.W., Richmond, R.K., Sargent, D.F., and Richmond, T.J. (1997). 
Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389, 251-
260. 
Lurie, L.J., Boyer, M.E., Grass, J.A., and Bresnick, E.H. (2008). Differential GATA 
factor stabilities: implications for chromatin occupancy by structurally similar 
transcription factors. Biochemistry 47, 859-869. 
Maeda, K., Nishiyama, C., Tokura, T., Akizawa, Y., Nishiyama, M., Ogawa, H., 
Okumura, K., and Ra, C. (2003). Regulation of cell type-specific mouse Fc epsilon RI 
beta-chain gene expression by GATA-1 via four GATA motifs in the promoter. J 
Immunol 170, 334-340. 
Mahfouz, M.M., Li, L., Shamimuzzaman, M., Wibowo, A., Fang, X., and Zhu, J.K. 
(2011). De novo-engineered transcription activator-like effector (TALE) hybrid nuclease 
with novel DNA binding specificity creates double-strand breaks. Proc Natl Acad Sci U S 
A 108, 2623-2628. 
Mahmoudi, T., Katsani, K.R., and Verrijzer, C.P. (2002). GAGA can mediate enhancer 
function in trans by linking two separate DNA molecules. Embo J 21, 1775-1781. 
166 
 
Marenduzzo, D., Faro-Trindade, I., and Cook, P.R. (2007). What are the molecular ties 
that maintain genomic loops? Trends Genet 23, 126-133. 
Martowicz, M.L., Grass, J.A., Boyer, M.E., Guend, H., and Bresnick, E.H. (2005). 
Dynamic GATA factor interplay at a multicomponent regulatory region of the GATA-2 
locus. J Biol Chem 280, 1724-1732. 
Matthews, J.M., and Visvader, J.E. (2003). LIM-domain-binding protein 1: a 
multifunctional cofactor that interacts with diverse proteins. EMBO Rep 4, 1132-1137. 
Mead, P.E., Deconinck, A.E., Huber, T.L., Orkin, S.H., and Zon, L.I. (2001). Primitive 
erythropoiesis in the Xenopus embryo: the synergistic role of LMO-2, SCL and GATA-
binding proteins. Development 128, 2301-2308. 
Meier, N., Krpic, S., Rodriguez, P., Strouboulis, J., Monti, M., Krijgsveld, J., Gering, M., 
Patient, R., Hostert, A., and Grosveld, F. (2006). Novel binding partners of Ldb1 are 
required for haematopoietic development. Development 133, 4913-4923. 
Metivier, R., Penot, G., Hubner, M.R., Reid, G., Brand, H., Kos, M., and Gannon, F. 
(2003). Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment 
of cofactors on a natural target promoter. Cell 115, 751-763. 
Miccio, A., and Blobel, G.A. (2010). Role of the GATA-1/FOG-1/NuRD pathway in the 
expression of human beta-like globin genes. Mol Cell Biol 30, 3460-3470. 
Miccio, A., Wang, Y., Hong, W., Gregory, G.D., Wang, H., Yu, X., Choi, J.K., Shelat, 
S., Tong, W., Poncz, M., et al. (2010). NuRD mediates activating and repressive 
functions of GATA-1 and FOG-1 during blood development. EMBO J 29, 442-456. 
Miele, A., and Dekker, J. (2008). Long-range chromosomal interactions and gene 
regulation. Mol Biosyst 4, 1046-1057. 
Migliaccio, A.R., Rana, R.A., Sanchez, M., Lorenzini, R., Centurione, L., Bianchi, L., 
Vannucchi, A.M., Migliaccio, G., and Orkin, S.H. (2003). GATA-1 as a regulator of mast 
cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J Exp 
Med 197, 281-296. 
Mikkola, H.K., Klintman, J., Yang, H., Hock, H., Schlaeger, T.M., Fujiwara, Y., and 
Orkin, S.H. (2003). Haematopoietic stem cells retain long-term repopulating activity and 
multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature 421, 547-551. 
167 
 
Miller, J.C., Tan, S., Qiao, G., Barlow, K.A., Wang, J., Xia, D.F., Meng, X., Paschon, 
D.E., Leung, E., Hinkley, S.J., et al. (2011). A TALE nuclease architecture for efficient 
genome editing. Nat Biotechnol 29, 143-148. 
Minegishi, N., Suzuki, N., Kawatani, Y., Shimizu, R., and Yamamoto, M. (2005). Rapid 
turnover of GATA-2 via ubiquitin-proteasome protein degradation pathway. Genes Cells 
10, 693-704. 
Mitchell, J.A., and Fraser, P. (2008). Transcription factories are nuclear subcompartments 
that remain in the absence of transcription. Genes Dev 22, 20-25. 
Montavon, T., Soshnikova, N., Mascrez, B., Joye, E., Thevenet, L., Splinter, E., de Laat, 
W., Spitz, F., and Duboule, D. (2011). A regulatory archipelago controls Hox genes 
transcription in digits. Cell 147, 1132-1145. 
Morcillo, P., Rosen, C., Baylies, M.K., and Dorsett, D. (1997). Chip, a widely expressed 
chromosomal protein required for segmentation and activity of a remote wing margin 
enhancer in Drosophila. Genes Dev 11, 2729-2740. 
Mukhopadhyay, M., Teufel, A., Yamashita, T., Agulnick, A.D., Chen, L., Downs, K.M., 
Schindler, A., Grinberg, A., Huang, S.P., Dorward, D., et al. (2003). Functional ablation 
of the mouse Ldb1 gene results in severe patterning defects during gastrulation. 
Development 130, 495-505. 
Munugalavadla, V., Dore, L.C., Tan, B.L., Hong, L., Vishnu, M., Weiss, M.J., and 
Kapur, R. (2005). Repression of c-kit and its downstream substrates by GATA-1 inhibits 
cell proliferation during erythroid maturation. Mol Cell Biol 25, 6747-6759. 
Nerlov, C., Querfurth, E., Kulessa, H., and Graf, T. (2000). GATA-1 interacts with the 
myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood 95, 
2543-2551. 
Nichols, K.E., Crispino, J.D., Poncz, M., White, J.G., Orkin, S.H., Maris, J.M., and 
Weiss, M.J. (2000). Familial dyserythropoietic anaemia and thrombocytopenia due to an 
inherited mutation in GATA1. Nat Genet 24, 266-270. 
Nishimura, S., Takahashi, S., Kuroha, T., Suwabe, N., Nagasawa, T., Trainor, C., and 
Yamamoto, M. (2000). A GATA box in the GATA-1 gene hematopoietic enhancer is a 
critical element in the network of GATA factors and sites that regulate this gene. Mol 
Cell Biol 20, 713-723. 
168 
 
Nolis, I.K., McKay, D.J., Mantouvalou, E., Lomvardas, S., Merika, M., and Thanos, D. 
(2009). Transcription factors mediate long-range enhancer-promoter interactions. Proc 
Natl Acad Sci U S A 106, 20222-20227. 
Ono, Y., Fukuhara, N., and Yoshie, O. (1998). TAL1 and LIM-only proteins 
synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute 
lymphoblastic leukemia by acting as cofactors for GATA3. Mol Cell Biol 18, 6939-6950. 
Orkin, S.H., and Zon, L.I. (2008). Hematopoiesis: an evolving paradigm for stem cell 
biology. Cell 132, 631-644. 
Osada, H., Grutz, G., Axelson, H., Forster, A., and Rabbitts, T.H. (1995). Association of 
erythoid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-
finger protein GATA-1. Proc Natl Acad Sci USA 92, 9585-9589. 
Ostendorff, H.P., Peirano, R.I., Peters, M.A., Schluter, A., Bossenz, M., Scheffner, M., 
and Bach, I. (2002). Ubiquitination-dependent cofactor exchange on LIM homeodomain 
transcription factors. Nature 416, 99-103. 
Pal, S., Cantor, A.B., Johnson, K.D., Moran, T.B., Boyer, M.E., Orkin, S.H., and 
Bresnick, E.H. (2004). Coregulator-dependent facilitation of chromatin occupancy by 
GATA-1. Proc Natl Acad Sci U S A 101, 980-985. 
Palstra, R.J., de Laat, W., and Grosveld, F. (2008a). Beta-globin regulation and long-
range interactions. Adv Genet 61, 107-142. 
Palstra, R.J., Simonis, M., Klous, P., Brasset, E., Eijkelkamp, B., and de Laat, W. 
(2008b). Maintenance of Long-Range DNA Interactions after Inhibition of Ongoing 
RNA Polymerase II Transcription. PLoS ONE 3, e1661. 
Palstra, R.J., Tolhuis, B., Splinter, E., Nijmeijer, R., Grosveld, F., and de Laat, W. 
(2003). The beta-globin nuclear compartment in development and erythroid 
differentiation. Nat Genet 35, 190-194. 
Patient, R.K., and McGhee, J.D. (2002). The GATA family (vertebrates and 
invertebrates). Curr Opin Genet Dev 12, 416-422. 
Pear, W.S., Nolan, G.P., Scott, M.L., and Baltimore, D. (1993). Production of high-titer 
helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90, 8392-
8396. 
169 
 
Petrascheck, M., Escher, D., Mahmoudi, T., Verrijzer, C.P., Schaffner, W., and Barberis, 
A. (2005). DNA looping induced by a transcriptional enhancer in vivo. Nucleic Acids 
Res 33, 3743-3750. 
Phillips, J.E., and Corces, V.G. (2009). CTCF: master weaver of the genome. Cell 137, 
1194-1211. 
Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H., and 
Klug, P.P. (1994). Mortality in sickle cell disease. Life expectancy and risk factors for 
early death. N Engl J Med 330, 1639-1644. 
Porcher, C., Liao, E.C., Fujiwara, Y., Zon, L.I., and Orkin, S.H. (1999). Specification of 
hematopoietic and vascular development by the bHLH transcription factor SCL without 
direct DNA binding. Development 126, 4603-4615. 
Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, F.W., and Orkin, S.H. (1996). 
The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all 
hematopoietic lineages. Cell 86, 47-57. 
Reik, A., Telling, A., Zitnik, G., Cimbora, D., Epner, E., and Groudine, M. (1998). The 
locus control region is necessary for gene expression in the human beta-globin locus but 
not for the maintenance of an open chromatin structure in erythroid cells. Mol Cell Biol 
18, 5992-6000. 
Rekhtman, N., Radparvar, F., Evans, T., and Skoultchi, A.I. (1999). Direct interaction of 
hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in 
erythroid cells. Genes Dev 13, 1398-1411. 
Rippe, K. (2001). Making contacts on a nucleic acid polymer. Trends Biochem Sci 26, 
733-740. 
Robb, L., Lyons, I., Li, R., Hartley, L., Kontgen, F., Harvey, R.P., Metcalf, D., and 
Begley, C.G. (1995). Absence of yolk sac hematopoiesis from mice with a targeted 
disruption of the scl gene. Proc Natl Acad Sci U S A 92, 7075-7079. 
Robinson, P.J., and Rhodes, D. (2006). Structure of the '30 nm' chromatin fibre: a key 
role for the linker histone. Curr Opin Struct Biol 16, 336-343. 
Rodrigues, N.P., Tipping, A.J., Wang, Z., and Enver, T. (2012). GATA-2 mediated 
regulation of normal hematopoietic stem/progenitor cell function, myelodysplasia and 
myeloid leukemia. Int J Biochem Cell Biol 44, 457-460. 
170 
 
Rodriguez, P., Bonte, E., Krijgsveld, J., Kolodziej, K.E., Guyot, B., Heck, A.J., Vyas, P., 
de Boer, E., Grosveld, F., and Strouboulis, J. (2005). GATA-1 forms distinct activating 
and repressive complexes in erythroid cells. Embo J 24, 2354-2366. 
Russell, R.R. (1979). Use of triton X-100 to overcome the inhibition of 
fructosyltransferase by SDS. Anal Biochem 97, 173-175. 
Salmon, J.M., Slater, N.J., Hall, M.A., McCormack, M.P., Nutt, S.L., Jane, S.M., and 
Curtis, D.J. (2007). Aberrant mast-cell differentiation in mice lacking the stem-cell 
leukemia gene. Blood 110, 3573-3581. 
Sankaran, V.G. (2011). Targeted therapeutic strategies for fetal hemoglobin induction. 
Hematology Am Soc Hematol Educ Program 2011, 459-465. 
Sankaran, V.G., Menne, T.F., Xu, J., Akie, T.E., Lettre, G., Van Handel, B., Mikkola, 
H.K., Hirschhorn, J.N., Cantor, A.B., and Orkin, S.H. (2008). Human fetal hemoglobin 
expression is regulated by the developmental stage-specific repressor BCL11A. Science 
322, 1839-1842. 
Sawado, T., Halow, J., Bender, M.A., and Groudine, M. (2003). The beta -globin locus 
control region (LCR) functions primarily by enhancing the transition from transcription 
initiation to elongation. Genes Dev 17, 1009-1018. 
Schoenfelder, S., Clay, I., and Fraser, P. (2010a). The transcriptional interactome: gene 
expression in 3D. Curr Opin Genet Dev 20, 127-133. 
Schoenfelder, S., Sexton, T., Chakalova, L., Cope, N.F., Horton, A., Andrews, S., 
Kurukuti, S., Mitchell, J.A., Umlauf, D., Dimitrova, D.S., et al. (2010b). Preferential 
associations between co-regulated genes reveal a transcriptional interactome in erythroid 
cells. Nat Genet 42, 53-61. 
Schubeler, D., Groudine, M., and Bender, M.A. (2001). The murine beta-globin locus 
control region regulates the rate of transcription but not the hyperacetylation of histones 
at the active genes. Proc Natl Acad Sci U S A 98, 11432-11437. 
Schuh, A.H., Tipping, A.J., Clark, A.J., Hamlett, I., Guyot, B., Iborra, F.J., Rodriguez, P., 
Strouboulis, J., Enver, T., Vyas, P., et al. (2005). ETO-2 associates with SCL in erythroid 
cells and megakaryocytes and provides repressor functions in erythropoiesis. Mol Cell 
Biol 25, 10235-10250. 
171 
 
Sera, T. (2009). Zinc-finger-based artificial transcription factors and their applications. 
Adv Drug Deliv Rev 61, 513-526. 
Sexton, T., Bantignies, F., and Cavalli, G. (2009). Genomic interactions: chromatin loops 
and gene meeting points in transcriptional regulation. Semin Cell Dev Biol 20, 849-855. 
Shivdasani, R.A., Fujiwara, Y., McDevitt, M.A., and Orkin, Stuart H. (1997). A lineage-
selective knockout establishes the critical role of transcription factor GATA-1 in 
megakaryocyte growth and platelet development. EMBO J 16, 3965-3973. 
Shivdasani, R.A., Mayer, E.L., and Orkin, S.H. (1995). Absence of blood formation in 
mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373, 432-434. 
Simonis, M., Kooren, J., and de Laat, W. (2007). An evaluation of 3C-based methods to 
capture DNA interactions. Nat Methods 4, 895-901. 
Soler, E., Andrieu-Soler, C., de Boer, E., Bryne, J.C., Thongjuea, S., Stadhouders, R., 
Palstra, R.J., Stevens, M., Kockx, C., van Ijcken, W., et al. (2010). The genome-wide 
dynamics of the binding of Ldb1 complexes during erythroid differentiation. Genes Dev 
24, 277-289. 
Song, S.H., Hou, C., and Dean, A. (2007). A positive role for NLI/Ldb1 in long-range 
beta-globin locus control region function. Mol Cell 28, 810-822. 
Song, S.H., Kim, A., Ragoczy, T., Bender, M.A., Groudine, M., and Dean, A. (2010). 
Multiple functions of Ldb1 required for {beta}-globin activation during erythroid 
differentiation. Blood. 
Spilianakis, C.G., and Flavell, R.A. (2004). Long-range intrachromosomal interactions in 
the T helper type 2 cytokine locus. Nat Immunol 5, 1017-1027. 
Splinter, E., Heath, H., Kooren, J., Palstra, R.J., Klous, P., Grosveld, F., Galjart, N., and 
de Laat, W. (2006). CTCF mediates long-range chromatin looping and local histone 
modification in the beta-globin locus. Genes Dev 20, 2349-2354. 
Stadhouders, R., Thongjuea, S., Andrieu-Soler, C., Palstra, R.J., Bryne, J.C., van den 
Heuvel, A., Stevens, M., de Boer, E., Kockx, C., van der Sloot, A., et al. (2012). 
Dynamic long-range chromatin interactions control Myb proto-oncogene transcription 
during erythroid development. EMBO J 31, 986-999. 
172 
 
Stamatoyannopoulos, G. (2005). Control of globin gene expression during development 
and erythroid differentiation. Exp Hematol 33, 259-271. 
Szalai, G., LaRue, A.C., and Watson, D.K. (2006). Molecular mechanisms of 
megakaryopoiesis. Cell Mol Life Sci 63, 2460-2476. 
Thaler, J.P., Lee, S.K., Jurata, L.W., Gill, G.N., and Pfaff, S.L. (2002). LIM factor Lhx3 
contributes to the specification of motor neuron and interneuron identity through cell-
type-specific protein-protein interactions. Cell 110, 237-249. 
Tiwari, V.K., McGarvey, K.M., Licchesi, J.D., Ohm, J.E., Herman, J.G., Schubeler, D., 
and Baylin, S.B. (2008). PcG proteins, DNA methylation, and gene repression by 
chromatin looping. PLoS Biol 6, 2911-2927. 
Tolhuis, B., Palstra, R.J., Splinter, E., Grosveld, F., and de Laat, W. (2002). Looping and 
interaction between hypersensitive sites in the active beta-globin locus. Mol Cell 10, 
1453-1465. 
Tripic, T., Deng, W., Cheng, Y., Zhang, Y., Vakoc, C.R., Gregory, G.D., Hardison, R.C., 
and Blobel, G.A. (2009). SCL and associated proteins distinguish active from repressive 
GATA transcription factor complexes. Blood 113, 2191-2201. 
Tsang, A.P., E, V.J., A, T.C., Fujiwara, Y., Yu, C., Weiss, M.J., Crossley, M., and Orkin, 
S.H. (1997). FOG, a multitype zinc finger protein, acts as a cofactor for transcription 
factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90, 109-119. 
Vakoc, C.R., Letting, D.L., Gheldof, N., Sawado, T., Bender, M.A., Groudine, M., 
Weiss, M.J., Dekker, J., and Blobel, G.A. (2005). Proximity among Distant Regulatory 
Elements at the beta-Globin Locus Requires GATA-1 and FOG-1. Mol Cell 17, 453-462. 
Valverde-Garduno, V., Guyot, B., Anguita, E., Hamlett, I., Porcher, C., and Vyas, P. 
(2004). Differences in the chromatin structure and cis-element organization of the human 
and mouse GATA1 loci: implications for cis-element identification. Blood 104, 3106-
3116. 
Vernimmen, D., De Gobbi, M., Sloane-Stanley, J.A., Wood, W.G., and Higgs, D.R. 
(2007). Long-range chromosomal interactions regulate the timing of the transition 
between poised and active gene expression. Embo J 26, 2041-2051. 
Vyas, P., McDevitt, M.A., Cantor, A.B., Katz, S.G., Fujiwara, Y., and Orkin, S.H. 
(1999). Different sequence requirements for expression in erythroid and megakaryocytic 
173 
 
cells within a regulatory element upstream of the GATA-1 gene. Development 126, 
2799-2811. 
Wadman, I.A., Osada, H., Grutz, G.G., Agulnick, A.D., Westphal, H., Forster, A., and 
Rabbitts, T.H. (1997). The LIM-only protein Lmo2 is a bridging molecule assembling an 
erythroid DNA-binding complex which includes the TAL1, E47, GATA-1 and Lbd1/NLI 
proteins. EMBO J 16, 3145-3157. 
Wang, H., Zhang, Y., Cheng, Y., Zhou, Y., King, D.C., Taylor, J., Chiaromonte, F., 
Kasturi, J., Petrykowska, H., Gibb, B., et al. (2006). Experimental validation of predicted 
mammalian erythroid cis-regulatory modules. Genome Res 16, 1480-1492. 
Wechsler, J., Greene, M., McDevitt, M.A., Anastasi, J., Karp, J.E., Le Beau, M.M., and 
Crispino, J.D. (2002). Acquired mutations in GATA1 in the megakaryoblastic leukemia 
of Down syndrome. Nat Genet 32, 148-152. 
Weiss, M.J., Keller, G., and Orkin, S.H. (1994). Novel insights into erythroid 
development revealed through in vitro differentiation of GATA-1_ embryonic stem cells. 
Genes Dev 8, 1184-1197. 
Weiss, M.J., and Orkin, S.H. (1995). GATA transcription factors: key regulators of 
hematopoiesis. Exp Hemtol 23, 99-107. 
Weiss, M.J., Yu, C., and Orkin, S.H. (1997). Erythroid-cell-specific properities of 
transcription factor GATA-1 revealed  by phenotypic rescue of a gene targeted cell line. 
Mol Cell Biol 17, 1642-1651. 
Welch, J.J., Watts, J.A., Vakoc, C.R., Yao, Y., Wang, H., Hardison, R.C., Blobel, G.A., 
Chodosh, L.A., and Weiss, M.J. (2004). Global regulation of erythroid gene expression 
by transcription factor GATA-1. Blood 104, 3136-3147. 
Williams, A., Spilianakis, C.G., and Flavell, R.A. (2010). Interchromosomal association 
and gene regulation in trans. Trends Genet 26, 188-197. 
Williams, C.J., Naito, T., Arco, P.G., Seavitt, J.R., Cashman, S.M., De Souza, B., Qi, X., 
Keables, P., Von Andrian, U.H., and Georgopoulos, K. (2004). The chromatin remodeler 
Mi-2beta is required for CD4 expression and T cell development. Immunity 20, 719-733. 
Wozniak, R.J., Keles, S., Lugus, J.J., Young, K.H., Boyer, M.E., Tran, T.M., Choi, K., 
and Bresnick, E.H. (2008). Molecular Hallmarks of Endogenous Chromatin Complexes 
Containing Master Regulators of Hematopoiesis. Mol Cell Biol. 
174 
 
Wu, W., Cheng, Y., Keller, C.A., Ernst, J., Kumar, S.A., Mishra, T., Morrissey, C., 
Dorman, C.M., Chen, K.B., Drautz, D., et al. (2011). Dynamics of the epigenetic 
landscape during erythroid differentiation after GATA1 restoration. Genome Res. 
Xu, Z., Huang, S., Chang, L.S., Agulnick, A.D., and Brandt, S.J. (2003). Identification of 
a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in 
erythroid gene expression and differentiation. Mol Cell Biol 23, 7585-7599. 
Xu, Z., Meng, X., Cai, Y., Liang, H., Nagarajan, L., and Brandt, S.J. (2007). Single-
stranded DNA-binding proteins regulate the abundance of LIM domain and LIM domain-
binding proteins. Genes Dev 21, 942-955. 
Yoon, Y.S., Jeong, S., Rong, Q., Park, K.Y., Chung, J.H., and Pfeifer, K. (2007). 
Analysis of the H19ICR insulator. Mol Cell Biol 27, 3499-3510. 
Zhang, J., Socolovsky, M., Gross, A.W., and Lodish, H.F. (2003). Role of Ras signaling 
in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow 
cytometry-based novel culture system. Blood 102, 3938-3946. 
Zhang, P., Behre, G., Pan, J., Iwama, A., Wara-Aswapati, N., Radomska, H.S., Auron, 
P.E., Tenen, D.G., and Sun, Z. (1999). Negative cross-talk between hematopoietic 
regulators: GATA proteins repress PU.1. Proc Natl Acad Sci U S A 96, 8705-8710. 
Zheng, M., Barrera, L.O., Ren, B., and Wu, Y.N. (2007). ChIP-chip: data, model, and 
analysis. Biometrics 63, 787-796. 
Zon, L.I., Gurish, M.F., Stevens, R.L., Mather, C., Reynolds, D.S., Austen, K.F., and 
Orkin, S.H. (1991). GATA-binding transcription factors in mast cells regulate the 
promoter of the mast cell carboxypeptidase A gene. J Biol Chem 266, 22948-22953. 
 
 
